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ABSTRACT 
 
BODIPY, also known as “porphyrin’s little sister,” belongs to a class of fluorescent dyes. 
It contains a dipyrromethene π-system with a disubstituted boron atom. The basic 4,4-difluoro-4-
bora-3a,4a-diaza-s-indacene (BODIPY) is known for its numerous useful applications in the fields 
of biology and materials. Modification of this well-known fluorophore has been shown to change 
its photophysical and chemical properties. There has been great interest in the modification at the 
boron center in recent years for synthesizing new dyads and cascade-type dyes. This work focuses 
on functionalization at the boron center with carbon and oxygen nucleophiles for further 
investigation as bioimaging agents.  
Chapter 1 of this dissertation describes an overview of BODIPYs including synthetic 
development, post-synthetic functionalization strategies, and how BODIPYs can be involved in 
many biological applications.  
 Chapter 2 discusses the synthesis, characterization, and computational studies of 4,4-
dialkoxy BODIPY and its derivatives. Preliminary studies with various Lewis acids and alcohols 
will be investigated and discussed. In collaboration with Dr. Petia Bobadova-Parvanova of 
Rockhurst University, the photophysical properties were studied using computational analysis. 
The structural, spectroscopic and fluorescence properties of all the synthesized BODIPYs will be 
studied and be compared. 
 Chapter 3 presents the synthesis and characterization of 4,4’-dicyano-BODIPYs. A novel 
route for preparation of 4,4’-difunctionalized BODIPYs bearing phenyl and various substituents 
at the boron center was developed. These compounds were synthesized in a three step one-pot 
reaction between dipyrromethenes and dichlorophenylborane, followed by replacement of chloride 
ix 
 
with fluoride and various carbon- and oxygen-centered nucleophiles. These BODIPYs’ structural, 
spectroscopic, and fluorescence properties are reported and discussed. 
 Chapter 4 represents the investigation of six 1,2,3-triazole-BODIPYs under the Cu(I)-
catalyzed Huisgen cycloaddition reaction conditions. A novel BODIPY bearing a chiral moiety 
was synthesized using method C and X-ray crystallography confirmed its identity.  
 Chapter 5 reports the synthesis of chloroalcohol compounds via triphosgene-triethylamine 
activation. An asymmetric SN1 reaction was investigated through the use of an oxazolidinone. 
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CHAPTER 1: INTRODUCTION 
 
1.1 Structure of BODIPY® Dyes  
 In the last two decades, biomedical scientists have continued to search for new organic 
dyes for medicinal therapies in order to visualize intracellular processes.1 New fluorophores that 
are capable of being excited and emitting within the “biological window” of 600-800 nm became 
an attractive and versatile tool as theranostic agents for various cancer treatments. Compounds in 
this red or near-infrared (NIR) region of the spectrum typically provided minimal interference 
from the endogenous chromophores, reduced light scattering, and prevented damage to cells and 
tissues.2-5 The boron dipyrromethene (designated BODIPY) family of dyes have the desired 
framework for facile modification, making them tunable probes and sensors for many biological 
applications, in comparison to other alternative nonradioactive fluorophores, such as rhodamines, 
cyanines, and fluorescein (Figure 1.1).  
 
 
Figure 1.1: Structural framework of selected common fluorophores. 
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4,4-Difluoro-4-bora-3a,4a-diaza-s-indacene, or BODIPY, is often recognized as 
“porphyrin’s little sister”.6 This family of fluorophores consists of a dipyrromethene framework 
complexed to a disubstituted boron unit. The dipyrromethene structure consists of two pyrrole 
units linked via an interpyrrolic methine bridge. The complexation system of dipyrromethene with 
a BF2 unit provides a “constrained” conjugated system, giving planarity to the BODIPY 
conjugated π-system.7 The advantage of complexation with the BF2 moiety is to increase the 
rigidity of the tricyclic system and to prevent cis/trans isomerization of the dipyrromethene core. 
This restricted conformation allows for π-electron delocalization along the carbon-nitrogen 
backbone, which provides high fluorescence quantum yields.8 The overall charge of BODIPY is 
neutral due to the zwitterionic species involving the boron and nitrogen atoms.  
The systematic naming for the dipyrromethene and BODIPY cores are shown in Figure 
1.2. In the BODIPY, positions 3 and 5 are denoted as alpha (α) while positions 1, 2, 6, and 7 are 
referred as beta (β) similar to the pyrrolic system.9 The meso-position is located at the 8-carbon, 
while positions 4 and 4’ are the two fluoride atoms connected to the boron center. 
 
Figure 1.2: Numbering system for dipyrrin and BODIPY frameworks. 
A single crystal structure analysis of the BODIPY core shows the three fused rings 
framework which consisting of a central six-membered ring and two five-membered pyrrolic rings 
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with a π-electron delocalization backbone (Figure 1.3).10 The presence of B-N bonds interrupts the 
π-conjugation which shows that the BF2 moiety does not play a significance role in extending the 
backbone delocalization. The approximate tetrahedral geometry of the boron atom (BF2N2) can be 
confirmed by the N1-B1-N2 and F1-B1-F2 bond angles.
11 The approximate bond length of N1-C4 
shows a single bond, while N1-C3 indicates double bond characteristic. BODIPY was initially 
thought to resemble a monomethine cyanine dye by having 6π electrons equally delocalized over 
five atoms but found to be isoelectronic with heptamine cyanine having 12π distributed over eleven 
atoms.12 
 
Figure 1.3: The X-ray crystal structure of unsubstituted BODIPY with atoms labeled and 50% 
probability displacement ellipsoids.10 
 
 The monoclinic unit cell of the BODIPY comprises of four molecules arranged head-to-
tail geometry, which utilities the π-π interactions between adjacent hydrophobic fragments and 
avoids the variation from the fluorine dipole moments.13 Little differences in heteroatoms dipole 
moment of BODIPY core provide modification at various positions via electrophilic and 
nucleophilic additions. The functionalization at the substituent-free positions unlocks new tunable 
routes to numerous novel BODIPY derivatives.14 
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BODIPY and its derivatives show remarkable photophysical characteristics. The 
characteristics are intense absorption and emission in the visible region (λmax ≥ 450 nm), high 
fluorescence quantum yields, high molar absorption coefficients (around 40,000 to 80,000 M-1 cm-
1), and relatively small Stokes shifts (~15 nm).6,8 Various properties of BODIPYs include excellent 
photophysical stability, thermal- and photochemical stability in solution and solid states, high 
solubility in many organic solvents, and resistance to changes in pH and solvent polarity.15-17 
The typically strong intense absorption band of the BODIPY fluorophore in the visible 
region comes from the S0-S1 (π-π*) transition containing a shoulder of high energy around 480 nm 
from the  0-1 vibrational transition, while a broad weaker band around 350 nm is assigned to the 
S0-S2 (π-π*) transition.12,18 Excitation of an electron in either the S1 or S2 states, an equally narrow 
band from the absorption and emission spectra is perceived from the S1 state. BODIPYs that have 
emission around 500-590 nm typically have a yellow to green color. Small Stokes shifts are often 
observed in many BODIPY compounds, which indicate that the S0-S1 transition and vibrational 
relaxation make no significant changes in the core structure.19 
Addition of functional groups to the carbon atoms at the α-, β-, and meso-positions as well 
as the boron atom of BODIPY can alter its photophysical properties. The BODIPY absorption 
band can be shifted into the red or near-IR region by increasing the degree of π-electron 
delocalization. Having functional groups that are electron-withdrawing or -donating on the 
BODIPY core as well as intramolecular rotation can significantly affect the absorption and 
emission properties.20 
Investigation of BODIPY’s functionalization will further research development in the 
synthesis of new fluorophores for multi-purpose applications. By altering the spectroscopic 
properties and functionalities of BODIPY dyes, there are boundless possibilities for designing 
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novel, challenging and versatile fluorescent compounds. Throughout this Dissertation, various 
synthetic methodologies and investigation techniques will be described. 
1.2 Synthetic Methodologies 
 
In 1968, Treibs and Kreuzer were the first to synthesize a BODIPY by mixing 2,4-
dimethylpyrrole, acetic anhydride, and BF3·OEt2, and found this robust class of compound could 
have potential application as tunable laser dyes.21 This fluorophore was not fully explored until 
the late 1980s, where BODIPYs were found to be useful for biological applications, such as 
cellular imaging and probe sensors. For example, Wories and coworkers22 reported the first water-
soluble BODIPYs for cellular visualization. Since the mid-1990s, publications and patents 
reported on BODIPYs have increased tremendously. Extensive modifications to the BODIPY 
framework have led to many BODIPY derivatives with numerous applications: biomolecular 
imaging,23-26 photosensitizers,27-30 fluorescent switches,31-34 chemosensors,35-40 
electroluminescence devices, laser dyes,41-43 drug delivery agents,28,44 and in photodynamic 
therapy.45-46  
1.2.1 Synthesis of the BODIPY Core 
There are many routes toward the synthesis of BODIPY using well-known pyrrole 
chemistry. First, a highly reactive electrophilic ketopyrrole and readily nucleophilic 2-
unsubstituted-pyrrole afford the corresponding dipyrromethene compounds. Using a non-
nucleophilic base, either a secondary or tertiary amine, followed by complexation using boron 
trifluoride etherate (BF3·OEt2) gives the desired BODIPY in moderate yields. Even though there 
are numerous reports of BODIPY syntheses in the literature, the fully unsubstituted BODIPY 1 
remained a challenge due to the compound’s reactivity. However, three independent research 
groups have reported successful routes to the fully unsubstituted BODIPY 1. The first method was 
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reported by Bruce and coworkers (Scheme 1.1, Method A),10 where dipyrromethane 3 was 
oxidized to the corresponding dipyrromethene by using DDQ or chloranil as the oxidizing agent. 
To avoid undesired side products, the oxidation step was carried out under inert conditions and at 
low temperature (-78 °C). The complexation step with BF3·OEt2 was performed in situ using DBU 
as an additive to yield the desired compound in 5-10% yield. This unsubstituted compound 1 was 
characterized by 1H-, 13C-, 11B-, and 19F-NMR spectroscopy and its structure was confirmed by 
single crystal X-ray analysis.     
 
 
 
Scheme 1.1: Methods for syntheses of unsubstituted BODIPY 1. 
 
Another approach to the unsubstituted BODIPY 1 was through a classic acid-catalyzed 
condensation method between pyrrole-2-carbaldehyde 5 and unsubstituted pyrrole 4, followed by 
complexation with BF3·OEt2 in the presence of a base to afford the desired product 1 in 8% yield 
(Scheme 1.1, Method B).14 However, the unsubstituted BODIPY can be synthesized in 98% yield 
from the most efficient method developed by Pena-Cabrera and coworkers,13 where a meso-
thiomethyl BODIPY 1 was treated with trimethylsilane under mild conditions using copper(I) 
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thienyl-2-carboxylate (CuTc) and palladium in THF for 45 min at reflux temperature (Scheme 1.1, 
Method C). No reaction was observed in the absence of CuTc or palladium. The impressive 
characteristic of BODIPY 1 is a high quantum yield (93%) in non-polar and polar solvents. 
1.2.2 Synthesis of Symmetric BODIPY Dyes 
 
 8-Substituted symmetrical BODIPYs can by synthesized by acid-catalyzed condensation 
between acid chlorides, aldehydes, or anhydrides with α-free pyrroles to give the corresponding 
dipyrromethene (or dipyrromethane in the case of aldehyde). Polymerization of pyrrole typically 
occurs when both α-positions of the pyrroles are unsubstituted. To avoid this polymerization, only 
one α-position (C2) is usually unsubstituted. The most popular route consists of a “one-pot three 
step” reaction and has become the most efficient way to synthesize a wide range of meso-
substituted BODIPYs with the desired appendages (Scheme 1.2).  
 Symmetrical BODIPY syntheses typically involve self-condensation between two 
equivalents of an α-free pyrrole with an aryl aldehyde to give a dipyrromethane (Scheme 1.2). A 
recent report shows that aldehydes and pyrroles can also react under neat conditions (no solvent 
required) to afford dipyrromethanes.47 The dipyrromethanes are subsequently oxidized to give 
dipyrromethenes which then undergo complexation with BF3·OEt2. Alternatively, another method 
to synthesize BODIPYs requires treating the same two units of an α-free pyrrole with acyl chloride 
to directly give dipyrromethene. The advantage of this method is that no oxidation step is 
necessary, which usually increases the reaction yields and eases purification. Similar to acyl 
chlorides, anhydrides also react with an α-free pyrrole to give the corresponding dipyrromethene. 
Although introducing aromatic groups onto the BODIPY core is expected to extend the π-
conjugation delocalization, the nearly perpendicular geometry of the groups at the meso-position 
prevent significant interaction of the two π-systems, but increases BODIPY stability.6,11,16,48  
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Scheme 1.2: General procedures for symmetrical BODIPY synthesis via condensation. 
 
The approach using a cyclic anhydride provides the corresponding BODIPY bearing a 
terminal carboxylic acid, which are receptive to coupling to biological molecules such as proteins, 
DNA and lipids.15,49 meso-Unsubstituted BODIPY can generally be prepared from pyrrole-2-
carbaldehyde and an α-free pyrrole in an acid-catalyzed condensation reaction. An acid catalyst, 
such as p-toluenesulfonic acid or Montmorillonite clay, is often used in order to generate the 
pyrrole carbinyl cation which reacts with the α-free pyrrole to give dipyrromethane.50-51 Symmetric 
and unsymmetric BODIPYs can also be synthesized from dipyrroketones.52 
1.2.3 Synthesis of Unsymmetrical BODIPY Dyes 
 
 The approach to synthesize unsymmetrical BODIPYs relies on the use of two different 
pyrroles, for example by reacting the ketopyrrole (carbonyl-containing pyrrole) with a different α-
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free pyrrole via Lewis acid mediated condensation (Scheme 1.3).53-54 The ketopyrrole precursor 
fragment can be synthesized from an α-free pyrrole and Grignard reagents and an acid 
chloride.53,55-56 The use of electron-rich and electron-deficient pyrroles determines the percent 
yields of the desired BODIPY product. Electron-rich pyrrole usually gives a high yield while 
electron-poor pyrrole usually gives a low yield due to self-condensation which results in the 
undesired symmetrical product. The dipyrromethene salt then reacts with BF3·OEt2 in the presence 
of a base to give a BODIPY scaffold with two different pyrrolic units for further functionalization. 
In addition, Zhao and coworkers57 recently reported that unsymmetric BODIPYs can be 
synthesized from dipyrroketone precursors. 
1.3 Derivatization of the BODIPY Core 
 
 Although BODIPYs have many advantages, some of their limitations are the typical 
absorption and emission wavelength maxima around 500 nm, relatively small Stokes shifts, poor 
solubility in an aqueous environment, and inability to directly conjugate to biomolecules. To 
overcome these drawbacks, functional groups can be attached directly to the BODIPY core via the 
use of a substituted pyrrolic precursor, substituted aldehyde, or by post-functionalization of the 
BODIPY dyes. The tunable properties of BODIPY allow the synthesis of derivatives that absorb 
and emit in the span over the desired wavelength in the visible and NIR ranges. 
Many research groups (including Vicente,48,58-59 Burgess,60 Ziessel,44 Boens,1,61 Nagano,30 
Akkaya,62 O’Shea,63 Rurack and Daub,64 and Carreira65) are currently exploring new methods to 
optimize the photophysical properties of these dyes while retaining their stabilities. BODIPY dyes 
can be derived from various approaches: i) nucleophilic substitutions or additions of styryl or 
alkynyl groups at the 3,5-positions, ii) electrophilic substitutions at the 2,6-positions, iii) cross-
coupling reactions with palladium(0) on halogenated BODIPYs, iv) nucleophilic substitution at 
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the boron center. Metal-mediated cross-coupling reactions provide one of the most convenient 
methods to incorporate functionalities directly into the BODIPY core with halogens at the 
2,3,5,6,8-positions. Typical palladium-mediated cross-coupling reactions can be accomplished 
through the Suzuki,66-68 Sonagashira,59,66,69 Heck,70-71 and Stille72 methods. 
 
Scheme 1.3: General procedure for unsymmetrical BODIPY via ketopyrrole and dipyrroketone. 
1.3.1 Functionalization at the 8-position 
 The meso-position (or 8-position) is the easiest position to introduce various “handles” on 
the BODIPY from the initial condensation step (examples are shown in Figure 1.4). This position 
can be functionalized with a variety of aromatic groups via acid-catalyzed condensation, using 
either an aldehyde or acyl chloride.73 The introduction of useful groups on the 8-position for 
specialized purposes, such as incorporation of metal ion binding ligands,1,6,74 functionality for 
donor-acceptor cassettes,75-77 water-soluble groups,5,17 and biomolecules78 for biological 
applications, including as pH probes and chemical sensors. For example, probes with aliphatic 
ester 8-aryl BODIPYs are being used to investigate dynamic effects in membranes (Figure 1.4, 
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structure 9).79 Boens and coworkers1,61,80 studied the effect of electron-donating and electron-
withdrawing groups at the meso-position. BODIPYs with substituents at the 1,7-positions or bulky 
substituents on the 8-aryl group show restricted rotation of the meso-aryl group, which in turn 
increases the fluorescence quantum yields (Figure 1.4, structure 9). In addition, replacing the meso-
aryl group with a trifluoromethyl unit also increases quantum yields due to the reduction in the 
nonradiative decay through rotation.1,15  
 Substitution of the carbon atom at the 8-position with a nitrogen atom generates a new class 
of fluorophore called “aza-BODIPYs,” which were not reported until 1994 (Figure 1.4, structure 
11). 81-84 The important characteristics of aza-BODIPYs are sharp absorption and emission 
wavelengths in the NIR (650-850 nm) range, high molar extinction coefficients, and moderate to 
good fluorescence quantum yields.85 The meso-nitrogen with the lone pair can dramatically 
decrease the HOMO-LUMO energy gap through stabilization,6 which induces a large red-shift in 
the absorption and fluorescence emission maxima (~100 nm). These aza-dipyrromethenes can be 
prepared by condensation between nitrosopyrrole and an α-free pyrrole or Michael addition 
product (reaction from chalcones and nitromethane) with formamide.81-83 This class of fluorophore 
has found its usefulness in various applications: as photosensitizers for PDT,72,86 NIR-emitting 
chemosensors, bioimaging probes,32,65,87 and fluorescent biological labels.88-89  
1.3.2 Modification at the 1,3,5,7-Positions 
 
 The photoelectronic properties of the BODIPY core can be fine-tuned by varying the 
subsitutents on the carbon framework. Analogous to other heteroaromatic systems, the methyl 
groups at the 1, 3, 5, and 7-positions are the most nucleophilic sites. The 3,5-methyl groups are 
considered relatively acidic due to being next to the pyrrolic nitrogen atom. In order to extend the 
π-conjugation, the methyl groups can be deprotonated and undergo condensation with electron-
12 
 
rich aromatic aldehydes through Knoevenagel reactions to generate trans-stryryl groups (Figure 
1.5). 
 
 
Figure 1.4: Selected examples of 8-substituted BODIPY structures: 6,80 7,79 8,90 9,79 10,80 11,91 
12,92 and 13.93 
 
Some groups, such as dimethylamino on the 3,5-aryls induce high quantum yields only in 
the protonated form by disfavoring intramolecular charge transfer (ICT) in the excited state. Post-
functionalization using various aryl-aldehyde groups provides a methodology for introducing 
“handle” through a simple modification, producing long-wavelength absorbing and emitting 
BODIPYs. Addition of halogens such as chloride or iodide at the 3,5-positions allows BODIPY to 
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become reactive toward nucleophilic aromatic substitutions (SNAr) and palladium-catalyzed cross-
coupling. 
 
 
Figure 1.5: Selected examples of 3,5-substituted BODIPY structures: 14,94 15,95 16,96 17,97 and 
18.97 
 
While carbon- and oxygen-based nucleophiles produce BODIPYs with largely unchanged 
λmax in the absorbance and emission spectral properties, nitrogen and sulfur with various 
substituents on the 3,5-positions have been demonstrated to red-shift the emission spectra. All 
these nucleophiles provided additional functionalities and extended conjugation.15 Incorporation 
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of ethynyl, aryl, and styryl groups can be accomplished through palladium-mediated cross-
coupling reactions, providing fluorescent probes for a variety of applications.  
1.3.3 Functionalization at the 2,6-Positions 
 
 The reactivity of the BODIPY core can be predicted based on the resonance structure, as 
shown in Figure 1.6, where positions 2 and 6 contain the least positive charge. For this reason, 
they undergo electrophilic aromatic substitution. Different functional groups have been introduced 
at the 2- and 6-positions via halogenation,30,98 nitration,99-100 sulfonation,15,49,101,22 and 
formylation.73 Particularly, the introduction of sulfonate groups increase the BODIPY’s water 
solubility properties for biological purposes (Figure 1.7, structure 19). Even though sulfonate 
groups do not make a significance change in the absorption and emission spectra, BODIPYs 
containing these groups are strongly fluorescent in polar solvents and more stable than their 
precursors. On the other hand, addition of nitro groups at the 2,6-positions reduces the BODIPY 
fluorescence quantum yields (Figure 1.7, structure 21).99 
 
Figure 1.6: Resonance structures of positive charge delocalization through BODIPY core. 
Addition of halogen groups (bromide or iodide) at the 2- and 6-positions can cause a 
significant red shift in the absorption and fluorescence emission maxima of BODIPYs but quench 
the quantum yield due to the heavy atom effect16 (Figure 1.7, structure 20). Furthermore, post-
modification on these 2,6-halogenated BODIPYs typically involves through palladium-mediated 
cross-couplings, such as Suzuki,102 Stille,71 Sonagashira,103 and Heck reactions.104  
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Figure 1.7: Selected examples of 2,6-functionalized BODIPY structures: 19,49 20,30 and 21.99 
 
1.3.4 Modifications at the Boron Center 
 
Boron-substituted BODIPYs have been of increased interest in the past few years. Many 
researches have investigated the increase in stability of BODIPYs, their redox properties, Stokes 
shifts, and development of donor-acceptor systems. There are many demonstrations using carbon 
nucleophiles to replace the fluoride atoms (Figure 1.8). The first example of 4,4-dialkyl-BODIPYs 
were synthesized via the reaction of dipyrromethenes with boron-alkyl compounds.105 
Alternatively, Ziessel and coworkers34,101,106-111 investigated the synthesis of 4,4-dialkyl-, 4,4-
diaryl-, and 4,4-diethynyl-BODIPYs by Grignard and organolithium methods. These 
modifications at the boron center can be used for synthesizing new BODIPY-based dyads and 
cascade-type dyes. These B-aryl BODIPYs have larger Stokes shifts compared to their BF2 parents. 
Cyano groups can replace the fluoride atoms using trimethylsilyl cyanide in high yields in the 
presence of a Lewis acid.15 Cyano substituents on the boron center enhance the fluorescence 
quantum yields and stability of BODIPYs. Recently, Ankush and coworkers112 reported a new 
method to introduce ethyl groups directly onto the boron center in high yields via treating BODIPY 
with Et2AlCl (Figure 1.8, structure 26). They also compared their method to the Grignard method 
and reported that their method is more efficient. 
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Figure 1.8: Selected examples of 4,4-dialky-, 4,4-diaryl-, and 4,4-diethynyl-BODIPYs: 22,105 
23,106 24,108 25,15 and 26.112 
 
 While carbon-substituted BODIPYs are used for increasing the Stokes shift and stability, 
oxygen groups on the boron atom increase the BODIPY aqueous solubility. In 1999, Burgess and 
coworkers demonstrated the first oxygen substitution on the boron center by intramolecular 
cyclization of 3,5-dihydroxy-ortho phenyl.113 Since then, a series of 4,4-dialkoxy- and diaryloxy-
BODIPYs were synthesized either by refluxing with sodium alkoxide114 in alcohol or with alcohols 
mediated by Lewis acid53 (Figure 1.9, 28 and 29). On the other hand, Courtis and coworkers115 
focused on the synthesis of mono-alkoxy BODIPYs to be used for bioimaging application.  
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Figure 1.9: Selected examples of 4,4-dialkoxy-BODIPYs: 27,113 28,114 29,53 and 30.115 
1.3.5 Ring Fusion to the BODIPY core 
In the last few decades, the development of compounds emitting in the red and NIR ranges 
became a focus of research for bioanalytical and optoelectrical imaging applications. Fluorescent 
organic dyes in the red and near-IR regions are important biomarker tools in DNA sequencing, gel 
electrophoresis, in vivo imaging, and tissue perfusion.101 In order to reach this longer wavelength 
(lower energy), extended conjugation via ring fusion became an efficient way to move forward.116-
118 Different approaches were applied for formation of the ring such as aryl-fused pyrroles, 2-
acetylphenols,111 and retro-Diels-Alder (rDA) syntheses of norbornane pyrroles (Figure 1.10).119-
120 Recently, Uppal and coworkers121 demonstrated aromatization of bicyclohexanyl BODIPY 
using DDQ as the oxidant agent. Ring fusion provides a red-shifted, sharper fluorescence emission 
and high fluorescence quantum yields due to the rigidification, which inhibits the rotation of the 
aromatic groups.  
1.4 Applications of BODIPY Dyes 
 There is a growing demand for new organic fluorophores that are capable of improving the 
luminescence, electrochemical, and fluorescence properties in all aspects of life sciences. BODIPY 
dyes have the desired framework and photophysical properties to meet those demands. There are 
many attractive applications that BODIPYs are involved in, including tunable dyes, environmental 
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fluorescent indicators, enzyme substrates, fluorescent pH probes, bioimaging, electroluminescent 
devices, donor-acceptor energy transfer cassettes, fluorescent chemosensors, light-emitting and 
ion signaling devices, and photosensitizer agents for photodynamic therapy (PDT) of cancer 
(Figure 1.11).  
 
 
Figure 1.10: Selected examples of 1,3,5,7-BODIPY structures: 32,122 33,123 34.122 
1.4.1 Biological Applications 
 
BODIPY compounds, as fluorophores, have become versatile visualization dyes in recent 
years due to the capability for biological tagging to various desired analytes (proton and metal-
bind ions) and to enzymes, polypeptides, proteins, and nucleic acids in DNA. For example, many 
organic fluorescent dyes have been used for in vivo imaging and for binding with a non-radioactive 
ligand in biological intracellular processes.101 Due to the recent advancement in bioanalytical and 
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optoelectrical imaging, rising effort for development of fluorescence dyes in the red and NIR 
region (600-900 nm) has become more important than ever for application in molecular imaging.  
 
Figure 1.11: Several biological applications of molecular fluorescent probes.124 Reprint with 
permission from [124] Copyright (2008) American Chemical Society. 
 
Fluorophores excited and emitting in the red/NIR region of the spectrum provided many 
advantages. One advantage is that fluorescent dyes in this region can afford significant light 
penetration and elimination of light scattering, typically caused by endogenous chromophores 
found in the biological issues. For example, many endogenous chromophores such as nucleic 
acids, aromatic amino acids, oxy- and deoxy-hemoglobin and chemicals in fluorescene microscopy 
faced a phenomenon known as tissue autofluorescence. These chromophores usually absorb and 
emit at short wavelengths, in turn resulting in only minimal penetration depth (Figure 1.12). By 
introducing fluorophores that can absorb and emit at longer wavelengths, a majority of background 
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noise can be eliminated, minimizing the autofluorescence which causes problems in the detection 
and quantification of biological signals.8,59 Another advantage is the absorption coefficient, which 
for NIR dyes is drastically lower than other shorter wavelength dyes. As a result, it helps deeper 
penetration in tissues up to several centimeters.4 
The low background noise and light scattering in the NIR region are significantly reduced 
based on the equation describing that the scattering intensity is proportional to the inverse fourth 
power of the wavelength. This also results in high signal to noise ratio (SNR) thus affording highly 
sensitivity in detection. In addition, long wavelength light also provides low interference in the 
Raman scattering and prevents degradation of the sample. There are numerous features for an ideal 
NIR absorber to be constructed as a fluorescent probe and indicator: photo- and chemo-stability, 
high molar absorption coefficients, high fluorescence quantum yields, high solubility in aqueous 
media, and resistance to self-quenching.1 
 
Figure 1.12: Mouse’s vital organs and BODIPY fluids autofluorescence with different 
excitation/emission filters.125 a) no filter; b) blue/green (460-500nm/505-560nm) filter; c) 
green/red (525-555nm/590-650 nm) filter; d) NIR (725-775nm/790-830nm) filter. GB = gall 
bladder, SI = small intestine, BL = bladder. Reprinted with permission from [125] Copyright 
(2002) Elsevier. 
21 
 
In addition to BODIPYs, other organic dyes such as porphyrin, phthalocyanine, cyanine, 
fluorescein, and squaraine with high photostability and long wavelength absorption and emission 
maxima have been extensively investigated and have made great contributions to the science field 
in the last several decades (Table 1.1). However, these fluorophore dyes have a few limitations, 
including low fluorescence quantum yields, poor photo- and chemo-stabilities, and also low 
solubility in aqueous media. To date, only indocyanine green (depited as IDG in Table 1.1) is FDA 
and EMA-approved as a NIR bioimaging dye to be used for biomedical purposes due to its 
nontoxic and minimal side effects, as an angiographic contrast agent. However, this dye has a low 
quantum yield, similar to its parent cyanine dye, and lacks functionalization for additional 
conjugation to biomolecules.126 On the other hand, one emerging promising NIR-fluorescent 
imaging dye is IR Dye®800CW (Table 1.1). This dye has an activated CO2H group that has the 
ability to react with biomolecules.127 This dye is currently in pre-clinical trials. 
 While many other organic fluorophore dyes have shortcomings, BODIPY dyes process a 
number of interesting characteristics that make them suitable for applications as indicators, probe 
sensors, biolabels and stains. Thus, distinct features such as sharp, narrow absorption and emission 
spectra (for multicolor imaging), not prone to solvent polarity, high molar absorption coefficients, 
tunability, solubility, and stability make BODIPY the potential fluorophore.   
Table 1.1: Commercially available NIR compounds for biomolecular conjugation with absorption 
and emission wavelength in the NIR region. 
 
Dye name 
(Manufacturer) 
Chemical Structure 
Absorption 
Max (nm) 
Emission 
Max (nm) 
ICG (Sigma 
Aldrich) 
 
800 810 
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(Table 1.1 continued) 
Dye name 
(Manufacturer) 
Chemical Structure 
Absorption 
Max (nm) 
Emission 
Max (nm) 
IRDye 800CW 
NHS Ester (LI-
COR Biosciences) 
 
778 794 
Dye 783 NHS 
Ester (Dyomics 
GmbH.) 
 
783 800 
La Jolla Blue 
(Hyperion, Inc.) 
 
680 700 
BODIPY 
630/650-X 
Succinimidyl 
Ester (Life 
Technologies Inc.) 
 
625 640 
BODIPY 
650/665-X 
Succinimidyl 
Ester (Life 
Technologies, Inc.) 
 
646 660 
 
1.4.2 Cellular Stains 
 
 In the microbial world, cellular visualization is an important tool that can provide 
significant information in studying the physiological and pathological processes of organelles. 
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Cells that are inked with specific stains have the ability to permeate through cell membranes and 
allow visibility under the lens of a high powered microscope. Numerous BODIPYs conjugated to 
various biomolecules have been used for in vivo and in vitro visualization of intracellular 
processes. These are commercially available BODIPYs from Life Technologies, Inc, being used 
for imaging of the endoplasmic reticulum and Golgi apparatus (Table 1.1).  
1.4.3 Environmental Indicators 
 
 In the last few years, there has been a wide range of development fluorescent chemosensors 
to use as probes for intracellular pH and metal ions probes (Figure 1.13). The design factors for 
selective and sensitive sensors are: i) fluorophore-spacer-chelator or ii) intrinsic fluorescent 
chelators. The two processes that contribute to the fluorophore-spacer-chelator are photoinduced 
electron transfer (PET) and photoinduced intramolecular charge transfer (ICT). The fluorescent 
probes are designed based on the idea that the fluorophore and chelator are separated by a short 
aliphatic spacer in order to diminish the electronic interaction between the fluorophore and the 
chelator. For example, a chelator on the meso-aryl substituent does not interact with the 
fluorophore due to its perpendicular orientation geometry. PET is the process where the electron-
transfer from the electron-donor chelator in the HOMO to the lower HOMO level of the electron-
acceptor fluorophore. ICT is the process of internal charge transfer (upon photo-excitation) 
between an electron-withdrawing group that is conjugated to an electron-donating group of the 
fluorophore.  
1.4.4 Enzyme Substrates 
 There are strategies for investigating enzymatic activity in live cells. Numerous systems 
and conjugates have been developed consisting of a BODIPY fluorescent dye conjugated to fatty 
acids, phospholipids, receptor ligands, and cholesterol for investigating enzymatic activities in 
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fluorometric assays. The BODIPY fluorophore has been investigated in fluorometric assays to 
study proteases using a useful tool, fluorescence resonance energy transfer (FRET). When the 
fluorescent dye binds to protease, it results in a no fluorescence due to the “self-quenching” effect. 
In the presence of the protease enzyme, it hydrolyzes the conjugated fragments and the 
fluorescence is restored due to the disruption from intramolecular FRET quenching. The enzymatic 
cleavage is correlated to the simple on/off fluorescent phenomenon, which in turn results in 
providing the simple and continuum assays for various proteases. 
 
Figure 1.13: Selected examples of meso-functionalized BODIPYs as pH and metal ions probes. 
 Jones and coworkers128 in 1997 reported two BODIPYs conjugated with casein to study 
protease enzymatic activity. Recently in 2009, Saba and coworkers129 demonstrated that BODIPY 
conjugated to a sphingosine-1-phosphate lyase (SPL) substrate is able to replace the standard 
radioactive SPL assays (Figure 1.14, 38 and 39). The BODIPY-labeled SPL provided an efficient 
way to measure SPL activity in cell tissues.  
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Figure 1.14: BODIPY-S1P 38 and NBD-S1P 39 containing sphingosine.129 
 
1.4.5 Biological Labels 
 
 Biological labeling has become one of the most common methods used for bioanalytical 
techniques, particularly in using fluorescent compounds with excellent electronic properties in the 
UV to the NIR regions. The search for new fluorescent dyes that are capable of easing the way to 
visualize the function of enzymes, proteins, DNA, and other biomolecules in intracellular 
processes is undergoing rapid development. BODIPY dyes are a promising target for fluorescent 
probes and labels due to their remarkable photophysical properties and low cellular toxicities.59 
The small framework size and low molecular weight of BODIPY makes it a good candidate to 
increase cell permeability for intracellular studies without drastic changes in their biological 
functions. There are many reports indicating that BODIPYs are used as fluorescent labels to 
conjugate to specific biological components, such as polylipids, various amino acids, DNA and 
RNA, dextran, polystyrene micropheres, and proteins.130-134 In order to attach to a particular 
biomolecule, the BODIPY dyes must contain a reactive functionalized group: terminal carboxylic 
acid and sulfonic acids (Figure 1.15).5 One of the most useful applications of BODIPY dyes is in 
gel electrophoresis and DNA sequencing, in which BODIPY is conjugated to oligonucleotides and 
it displays a minimal effect on the DNA fragment mobility.135 BODIPY-based fluorescent 
compounds have found uses in HPLC and capillary electrophoresis, especially when it is bound to 
cysteine residues in proteins.  
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1.5 Research Outlook 
 
 There are numerous efforts on the synthesis and development of functionalized BODIPYs 
for various applications, as biological probes in the NIR region (>700 nm), and as radioactive 
agents for positron emission tomography (PET) or SPECT. Thus, there is still much work needed 
to be done on improving the electronic properties of BODIPY dyes. In addition, there are still new 
demands for versatile fluorophores with enhanced water solubility and high quantum yields for 
cellular studies.  
 
 
Figure 1.15: Soraphen A derivatives 40 and 41 conjugated to BODIPY.78 
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CHAPTER 2: SYNTHESIS, SPECTROSCOPIC STUDIES, AND COMPUTATIONAL 
MODELING OF 4,4-DIALKOXY-BODIPYS[a]  
 
2.1 Introduction 
Boron-substituted BODIPYs have been explored in the last decade due to their ease of 
synthetic post-modification, increased aqueous hydrophilic solubility, decreased 
oxidation/reduction potentials, use as biological probes for bioimaging, and development as 
cassette devices with donor-acceptor systems.1-2 Even though replacements of the fluoride atoms 
with carbon or oxygen nucleophiles have shown no substantial changes on the absorption or 
emission properties, there are potential enhancements on the Stokes shift and fluorescence 
quantum yields. Development in boron functionalization has been slow compared to carbon 
modification of the dipyrromethene core. Nevertheless, nucleophilic substitution at the boron atom 
remains a tremendous synthetic challenge for further functionalization with various groups.  
There are several methods for BODIPY boron-functionalization with oxygen nucleophiles: 
i) post-modification of F-BODIPYs and ii) complexation of dipyrromethenes with reactive boron 
compounds.3-4 Derivatization of B-F can be done in a variety of ways: elevated temperature5-6 with 
alkoxide or Lewis acid mediated7-16 with alcohols. For example, Nagano and coworkers5 
demonstrated that refluxing a mixture of 8-phenyl-BODIPY with sodium methoxide in methanol 
for 14 hours can afford the mono- and di-methoxyl BODIPYs (up to 52% yield). Alternatively, 
BODIPYs can be heated in a microwave-assisted reactor with alkoxide.6 However, a milder 
method7 was developed via activating of B-F bonds with Lewis acid (aluminum trichloride) 
followed by addition of various alcohols. The Lewis acid was an essential part for cleavage of 
fluoride atoms, which led to nucleophilic attack of weak oxygen nucleophiles. Various alcohols 
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have been demonstrated to directly replace the fluorine atoms, including methanol, ethanol, benzyl 
alcohol, polyethylene glycol, and phenol. However, the yields for the corresponding 4,4-dialkoxy- 
and diaryloxy-BODIPYs are often low (ranging from 20% to quantitative) due to difficulty in 
removal of large excesses of alcohols. Using latter methodologies, antenna-containing BODIPY 
with donor-acceptor-acceptor triad components and BODIPY-oxazine dyads were developed.9-11 
Furthermore, these mild conditions are being used extensively and found to be compatible with 
amine, ester, and aldehyde groups.12 In the last few years, several O-BODIPYs have been used in 
circularly polarized luminescence spectroscopy using the latter methodology.13-14  
Recently, Thompson and coworkers17 developed a milder strategy which involves a two 
step one-pot reaction using boron trichloride with F-BODIPYs to afford a reactive intermediate 
4,4-dichloro-BODIPY, which readily undergoes reaction with alkoxides or alkyls to give the 
corresponding 4,4-dialkoxy- and dialkyl-BODIPYs in relatively high yields. Another mild method 
was reported for the synthesis of 4-monoalkoxy-BODIPYs in moderate yields (38-70%), which 
involves activation of the BODIPY using trimethylsilyltrifluoromethanesulfonate (TMSOTf) 
followed by addition of an alcohols.18 Similar methodology was used previously for boron 
functionalization in subphthalocyanines via a triflate-subphthalocyanine intermediate.19 There are 
several ways for complexation of dipyrromethenes with halogenated boron compounds.3-4,20 The 
usefulness of dipyrromethenes as a platform is that many 4,4-functionalized BODIPYs can be 
synthesized via a one-step reaction. 
2.1.1 Radioactive 18-Fluoride Imaging 
 The use of radioactively labeled atoms (123I, 18F, etc.) for nuclear imaging has become a 
promising tool for physicians to diagnose many diseased patients. The ability to produce images 
of particular parts in the body using a trace amount of radioactive nuclei is tremendously 
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advantageous in the biomedical field. Positron emission tomography (PET) and single photon 
emission computed tomography (SPECT) have been utilized in many bioimaging applications. 
The practical uses of PET include creating a three dimensional image upon radiation using the 
radioactive fluoride to allow mapping of uptake in vivo. For imaging of endogenous antibodies 
and polypeptides, SPECT is preferred over PET due to the slow kinetic measurements and 
relatively long isotope half-life. Many FDA-approved radiotracers have been used exclusively for 
clinical theranostic treatments. Moreover, iodinated compounds have emerged as potential 
radiotherapy candidates in PET and SPECT imaging for bioimaging applications.21-22 However, 
the use of [18F]-radiolabelling of BODIPYs as PET/fluorescence dual imaging probes has been 
extensively studied recently.23-28 Incorporation of 4-mono-radioactive fluorine onto the boron 
center of BODIPY can provide PET and fluorescence components for a faster and effective 
diagnosis in organic and aqueous environments. 
2.1.2 Research Prospective 
Although several boron functionalization methods have been developed, alternative 
functionalization strategies must be explored due to low yields and difficult purifications. This 
chapter aims to report further investigation of these boron-functionalization methodologies and 
extend them to the synthesis of 4,4-dialkoxy-BODIPYs. In addition, we also explored using Cu(I)-
catalyzed alkyne-azide click conditions using 4,4-dipropargyloxy-BODIPY in order to produce 
the first boron-bis(1,2,3)triazole-functionalized BODIPY. In our study, the structural, 
spectroscopic and fluorescence properties of all the synthesized BODIPYs were investigated and 
are compared using computational and experimental methods. 
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2.2 Results and Discussion 
2.2.1 Syntheses 
 Three 8-aryl-1,3,5,7-tetramethyl-BODIPYs 1-3 were synthesized through a classical 
BODIPY synthetic routes (Scheme 2.1). The route was a 3-step-1-pot synthesis, which began with 
acid-catalyzed condensation29-30 of the commercially available 2,4-dimethylpyrrole with the 
corresponding aryl aldehydes in dichloromethane. An acid catalyst, boron trifluoride etherate 
(BF3·OEt2), was used in order make the carbonyl more electrophilic toward nucleophilic attack. 
After stirring the reaction mixture under inert argon at room temperature for 48 hours, 2,3-
dichloro-5,6-dicyano-1,4-benzoquinone (DDQ) was used as the oxidant to oxidize the 
dipyrromethanes to dipyrromethenes. The dipyrromethenes were deprotonated under basic 
conditions with triethylamine (Et3N), followed by complexation with boron trifluoride etherate 
(BF3•OEt2) to give BODIPYs 1-3 in yields ranging from 6-26%. Electron-donating groups (3,4-
dimethoxy BODIPY 2) and electron-withdrawing groups (4-methoxycarbonyl BODIPY 3) were 
introduced at the meso-phenyl positions to study the effect on the boron-substitution reaction.                    
 
Scheme 2.1: Synthesis of BODIPY 1-3 from acid-catalyzed condensation between 2,4-
dimethylpyrrole with aryl aldehydes. 
 
 We first began our methodology investigation by employing conditions as previously 
described by Nagano and coworkers5 to synthesize 4,4-dimethoxy-BODIPY 1a. Method A is a 
one-step reaction between BODIPY 1 with 6 equiv. of sodium methoxide in methanol and the 
reaction mixture was refluxed for 12 hours to afford the corresponding 4,4-dimethoxy-BODIPY 
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1a in 66% yield (Scheme 2.2). In addition, TLC also indicated the 4-monoalkoxy-BODIPY 
intermediate under these conditions. Next, we investigated BODIPYs with electron-donating and 
electron-withdrawing groups on the 8-phenyl. When BODIPY 2, containing two electron-donating 
methoxy groups (positions 3 and 4 of the 8-phenyl group), was exposed to the above reaction 
conditions, the corresponding 4,4-dimethoxy-BODIPY 2a was afforded in a yield of 50%. On the 
other hand, BODIPY 3, containing an electron-withdrawing (4-methoxycarbonyl), produced the 
corresponding 4,4-dimethoxy-BODIPY 3a in poor yield of 4% although 53% of the starting 
material was recovered.  
 
Scheme 2.2: Synthesis of BODIPYs 1a-3a from Method A-C. 
 
 DFT calculations at the B3LYP/6-31+G(d,p) level for evaluation of the atomic charges on 
BODIPYs 1-3 indicate that there are no significance differences between the charges on the 12-
atom BODIPY core. This shows that the electron donating or withdrawing nature of the 8-aryl 
group does not greatly affect the dipyrromethene core. This could be explained by the loss of 
electronic communication between the meso-aryl and 1,7-dimethyl substituent on the BODIPY 
core (Figure 2.1) due to the large dihedral angles. With the aim to increase the yields of the 
substitution reaction in the presence of electron-withdrawing groups, such as in BODIPY 3, since 
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the methoxycarbonyl group can be used as a precursor to carboxyl-substituted BODIPYs for 
further derivatization, we decided to explore alternative methodologies using milder reaction 
conditions (at lower temperature and with milder nucleophiles). 
Table 2.1: Methods A, B, and C for synthesis of 4,4-dimethoxy-BODIPYs 1a, 2a, and 3a with 
isolated yields. 
 
BODIPY Method A  Method B Method C 
1a 66% 52% 98% 
2a 50% 11% 8% 
3a 4% 58% 70% 
 
Our approach was to optimize the conditions as reported by Tahtaoui and coworkers7 in 
order to synthesize 4,4-dimethoxy-BODIPY 1a. Our preliminary investigation began with the 
absence of and changing Lewis acids as shown on Table 2.2. In the absence of a Lewis acid, the 
reaction did not proceed and resulted in re-isolation of the starting material BODIPY 1, which was 
in agreement with Tahtaoui and coworkers. This indicates that BODIPY 1 requires chelation of a 
Lewis acid in order to make the B-F bonds more labile toward nucleophilic substitution. Lewis 
acids such as Zn(OAc)2, TiCl4, SnCl2, SnCl4, and BCl3 did not produce the desired 4,4-dimethoxy-
BODIPY 1a. Also, the reaction with TiCl4 led to decomposition of the starting material. Indeed, 
AlCl3 as Lewis acid gave BODIPY 1a in an isolated 52% yield at reflux temperature after 15 min 
with excess amount of methanol (278 equiv), which is in agreement with previous reports7 (entry 
6). However, the excess of alcohol were difficult to remove and the product was hard to purify.  
At room temperature and with longer reaction time (12 h), the desired BODIPY 1a was 
obtained in 44% yield (entry 7). When reducing the amount of methanol equivalent from 278 to 5, 
BODIPY 1a was afforded in a lower yield of 19% (entry 8). These preliminary data show that 
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AlCl3 and an excess of alcohol were necessary for the synthesis of 4,4-dimethoxy-BODIPY 1a in 
good yield.7 
Table 2.2: Preliminary studies for synthesis of 4,4-Dimethoxy-BODIPY 1a using methanol as 
nucleophile. 
 
 
 
Entry Lewis Acid  Temp Product, Yield 
1 --- 25 °C 1 
2 Zn(OAc)2 40 °C 1 
3 TiCl4 25 °C decomp 
4 SnCl4 40 °C 1 
5 SnCl4 40 °C 1 
6 AlCl3 40 °C 1a, 52% 
7 AlCl3 25 °C 1a, 44% 
 8a AlCl3 40 °C 1a, 19% 
9 BCl3 25 °C 1 
a: 5.0 equiv of MeOH was used 
To further explore the scope of our reaction, we also investigated variation of the solvents 
at room temperature (Table 2.3). Using acetonitrile, compound 1a was obtained in 16% yield, 
which is due to the possible competition reaction between the nitrile and methanol as nucleophiles 
toward the boron center. With tetrahydrofuran, the oxygen could possible poison the aluminum 
catalyst to give the starting material 1 before the addition of methanol. Similar to when using 
methanol, dipyrromethene was the only product due to the possible competing reaction between 
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methanol and the Lewis acid. These results demonstrated that dichloromethane is the best solvent 
to use for method B. 
Table 2.3: Synthesis of BODIPY 1a in various solvents using Method B at reflux temperature. 
 
Entry solvent Product, Yield 
1 dichloromethane 1a, 44% 
2 acetonitrile 1a, 16% 
3 methanol dipyrromethene 
4 tetrahydrofuran 1 
 
 The next step was replacing methanol with a stronger nucleophile, sodium methoxide. As 
shown on Table 2.4, aluminum chloride as the Lewis acid gave the desired product 1a in 46% 
yield. However, these conditions were not reproducible (Table 2.4, entry 1). Similar to Table 2.1, 
varying the Lewis acids resulted in the recovery of starting material, except for boron trichloride. 
Under these conditions (2 equiv. of AlCl3, 278 equiv. of alcohol, reflux in dichloromethane 
for 15 min), BODIPYs 1a (52%), 2a (11%) and 3a (58%) were afforded in moderate yields 
(Method B, Scheme 2.2). Notably, BODIPY 3a was obtained in 58% yield, a remarkable increase 
in the yield obtained using method A. While method B gave the desired 4,4-dimethoxy-BODIPY 
in moderate yield, we further investigated the optimization of the conditions and developed new 
method C. This novel method consists of activating the BODIPY with TMSOTf at elevated 
temperature, followed by addition of alcohols (5.0 equiv.) and a non-nucleophilic base (DIPEA) 
at room temperature. 
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Table 2.4: Preliminary studies for synthesis of 4,4-Dimethoxy-BODIPY 1a using sodium 
methoxide as nucleophile. 
 
 
 
Entry Lewis Acid  Temp Product, Yield 
 1 AlCl3 50 °C 1a, 46% 
 2 ZnCl2 50 °C 1 
 3 MgCl2 50 °C 1 
4 SnCl4 50 °C 1 
 5 InCl3 50 °C 1 
 6 FeCl3 50 °C 1 
 7 BCl3 25 °C 1a, 19% 
 
Similar to method B, we also screened various solvents (toluene, dichloromethane, 
tetrahydrofuran, and chloroform) at room temperature to afford BODIPY 1a (Table 2.5). The 
desired BODIPY 1a yields were obtained at room temperature with toluene (50%), 
dichloromethane (25%), chloroform (29%), and tetrahydrofuran (0% and 100% of starting material 
was recovered). The conditions with dichloromethane also gave the starting material 1 (20%) and 
the mono-substituted (17%) product. Notably, toluene and dichloromethane gave the yields within 
2 hours while chloroform required overnight. In addition, silver triflate (AgOTf) was used in place 
of TMSOTf and resulted in isolation of the starting material. These results indicated that the 
reaction yields were dependent on the solvent used and reaction temperature.  
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With Method C using toluene at elevated temperature, compound 1a was remarkably 
synthesized in high yield (98%). As expected, compound 3a was also isolated in high yield (70%) 
compared to method B (58%). However, compound 2a with an electron donating group at the 
meso-phenyl afforded a low yield (8%) with uncomplexed dipyrromethene as a by-product. The 
three methodologies were used for synthesis of 4,4-dimethoxy-BODIPYs 1a-3a as summarized in 
Table 2.1 with yields ranging from 4% to 98%. Therefore, BODIPYs 1a and 3a were accessed in 
high yield using the newly developed method C, providing an efficient and convenient synthetic 
route for boron functionalization. 
Table 2.5: Synthesis of 4,4-dimethoxy-BODIPY 1a in various solvents using Method C at room 
temperature. 
 
 
 
Entry Solvent Product, Yield 
1 dichloromethane 1a, 25% 
2 toluene 1a, 50% 
3 chloroform 1a, 29% 
4 tetrahydrofuran 1 
 
Since there is wide range of yields obtained for BODIPYs 1a-3a under the three methods, 
we suspected that the intermediates formed upon fluoride dissociation from boron under these 
reaction conditions can be investigated using computational modeling. All these reactions likely 
undergo the same boronium cation intermediate INT1 formation (Scheme 2.3) and 19F-NMR and 
X-ray crystallography have confirmed the existent of these cations.31 DFT modeling showed the 
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Scheme 2.3: Synthesis of BODIPYs 1a-e using Methods B and C via Boronium Intermediate 
INT1. 
 
calculated Gibbs free energies for the formation of INT1 from BODIPY 1 (Table 2.6). The 
intermediates were computationally modeled for method A (in methanol), method B (in 
dichloromethane), and method C (in toluene). Indeed, fluoride dissociation from BODIPY 1 in 
method A requires the least amount of energy (37 kcal/mol) in methanol, followed by 56 kcal/mol 
in dichloromethane, and the largest amount of energy (92 kcal/mol) in toluene. This tendency can 
be explained by the three solvents’ relative dielectric permittivities: methanol (ε = 32.6), 
dichloromethane (ε = 8.93), and toluene (ε = 2.37). From these values, the direct dissociation of 
fluoride ion from BODIPY 1 is likely to occur in method A, since the reaction barrier for the 
formation of INT1 can be overcome by refluxing the mixture in methanol at 70-75 oC. This is 
unlikely to happen in method B since a larger amount of energy (56 kcal/mol) is required to 
overcome this barrier. However, computational calculations show that the addition of Lewis acid 
AlCl3, followed by fluoride dissociation to form the counter ion AlCl3F significantly stabilizes 
the boronium cation INT1. Indeed, this is in agreement with the milder conditions required for 
method B. Furthermore, the calculations also suggest that the milder reaction can occur at a lower 
temperature. While performing the reaction entirely at room temperature, BODIPY 1a was 
afforded in lower yield (44 vs. 52%) after 12 hours.  
 For method C, the potential energy barrier of 25 kcal/mol for the fluoride abstraction with 
triflate anion to give trimethylsilyl fluoride can be easily overcome by refluxing in toluene at 110 
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°C. Indeed, NMR spectroscopy and X-ray crystallography have shown that such a boronium 
species bearing a triflate ligand exists.32 Moreover, our calculations for method A also show 
similar Gibbs free energies and stabilities for INT1 from all starting BODIPYs 1-3: for BODIPY 
1 (ΔG = 37.4 kcal/mol), for BODIPY 2 (ΔG = 37.5 kcal/mol), and for BODIPY 3 (ΔG = 38.7 
kcal/mol). 
Table 2.6: Calculated ΔG energies for formation of INT1 through methods A, B, and C. 
Method modeled solvent Anion Δ G (kcal/mol) 
A CH3OH F- 37 
B CH2Cl2 F- 56 
B CH2Cl2 AlCl3F- -22 
C PhCH3 F- 92 
C PhCH3 OTf- 25 
 
 Various alcohols were investigated for the synthesis of new 4,4-dialkoxy-BODIPYs 1a-e 
using the milder methods B and C, as shown in Scheme 2.3 with the isolated yields given in Table 
2.7. In method B, all desired BODIPYs were obtained in moderate yields (21-64%) while method 
C was highly sensitive to the sterics of the alcohol. This is likely due to the close distance of the 
triflate anion to the boron center.33 Indeed, no product was obtained for method C when 
isopropanol was used. It has shown previously that the use of tert-butanol/tert-butoxide has 
resulted in BODIPY deboronation.6 When a larger excess of ethanol was used for BODIPY 1b 
using method C, the yield could be increased to 37% and the mono-4-ethoxy-BODIPY was also 
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afforded in 20% yield. In addition, we also investigated the addition sequence of DIPEA. When 
we added the DIPEA before addition of alcohols, a 35% yield of BODIPY 1b resulted. Therefore, 
in order to obtain the highest yield of the desired 4,4-dialkoxy-BODIPYs, the starting BODIPY 
and various alcohol nucleophile with selected methods must be considered.  
Table 2.7: Synthesis of BODIPYs 1a-e with isolated yields using Method B and C. 
BODIPY R Method B (%) Method C (%) 
1a Me 52 98 
1b Et 64 18 
1c iPr 26 0 
1d allyl 57 30 
1e propargyl 52 40 
 
We also investigated the tolerance of 4,4-dipropargyloxy-BODIPY 1e toward further 
functionalization by using the Cu(I)-catalyzed Huisgen cycloaddition conditions as previously 
reported for the click reaction of alkyne-functionalized BODIPYs with azide containing 
carbohydrate34 and folate35 moieties (Scheme 2.4). As a result, the 4,4-bis(N-benzyl-1,2,3-
triazole)-BODIPY 4 was obtained in 78% yield from BODIPY 1e. The click conditions consist of 
using in situ generated copper(I) catalyst from copper(0) and copper (II) sulfate, in the presence of 
sodium ascorbate and benzyl azide in an aqueous water/THF mixture. To the best of our knowledge 
this is the first report demonstrated that post-modification of a BODIPY boron functionalized 
bearing an alkyne group can occur with the click cycloaddition reaction. 
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Scheme 2.4: Click reaction of BODIPY 1e. 
2.2.2 Structural Characterization 
 All BODIPYs were characterized by 1H-, 13C-, and 11B-NMR, HRMS, UV-Vis, 
fluorescence, and in the case of 1a-c, 1e, 3a and 4 also by X-ray crystallography. The 
disappearance of the triplet for the BF2 (at ca. 0.6 ppm) and the appearance of the singlet attributed 
to B(OR)2 (at ca. 2 ppm) in the 
11B-NMR spectra clearly showed the formation of the targeted 4,4-
dialkoxy-BODIPY. The 1H-NMR spectrum clearly indicated the formation of the 1,2,3-triazoles 
of BODIPY 4 with two singlets at 7.50 ppm (triazole) and 5.43 ppm (benzyl CH2) protons, 
respectively.  
Full structural confirmation of all compounds was obtained from the X-ray crystal 
structures. Crystals suitable for X-ray analysis were grown from slow evaporation of hexane 
diffused in dichloromethane (for 1a-c), and acetone (for 1e and 3a). As expected, the meso-aryl 
groups are oriented perpendicular to the dipyrromethene core to avoid steric congestion caused by 
the 1,7-dimethyl groups. In addition, the alkoxy groups on the boron center adopt a nearly 
tetrahedral geometry. BODIPYs 1a-c, e, and 3a structures as shown in Figure 2.1, have at least 
approximate two-fold symmetry. BODIPY 1b has crystallographic C2 symmetry, and BODIPY 1a 
has one molecule on a two-fold axis and another in a general position. The central six-membered 
C3N2B rings of all five compounds deviate little from planarity, with mean and maximum 
deviations of 0.021 and 0.057 Å respectively for 1a, 0.024 and 0.037 Å for 1b, 0.003 and 0.005 Å 
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for 1c, 0.008 and 0.021 Å for 1e, 0.035 and 0.075 Å for 3a, and 0.014 and 0.032 Å for 4. In all 
cases, the phenyl plane forms a large dihedral angle with the best plane of the C9N2B BODIPY 
core; these dihedral angles are 84.2 and 83.8˚ (2 independent molecules) for 1a, 86.5˚ for 1b, 84.7˚ 
for 1c, 79.8 and 82.1˚ (2 independent molecules) for 1e, 84.0 and 84.6˚ (2 independent molecules) 
for 3a, and 78.9 and 79.1˚ (two independent molecules) for 4. The geometry of the boron atoms is 
tetrahedral, and 18 B-O bond distances over the six compounds have lengths in the range 1.420(4) 
– 1.444(5) Å, with an average value of 1.432 Å. These distances are in good agreement with those 
in the p-iodo-aryl analogue of BODIPY 1a, 1.420(4) and 1.437(3) Å.7 As in that compound, the 
conformations of the B-OR groups in all six compounds have the alpha C atoms of both alkyl 
groups folded symmetrically toward the BODIPY core. 
 In addition, the geometries of BODIPYs 1a-e and 4 were also investigated and confirmed 
computationally. The computational results show that the boron atom adopted a nearly tetrahedral 
geometry and the 8-aryl groups were oriented nearly perpendicular to the BODIPY plane, which 
is in agreement with the X-ray data. Surprisingly, there exist two conformers for all BODIPYs, as 
revealed by the computational optimization of the structures. As shown in Figure 2.2, the most 
stable conformer 1a is symmetric (the two B-OR groups symmetrically oriented on both sides of 
the BODIPY plane, see Figure 2.2a) and in the other conformer 1a’ the B(OR)2 groups positioned 
sideways, as shown in Figure 2.2b.  
The data given in Table 2.8 suggest that there are deviations from planarity (ranging 
between 15 and 17) for the non-symmetric conformers of the BODIPYs and there no significant 
differences in the relative Gibbs free energies between the two conformers. At room temperature, 
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Figure 2.1: Molecular structures of BODIPYs 1a-c,e, 3a, and 4 from X-ray crystal analysis, with 
50% probability ellipsoids. Only one of the independent molecules is shown for those structures 
with Z’ > 1. 
 
the two conformers interconvert rapidly in THF solution since the Gibbs energy differences are 
very small. However, only the symmetric conformer is depicted in the crystal structures shown in 
Figure 2.1 while the unsymmetric BODIPY conformer with the boron lying out of the C3N2 plane 
for related BF2 systems has previously been observed.
36 
 
1a 1b 1c 
1e 3a 4 
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Figure 2.2: Molecular structures of (a) the symmetric conformer 1a and (b) the unsymmetric 
conformer 1a’ from B3LYP/6-31+G(d,p) optimization. 
 
Table 2.8: Calculated relative Gibbs free energies, HOMO and LUMO energies, and HOMO-
LUMO gap in THF for the symmetric (1a-e, 4) and unsymmetric (1a’-e’, 4’) BODIPY conformers. 
BODIPY HOMO (a.u.) LUMO (a.u.) Gap (eV) Δ G (kcal/mol) 
1a -0.20599 -0.09520 3.01 0 
1a -0.2044 -0.09280 3.04 6.76 
1b -0.20542 -0.09440 3.02 0 
1b -0.20393 -0.09245 3.03 8.39 
1c -0.20548 -0.09436 3.02 0 
1c -0.20315 -0.09117 3.05 9.92 
1d -0.20694 -0.09608 3.02 0 
1d -0.20143 -0.09077 3.01 7.82 
1e -0.21009 -0.09941 3.01 0 
1e -0.20776 -0.09635 3.03 7.45 
4 -0.20686 -0.09602 3.02 0 
4 -0.20778 -0.09638 3.03 6.55 
 
 
 
 
(a) (b) 
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2.2.3 Spectroscopic Study 
 The spectroscopic properties of BODIPYs 1-1e, 2-2a, 3-3a, and 4 were investigated in 
tetrahydrofuran and toluene and the results are shown in Table 2.9.  All BODIPYs showed 
absorption bands between 501 and 506 nm and emission bands between 505 and 517 nm in THF 
and toluene with strong absorption bands (log  = 4.4-5.7). Indeed, previous studies have showed 
that replacement of fluorides of BODIPY dyes with alkoxy groups afford only small changes in 
the absorption and emission wavelengths, which is in agreement with these results.7-8,12 Moreover, 
the bis(1,2,3-triazole)-BODIPY 4 in THF and toluene indicated a slight blue-shifted absorption 
(max ca. 495 nm) and thus the largest Stokes shift. The observed experimental data are in 
agreement with the computational modeling data (Table 2.8), showing similar HOMO-LUMO 
gaps for BODIPYs 1a-e and 4. Interestingly, it is impossible to distinguish spectroscopically 
between the two conformers since the HOMO-LUMO gaps are very similar as shown in Figure 
2.2. 
 In both solvents, the 4,4-dimethoxy-BODIPY derivatives 1a, 2a and 3a bearing flexible 
methoxy groups show decreased fluorescence quantum yields due to the increased rotational 
energy lost in non-radiative decay to the ground state. BODIPY derivative 1b (in THF) and all 
4,4-alkoxy-BODIPYs (in toluene) demonstrated this trend in decreased fluorescence quantum 
yields. Interestingly, BODIPYs 1c and 1e bearing the isopropoxy and progargyloxy groups showed 
significant enhancements in fluorescence quantum yield in THF. This result is in agreement with 
previous reports showing BODIPY derivatives bearing isopropoxy and benzyloxy groups also 
have increased fluorescence quantum yields compared to its F-BODIPY precursor.7 In addition, 
the bis(1,2,3-triazole)-BODIPY 4 also showed enhancement of the fluorescence quantum yield in 
THF, but not in toluene. Furthermore, bis(1,2,3-triazole)-BODIPY 4 has a larger Stokes shift in 
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both solvents. These results conclude that substitution at the boron center with alkoxy groups is 
likely to decrease the quantum yields in toluene, but in a more polar solvent such as THF, certain 
BODIPYs have shown enhancement of the quantum yields. 
Table 2.9: Absorption and emission spectal properties of BODIPYs 1-1e, 2-2a, 3-3a, and 4 in THF 
and PhMe (in parentheses) at room temperature. 
 
BODIPY 
Absorption 
λmax/nm 
Emission  
λmax/nm 
log ε (M-1.cm-1) Φf 
Stokes’ shift 
(nm) 
1 501 (504) 505 (511) 4.96 (5.33) 0.56 (0.96) 4 (7) 
1a 502 (504) 507 (512) 4.86 (5.38) 0.44 (0.73) 5 (8) 
1b 502 (504) 507 (512) 4.54 (5.24) 0.46 (0.70) 5 (8) 
1c 501 (504) 505 (509) 4.70 (5.48) 0.63 (0.70) 4 (5) 
1d 503 (505) 507 (511) 4.66 (5.47) 0.56 (0.57) 4 (6) 
1e 504 (506) 508 (513) 4.74 (5.04) 0.62 (0.82) 4 (7) 
2 501 (505) 505 (509) 5.00 (5.66) 0.93 (0.87) 4 (4) 
2a 503 (505) 507 (512) 4.38 (5.06) 0.42 (0.57) 4 (7) 
3 503 (506) 508 (515) 4.42 (5.62) 0.43 (0.51) 5 (9) 
3a 504 (506) 510 (517) 4.73 (5.48) 0.31 (0.34) 6 (11) 
4 494 (496) 511 (512) 4.80 (4.94) 0.72 (0.56) 17 (16) 
ε = extinction coefficient;  Φf  = fluorescence quantum yield 
2.3 Conclusions 
 
 In summary, we have investigated three different methods for the synthesis of 4,4-
dimethoxy-BODIPYs containing electron-withdrawing and electron-donating meso-aryl groups. 
Method A consists of heating NaOMe in refluxing methanol at 80 ºC for 12 hours, and gave  
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Figure 2.3: Normalized absorption (full lines) and emission (dashed lines) spectra of BODIPYs 
1c (red), 1e (blue), and 4 (purple) in THF at room temperature. 
 
BODIPY 2a (8-(3,4-dimethoxyphenyl)) with the highest yield of 50%. Method B involves treating 
BODIPYs with AlCl3 in refluxing dichloromethane, followed by large excess of alcohol, and 
afforded the desired 4,4-dialkoxy-BODIPYs 1a-f in moderate yields ranging from 26% to 64%. 
On the other hand, method C was the most effective way to synthesize BODIPYs 1a and 3a in 98 
and 70% yields, respectively. Method C employs TMSOTf in refluxing toluene, followed by 
addition of 5 equiv. of methanol and DIPEA. However, methanol was best used in method C since 
all other alcohols as nucleophiles gave lower yields of the targeted 4,4-disubstituted BODIPYs. 
The 4,4-progargyloxy-BODIPY 1e was subjected under the Cu(I)-catalyzed Huisgen 
cycloaddition reaction conditions and produced to the corresponding bis-(1,2,3-triazole)-BODIPY 
4.  
 These 4,4-dialkoxy-BODIPYs showed minor changes in absorption and emission spectra 
in THF and toluene. However, BODIPY 4 with two large N-benzyl-(1,2,3-triazole) groups on the 
boron center resulted blue-shifted absorption maxima in both solvents (THF and toluene). All 4,4-
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dialkoxy-BODIPYs 1a-e have shown a decrease in fluorescence quantum yields compared to 
BODIPY 1 likely due to the higher rotational freedom of the alkoxy groups, therefore increasing 
the amount of energy lost to non-radiative decay to the ground state. In contrast, BODIPYs 1c,e 
and 4 showed enhancements in the fluorescence quantum yields in THF. Furthermore, BODIPY 4 
displayed the largest Stokes shifts in both solvents.  
2.4 Experimental 
2.4.1 General Information 
All the reagents and solvents were purchased from Sigma-Aldrich and were used without 
further purification. All reactions were carried out with oven-dried glassware under a dry argon 
atmosphere. All the reactions were monitored using Sorbent Technologies 0.2 mm silica gel TLC 
plates with UV-254 nm indicator. Flash column chromatography was performed using Sorbent 
Technologies 60 Å silica gel (230-400 mesh). Prep-TLC 60 Å silica gel 20 x 20 cm (210-270 µm) 
was used. All 1H-, 13C-, 11B-NMR spectra were collected on a Bruker AV-400 spectrometer in 
deuterated chloroform. The CDCl3 chemical shifts (δ) are reported in ppm using as reference 7.27 
for proton and 77.16 for carbon and BF3•OEt2 was used as reference (0.00 δ) for boron NMR. 
Coupling constants are reported in Hertz (Hz). All the mass spectra were collected using a Agilent 
6210 ESI-TOF mass spectrometer. All melting points were recorded using a MEL-TEMP 
electrothermal instrument. 
2.4.2 Syntheses 
General procedure for synthesis of BODIPYs 1-3.29-30,37-38 Aryl aldehyde (9.81 mmol) was 
suspended in anhydrous CH2Cl2 (300 mL). 2,4-Dimethylpyrrole (2.12 mL, 20.6 mmol) was added, 
followed by 6 drops of BF3•OEt2 to the reaction mixture. After stirring for 48 h, TLC indicated no 
more aryl aldehyde in the reaction mixture, and DDQ (1.113 g, 4.91 mmol) in CH2Cl2 was then 
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added. After 1.5 h stirring at room temperature, NEt3 (10.3 mL, 73.58 mmol) was added and after 
another 1 h BF3•OEt2 (12.1 mL, 98.1 mmol) was added. The final mixture was stirred at room 
temperature for 6 h and then poured into water (50 mL). The organic layer was washed with water 
(2 x 50 mL). The combined organic layers were dried over anhydrous Na2SO4 and concentrated 
under reduced pressure. The product was purified by silica gel flash column chromatography using 
mixtures of petroleum ether and dichloromethane for elution. 
 
4,4-Difluoro-8-phenyl-1,3,5,7-tetramethyl-BODIPY (1). Obtained as a green/orange solid 
(20% yield, 650 mg), mp: 168-169 ᵒC; 1H NMR (CDCl3, 400 MHz) δ 7.47-7.26 (m, 5H), 5.98 (s, 
2H), 2.56 (s, 6H), 1.38 (s, 6H); 13C NMR (CDCl3, 100 MHz) δ 155.57, 143.29, 141.87, 135.14, 
131.57, 129.26, 129.26, 128.08, 121.34, 14.71, 14.46; 11B NMR (CDCl3, 128 MHz) δ 0.65 (t, J = 
33.4 Hz); HRMS (ESI-TOF) m/z 324.1718 [M + H]+ calculated for C19H20BF2N2: 324.1728. These 
data are in agreement with those previously reported.29-30 
 
4,4-Difluoro-8-(3,4-dimethoxyphenyl)-1,3,5,7-tetramethyl-BODIPY (2). Obtained as a 
red solid (6% yield, 229 mg), mp: 182-183 ᵒC; 1H NMR (CDCl3, 400 MHz) δ 6.97 (d, J = 8.1 Hz, 
1H), 6.84 (d, J = 8.1 Hz, 1H), 6.78 (s, 1H), 5.60 (s, 2H), 3.96 (s, 3H), 3.86 (s, 3H), 2.56 (s, 6H), 
1.49 (s, 6H); 13C NMR (CDCl3, 100 MHz) δ 155.35, 149.80, 149.53, 143.14, 141.59, 131.71, 
127.09, 121.12, 120.44, 111.57, 111.10, 56.10, 55.88, 14.53, 14.42; 11B NMR (CDCl3, 128 MHz) 
δ 0.62 (t, J = 33.0 Hz); HRMS (ESI-TOF) m/z 384.1930 [M + H]+ calculated for C21H24BF2N2O2: 
384.1939. These data are in agreement with those previously reported.29,37 
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4,4-Difluoro-8-(4-methoxycarbonylphenyl)-1,3,5,7-tetramethyl-BODIPY (3). Obtained as 
a bright red solid (26% yield, 483 mg) mp: 181-183 ᵒC; 1H NMR (CDCl3, 400 MHz) δ 8.19 (d, J 
= 8.5 Hz, 2H), δ 7.42 (d, J = 8.1 Hz, 2H), 5.99 (s, 2H), 3.98 (s, 3H), 2.57 (s, 6H), 1.37 (s, 6H); 13C 
NMR (CDCl3, 100 MHz) δ 166.58, 156.10, 143.01, 140.35, 139.94, 131.04, 130.94, 130.48, 
128.50, 121.62, 52.50, 14.71, 14.61; 11B NMR (CDCl3, 128 MHz) δ 0.61 (t, J = 32.8 Hz); HRMS 
(ESI-TOF) m/z 382.1773 [M + H]+ calculated for C21H22BF2N2O2: 382.1752. These data are in 
agreement with those previously reported.29,38 
 
General procedure for synthesis of O-BODIPYs using method A. In an oven-dried flask, 
BODIPY (20.0 mg, 0.062 mmol) and NaOMe (21.0 mg, 0.389 mmol) were dissolved in anhydrous 
methanol (2 mL). The mixture was refluxed for 12 h and then cooled down to room temperature. 
The reaction mixture was poured into ice water (5.0 mL), extracted with CH2Cl2 (3 x 5.0 mL), 
washed with brine (1 x 5.0 mL), and dried over anhydrous Na2SO4. The crude product was 
concentrated under reduced pressure and the resulting residue was purified by TLC, using ethyl 
acetate for elution. 
 
General procedure for synthesis of O-BODIPYs using method B. In an oven-dried flask, 
BODIPY (20.0 mg, 0.062 mmol) and AlCl3 (16.4 mg, 0.123 mmol) were dissolved in anhydrous 
CH2Cl2 (5 mL). The mixture was refluxed for 15 min before alcohol (17.15 mmol, 278.0 equiv) 
was added. The final reaction mixture was refluxed for 15 min. The mixture was allowed to cool 
down to room temperature and then concentrated under reduced pressure. The resulting residue 
was purified by TLC, using the eluents indicated below. 
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General procedure for syntheis of O-BODIPYs using method C. In an oven-dried flask, 
BODIPY (20 mg, 0.06 mmol) and TMSOTf (28.0 µL, 0.154 mmol) were dissolved in anhydrous 
toluene (5 mL) and the mixture was refluxed for 30 min. The solution was allowed to cool down 
to room temperature and alcohol (0.308 mmol, 5.0 equiv) was added, followed by DIPEA (27.0 
µL, 0.154 mmol, 2.5 equiv.). After 1 h stirring at room temperature, the crude product was 
concentrated under reduced pressure and purified by TLC, using the eluents indicated below. 
 
4,4-Dimethoxy-8-phenyl-1,3,5,7-tetramethyl-BODIPY (1a). This BODIPY was produced 
in 66% yield by method A, 58% by method B and 98% by method C. The crude product was 
purified by TLC (eluent EtOAc) to give an orange solid that was recrystallized from 1:1 
hexane/dichloromethane. Mp: 125-130 ᵒC; 1H NMR (CDCl3, 400 MHz) δ 7.50-7.30 (m, 5H), 5.97 
(s, 2H), 2.97 (s, 6H), 2.54 (s, 6H), 1.39 (s, 6H); 13C NMR (CDCl3, 100 MHz) δ 155.77, 141.71, 
141.38, 135.81, 133.01, 129.10, 128.82, 128.35, 121.05, 49.24, 14.70, 14.58; 11B NMR (CDCl3, 
128 MHz) δ 2.52 (s); HRMS (ESI-TOF) m/z 370.1938 [M + Na]+ calculated for C21H25BN2NaO2: 
370.1923. These data are in agreement with literature.5 
 
4,4-Dimethoxy-8-(3,4-dimethoxyphenyl)-1,3,5,7-tetramethyl-BODIPY (2a). This 
BODIPY was produced in 50% yield by method A, 11% by method B and 8% by method C. The 
crude product was purified by TLC (eluent 50:50 hexane/EtOAc) to afford a dark orange/red solid, 
that was recrystallized from acetone. Mp: 100-105 ᵒC (decomposes); 1H NMR (CDCl3, 400 MHz) 
δ 6.97 (d, J = 8.1 Hz, 1H), 6.84 (d, J = 8.1 Hz, 1H), 6.78 (s, 1H), 5.98 (s, 2H), 3.96 (s, 3H), 3.89 
(s, 3H), 2.97 (d, J = 12.5 Hz, 6H), 2.54 (s, 6H), 1.49 (s, 6H); 13C NMR (CDCl3, 100 MHz) δ 
155.79, 149.85, 149.53, 141.54, 141.37, 133.30, 128.02, 120.96, 120.86, 111.58, 111.53, 56.31, 
62 
 
56.06, 49.33, 49.26, 14.72; 11B NMR (CDCl3, 128 MHz) δ 2.52 (s); HRMS (ESI-TOF) m/z 
430.2149 [M + Na]+ calculated for C23H29BN2NaO4: 430.2136. 
 
4,4-Dimethoxy-8-(4-methoxycarbonylphenyl)-1,3,5,7-tetramethyl-BODIPY (3a). This 
BODIPY was produced in 4% yield by method A, 58% by method B and 70% by method C. The 
crude product was purified by TLC (eluent EtOAc) to afford an orange solid that was recrystallized 
from acetone. Mp: 100-105 ᵒC (decomposed);. 1H NMR (CDCl3, 400 MHz) δ 8.19 (d, J = 8.5 Hz, 
2H), δ 7.42 (d, J = 8.1 Hz, 2H), 5.99 (s, 2H), 3.98 (s, 3H), 2.97 (s, 6H), 2.57 (s, 6H), 1.37 (s, 6H); 
13C NMR (CDCl3, 100 MHz) δ 166.70, 156.34, 141.17, 140.70, 140.21, 132.48, 130.72, 130.37, 
128.79, 121.40, 52.50, 49.24, 14.76, 14.73; 11B NMR (CDCl3, 128 MHz) δ 2.51 (s); HRMS (ESI-
TOF) m/z 428.1992 [M + Na]+ calculated for C23H27BN2NaO4: 428.1981. 
 
4,4-Diethoxy-8-phenyl-1,3,5,7-tetramethyl-BODIPY (1b). This BODIPY was produced in 
64% yield by method B and 37% by method C. The crude product was purified via TLC (eluent 
80:20 hexane/EtOAc) to give an orange solid, that was recrystallized from 1:1 
hexane/dichloromethane. Mp: 140-145 ᵒC; 1H NMR (CDCl3, 400 MHz) δ 7.48-7.29 (m, 5H), 5.95 
(s, 2H), 3.07 (q, J = 7.0 Hz, 4H), 2.58 (s, 6H), 1.38 (s, 6H), 1.07 (t, J = 7.0 Hz, 6H); 13C NMR 
(CDCl3, 100 MHz) δ 155.87, 141.61, 141.25, 135.85, 132.84, 129.09, 128.80, 128.37, 121.00, 
56.64, 17.83, 14.94, 14.59; 11B NMR (CDCl3, 128 MHz) δ 1.82 (s); HRMS (ESI-TOF) m/z 
398.2251 [M + Na]+ calculated for C23H29BN2NaO2: 398.2264. 
 
4,4-Diisopropyloxy-8-phenyl-1,3,5,7-tetramethyl-BODIPY (1c). This BODIPY was 
produced in 26% yield by method B and could not be obtained by method C. The crude product 
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was purified via TLC (eluent 80:20 hexane/EtOAc) to give an orange solid, that was recrystallized 
from 1:1 hexane/dichloromethane. Mp: 140-145 ᵒC; 1H NMR (CDCl3, 400 MHz) δ 7.49-7.30 (m, 
5H), 5.96 (s, 2H), 3.40-3.34 (septuplet, J = 6.24 Hz, 2H), 2.61 (s, 6H), 1.39 (s, 6H), 0.89 (d, J = 
6.08 Hz, 12H); 13C NMR (CDCl3, 100 MHz) δ 156.26, 141.50, 141.42, 135.96, 132.28, 129.06, 
128.78, 128.46, 121.16, 63.01, 24.93, 15.76, 14.65; 11B NMR (CDCl3, 128 MHz) δ 1.30 (s); HRMS 
(ESI-TOF) m/z 426.2564 [M + Na]+ calculated for C25H33BN2NaO2: 426.2575. 
 
4,4-Diallyloxy-8-phenyl-1,3,5,7-tetramethyl-BODIPY (1d). This BODIPY was produced 
in 57% yield by method B and 30% by method C. The crude product was purified by TLC (eluent 
80:20 hexane/EtOAc) to give an orange solid that was recrystallized from 1:1 
hexane/dichloromethane. Mp: 70-73 ᵒC; 1H NMR (CDCl3, 400 MHz) δ 7.52-7.29 (m, 5H), 5.95 
(s, 2H), 5.92-5.82 (m, 2H), 5.15 (d, J = 1.84 Hz, 1H), 5.11 (d, J = 1.88 Hz, 1H), 4.92 (d, 1H), 4.89 
(d, 1H), 3.63 (d, J = 5.24 Hz, 4H), 2.56 (s, 6H), 1.38 (s, 6H); 13C NMR (CDCl3, 100 MHz) δ 
156.06, 141.53, 138.70, 135.77, 132.78, 129.13, 128.85, 128.34, 128.23, 121.18, 113.42, 63.41, 
15.03, 14.59; 11B NMR (CDCl3, 128 MHz) δ 2.01 (s); HRMS (ESI-TOF) m/z 422.2251 [M + Na]+ 
calculated for C25H29BN2NaO2: 422.2254. 
 
4,4-(Diprop-2-yn-1-yloxy)-8-phenyl-1,3,5,7-tetramethyl-BODIPY (1e). This BODIPY 
was produced in 52% yield by method B and 40% by method C. The crude product was purified 
via TLC (eluent 80:20 hexane/EtOAc) to give an orange solid, that was recrystallized from 1:1 
hexane/dichloromethane. Mp: 70-73 ᵒC; 1H NMR (CDCl3, 400 MHz) δ 7.49-7.27 (m, 5H), 5.97 
(s, 2H), 3.86 (s, 4H), 2.61 (s, 6H), 1.52 (s, 2H), 1.40 (s, 6H); 13C NMR (CDCl3, 100 MHz) δ 
156.62, 142.22, 141.42, 135.58, 132.79, 129.16, 128.92, 128.26, 121.52, 83.16, 70.83, 49.96, 
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15.19, 14.58; 11B NMR (CDCl3, 128 MHz) δ 1.78 (s); HRMS (ESI-TOF) m/z 418.1938 [M + Na]+ 
calculated for C25H25BN2NaO2: 418.1934. 
 
4,4’-(Di-N-Benzyl,-1,2,3,triazoloxy)-8-phenyl-1,3,5,7-tetramethyl-BODIPY (4). 4,4-
Dipropargyloxy-BODIPY 1e (15.7 mg, 0.040 mmol, 1.0 equiv.) and Cu(0) (10.1 mg, 0.158 mmol, 
4.0 equiv.) were dissolved in a mixture of THF/water (8 mL, 3:1) under inert gas atmosphere. 
Benzyl azide (0.074 mL, 0.594 mmol, 5.0 equiv.) was added dropwise to the reaction mixture. A 
solution of CuSO4·5H2O (7.4 mg, 0.030 mmol, 0.75 equiv.) and sodium ascorbate (15.7 mg, 0.079 
mmol, 2.0 equiv.) in THF/water (8 mL, 3:1) was added (after sonication for 30 min) and the 
reaction mixture was heated for 1.5 h at 70 °C. Once TLC indicated reaction completion the 
mixture was cooled to room temperature and partitioned between ethyl acetate (30 mL) and water 
(30 mL). The combined organic layers were dried over Na2SO4 and then concentrated under 
reduced pressure. The crude product was purified via prep-TLC eluted with 20:80 hexane/EtOAc 
and recrystallized from 3:1 hexane/dichloromethane to afford the bis(1,2,3-triazole)-BODIPY 4  
as a dark orange solid (20.4 mg, 78% yield). 1H NMR (CDCl3, 400 MHz) δ 7.50 (s, 2H), 7.36-7.27 
(m, 15H), 5.84 (s, 2H), 5.43 (s, 4H), 4.28 (s, 4H), 2.40 (s, 6H), 1.36 (s, 6H); 13C NMR (CDCl3, 
100 MHz) δ 155.63, 149.42, 142.17, 135.48, 134.93, 129.21, 129.15, 128.75, 128.35, 128.30, 
121.68, 121.48, 56.80, 54.15, 31.06, 29.84, 29.41, 14.96, 14.57; 11B NMR (CDCl3, 128 MHz) δ 
2.06 (s); HRMS (ESI-TOF) m/z 684.3218 [M + Na]+ calculated for C39H39BN8NaO2: 684.3229. 
 
2.4.3 X-ray Determined Molecular Structures 
 Crystal structures were determined using low-temperature data from a Bruker Kappa 
APEX-II DUO diffractometer with either MoKα or CuKα radiation. For all structures, H atoms 
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were located from difference maps but constrained in calculated positions during refinement. For 
1a, Z' = 3/2, for 1b, Z' = 1/2, and for 1e, 3a and 4, Z' = 2. 3a was the hemihydrate and a 
nonmerohedral twin, and 4 was also a nonmerohedral twin. 
 
Crystal data 1a: C21H25BN2O2, M = 348.24, monoclinic, a = 20.2592(14), b = 11.2886(8), 
c = 12.7820(8) Å, β = 93.968(3)ᵒ, U = 2916.2(3) Å3, T = 100 K, space group P2/c, Z = 6, Dc = 
1.190 g cm-3, μ(Cu Kα) = 0.597 mm-1, 24457 reflections measured, θmax = 68.8˚, 5251 unique (Rint 
= 0.032). The final R = 0.040 (4321 I>2σ(I) data), wR(F2) = 0.105 (all data), CCDC 1035578.  
 
Crystal data 1b: C23H29BN2O2, M = 376.29, monoclinic, a = 9.1588(4), b = 11.4850(7), c 
= 10.1066(4) Å, β = 96.860(2)ᵒ, U = 1055.49(9) Å3, T = 100 K, space group P2/n, Z = 2, Dc = 
1.184 g cm-3, μ(Mo Kα) = 0.075 mm-1, 33635 reflections measured, θmax = 29.4˚ 3096 unique (Rint 
= 0.045). The final R = 0.043 (2411 I>2σ(I) data), wR(F2) = 0.119 (all data), CCDC 1035579.  
 
Crystal data 1c: C25H33BN2O2, M = 404.34, monoclinic, a = 9.0299(11), b = 16.252(2), c 
= 16.2554(19) Å, β = 102.241(7)ᵒ, U = 2331.3(5) Å3, T = 100 K, space group P21/c, Z = 4, Dc = 
1.152 g cm-3, μ(Mo Kα) = 0.072 mm-1, 12118 reflections measured, θmax = 25.9˚, 4417 unique (Rint 
= 0.091). The final R = 0.058 (2457 I>2σ(I) data), wR(F2) = 0.134 (all data), CCDC 1035580.  
 
Crystal data 1e: C25H25BN2O2, M = 396.28, monoclinic, a = 7.9474(8), b = 11.8269(10), c 
= 45.453(4) Å, β = 92.521(6)ᵒ, U = 4268.2(7) Å3, T = 100 K, space group P21/n, Z = 8, Dc = 1.233 
g cm-3, μ(Cu Kα) = 0.611 mm-1, 18058 reflections measured, θmax = 67.4˚, 7057 unique (Rint = 
0.045). The final R = 0.080 (5633 I>2σ(I) data), wR(F2) = 0.180 (all data), CCDC 1035581.  
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Crystal data 3a: C23H27BN2O4•0.5(H2O), M = 415.28, triclinic, a = 7.6310(6), b = 
15.4871(12), c = 19.4805(16) Å, α = 72.585(4), β = 84.215(4), γ = 89.809(4)˚, U = 2184.7(3) Å3, 
T = 100 K, space group P-1, Z = 4, Dc = 1.263 g cm
-3, μ(Cu Kα) = 0.703 mm-1, 15119 reflections 
measured, θmax = 66.9˚, 7555 unique (Rint = 0.108). The final R = 0.067 (5951 I>2σ(I) data), 
wR(F2) = 0.196 (all data), CCDC 1035582.  
 
Crystal data 4: C39H39BN8O2, M = 662.59, triclinic, a = 11.1659(8), b = 16.0899(12), c = 
19.5309(13) Å, α = 90.127(5), β = 92.245(5), γ = 96.332(5)˚, U = 3484.7(4) Å3, T = 90 K, space 
group P-1, Z = 4, Dc = 1.263 g cm
-3, μ(Cu Kα) = 0.639 mm-1, 33229 reflections measured, θmax = 
67.7˚, 11371 unique (Rint = 0.062). The final R = 0.049 (8767 I>2σ(I) data), wR(F2) = 0.123 (all 
data), CCDC 1051095. 
 
2.4.4 Steady-state Absorption and Fluorescence Spectroscopy 
 The photophysical properties of compounds 1, 1a-e, 2, 2a, 3, 3a and 4 were determined by 
preparing a stock solution with a concentration of 5 × 10-5 M and diluting it to appropriate 
concentrations for absorbance and emission spectra measurements. All the absorption spectra were 
obtained using a Varian Cary 50 UV/visible spectrophotometer. The optical density, ε, were taken 
by preparing solution concentrations between 7.5 × 10-6 and 2.5 × 10-5 M in order to get λmax 
between 0.5 and 1.0. Emission spectra were measured on a PTI QuantaMaster4/2006SE 
spectrofluorometer with the slit width set at 3 nm. All absorbance and emission spectra were 
acquired within 3 h of fresh solution preparation, at room temperature. BODIPYs 1, 2, and 3 were 
used as a standard in THF for calculating the fluorescence quantum yields with an excitation at 
480 nm (BODIPY 1 Φf = 0.56,30 BODIPY 2 Φf = 0.93,29 BODIPY 3 Φf = 0.43),29 as previously 
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reported. Rhodamine 6G (Φf = 0.95 in EtOH) was used as the reference for compounds 1, 1a-e, 2, 
2a, 3, 3a, and 4 in toluene. A spectrophotometric cell with a path length of 10 mm was used.  
2.4.5 Computational Modeling 
 The reaction mechanism was studied by electronic structure calculations at the B3LYP/6-
31+G(d,p) level. The hybrid Becke’s Three Parameter DFT Functional was used.39-40 The solvent 
effects were taken into account using the Polarized Continuum Model (PCM).41-42 Atomic charges 
were calculated following the NPA method.43-44 The geometries of all structures were optimized 
without symmetry constraints. The stationary points on the potential energy surface were 
confirmed with frequency calculations. All calculations were performed using the Gaussian 09 
program package.  
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CHAPTER 3: SYNTHESIS AND CHARACTERIZATION OF 4,4-DICYANO- AND 4,4-
FUNCTIONALIZED BODIPYS[a]  
 
3.1 Introduction 
Recent growth in fluorescence labeling for bioanalytical purposes has provided new 
developments in cellular biology, bioimaging, medicine, and pharmacy fields. One of the most 
promising fluorophores to be used for these applications is boron dipyrromethene (also known as 
BODIPY). The distinct characteristics of BODIPY are high photochemical and thermal stabilities, 
large molar extinction coefficients, high fluorescence quantum yields, and ease of modification.  
Postmodification of the BODIPY core has been an appealing topic in the past years.1-3 
Functionalization at various positions of the BODIPY core provides new robust organic dyes with 
fascinating optical properties such as with fluorescence quantum yield, moderate Stokes shifts, 
and large molar extinction coefficients. However, one of the limitation is the moderate Stokes shift 
(~20 mm) generally displayed by many known BODIPY dyes. One particular position on the 
BODIPY framework that is being investigated is the boron center for its potential enhancement of 
the Stokes shifts and fluorescence quantum yields of BODIPYs.  
There are a few boron functionalization approaches toward synthesis of C- and E-
BODIPYs. C-BODIPYs have an aryl or alkyl group chelated to the boron center while E-
BODIPYs have ethynyl groups. The first approach consists of reaction between dipyrromethenes 
with haloborane compounds.4-12 Holten and coworkers4 reported the first 4,4-dialkyl-BODIPYs 
via dipyrromethene complexation with dialkyboron analogues such as bromodimethylborane, 
dibutylboron triflate, or 9-BBN triflate. Using the latter methodology, BODIPYs bearing 4-mono- 
and 4,4’-substituents have been reported.5 Several groups have reported the use of halogenated 
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boranes to introduce oxygen substituents on boron in one step.6-8 On the other hand, more 
constrained BODIPYs were synthesized through cyclization of 3,5-diaryl-substituted groups with 
boron-containing compounds.9-12  
Another approach is the direct substitution of the fluoride atoms at the boron center with 
carbon nucleophiles. Using Grignard or organolithium reagents, several C- and E-BODIPYs were 
synthesized in one or two steps with dialkyl, diaryl, and dialkynyl groups.13-21 These E-BODIPYs 
have been shown to induce large Stokes shifts and found to be relatively stable under strong basic 
and acidic conditions. Using the latter method, dimeric dialkynyl-BODIPYs were reported.17 A 
similar strategy was previously employed for the synthesis of a 4,4’-dicyano-BODIPY using 
trimethylsilylcyanide in the presence of BF3•OEt2 or SnCl4 as catalyst.18 Carbon nucleophiles 
chelating to the boron center provides a more stable BODIPY compared to its BF2 precursor.
22 
In order to broaden the scope of boron functionalization, development of milder carbon 
nucleophiles and unsymmetric substitution on the boron center must be studied. In this chapter, 
we investigated the reactivity of Lewis acid mediated boron functionalizations and extend this 
methodology to the synthesis of new 4,4-dicyano-BODIPYs. In addition, we also explored and 
prepared a series of novel functionalized BODIPYs bearing phenyl and various substituents at the 
boron center. These compounds 7a-g and 8a-g were synthesized in a three step one-pot reaction 
between dipyrromethenes and dichlorophenylborane, followed by replacement of chloride atom 
with fluoride and various carbon- and oxygen-centered nucleophiles. These BODIPYs’ structural, 
spectroscopic, and fluorescence properties are reported and discussed in this chapter.  
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3.2 Results and Discussion 
3.2.1 Syntheses  
Five BODIPYs 1-5 were synthesized according to previous reports.23-24 We begin by 
following a previously reported procedure from Burgess and coworkers18 for the synthesis of 4,4-
dicyano-BODIPYs. Our preliminary investigation began with various Lewis acids (Table 3.1). 
Using tin tetrachloride (SnCl4) and shorter amount of time (10 min) at ambient temperature, 
BODIPY 1a can be synthesized and isolated with 79% yield while boron trifluoride etherate 
(BF3OEt2) and longer time (2 hours) gave 84% yield. Indeed, the product yield decreased to 39% 
yield when a milder Lewis acid (AlCl3) was used. However, the isolated yield increased up to 49% 
at reflux temperature. This is in agreement with our previous studies of reaction conditions at room 
temperature reflux conditions.25 
Table 3.1: Preliminary studies for synthesis of Lewis acid mediated 4,4’-dicyano-BODIPY. 
 
Entry Lewis acid Temp Time Yield (%) 
1 SnCl4 25 ᵒC 10 min 79 
2 BF3·OEt2 25 ᵒC 2 h 84 
3 AlCl3 40 ᵒC 2 h 49 
4 AlCl3 25 ᵒC 1 h 39 
 
To further investigate and optimize the scope of our reaction, we subjected BODIPYs 1-5 
to Lewis acid mediated substitutions using TMSCN as nucleophile to study their reactivity toward 
boron functionalization (Table 3.2). When BODIPY 2 containing two electron-donating groups on 
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the 8-aryl substituent was subjected to above conditions, the corresponding 4,4’-dicyano-BODIPY 
2a was obtained in 37% yield. On the other hand, BODIPY 3 with an electron-withdrawing 
methoxycarbonyl group on the 8-aryl produced BODIPY 3a in 65% yield. BODIPYs 4a and 5a 
with meso-free and meso-phenyl substituent, respectively were obtained in 51% and 81% yields. 
Table 3.2: Synthesis of 4,4’-dicyano-BODIPYs 1a-5a with isolated yields. 
 
BODIPY R Ar Yield (%) 
1a H Ph 79 
2a H 3,4-(OMe)2Ph 37 
3a H 4-CO2MePh 65 
4a Et Ph 81 
5a Et H 51 
 
In the presence of a Lewis acid (AlCl3, BF3OEt2, BCl3 and SnCl4), these methods can 
afford either the 4-mono- or 4,4’-disubstituted BODIPYs depending on the reaction conditions. In 
order to prepare 4,4’-difunctionalized BODIPYs containing two different substituents on the boron 
center, additional synthetic steps are required. The aim of our work is to synthesize 4,4’-
difunctionalized BODIPYs in one pot. Our initial synthetic approach was to treat BODIPY 4 with 
triethylamine and dichlorophenylborane to produce BODIPY 7b, as previously reported.8,26 
Unfortunately, thin layer chromatography (TLC) indicated presence of the starting material. It has 
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been recently reported that BODIPYs can react with boron trichloride followed by a Grignard 
reagent or alkoxide to afford the corresponding difunctionalized BODIPYs.26 
 
Scheme 3.1: Attempted reaction for synthesis of 4,4-difunctionalized-BODIPY 7b. 
 Alternatively, we also attempted to use the commercially available 2,4-dimethyl pyrrole in 
a three-step one-pot reaction BODIPY synthesis with dichlorophenylborane, followed by sodium 
methoxide to give BODIPY 6 with phenyl and methoxy substituents with an overall yield of 4%. 
Due to the low overall percent yield, we investigated the use of dipyrromethenes as our starting 
material for further functionalization with various nucleophiles. 
 
 
Scheme 3.2: Synthesis of 4,4-difunctionalized-BODIPY 6 from 2,4-dimethyl pyrrole. 
 
The starting dipyrrin hydrochloride salts 7 and 8 were synthesized from ketopyrrole and 
the corresponding pyrroles as previously reported.27 The three-step one-pot reaction consists of 
treating dipyrrins 7 or 8 in anhydrous dichloromethane with 5 equiv of triethylamine (TEA). After 
30 min, phenylboron dichloride (5 equiv) was added dropwise to the mixture, followed by 10 equiv 
of a nucleophile, and the reaction was stirred at room temperature for an additional 1-2 hours to 
afford the corresponding 4,4-difunctionalized BODIPYs 7a-g and 8a-g.  
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Scheme 3.3: One-pot synthesis of BODIPYs from dipyrrins. 
For comparison purposes between various substituents on the boron center, dipyrrins 7 and 
8 were also reacted with triethylamine and complexation with BF3•OEt2 to give F-BODIPYs 4 and 
9 in 68 and 41% yields, respectively.28 The isolated yields (14-63%) obtained for the target 4,4’-
difunctionalized BODIPYs 7a-g and 8a-g are given in Table 3.3. Some nucleophiles resulted in 
lower yields due to the competing reaction with water to give the hydroxide derivatives as by-
products, which have been previously isolated and characterized.6,29 Using tetrabutylammonium 
fluoride (TBAF) as the fluoride source, 4-phenyl-BODIPYs 7a and 8a were obtained in 52% and 
41% yields, respectively which are milder conditions than those reported in the literature.6,29-30 
This indicates that the B-Cl bond strength is weaker and more easily displaced than the B-F bond, 
and thus the reaction does not require elevated temperature or the presence of Lewis acid 
activators. 
 
Scheme 3.4: Synthesis of F-BODIPYs 4 and 9 from dipyrrins. 
Hard and soft nucleophiles were screened under our above milder reaction conditions. Soft 
nucleophile such as trimethylsilyl cyanide (TMSCN) has been used previously for boron 
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functionalization through Lewis acid mediation (tin tetrachloride or boron trifluoride).18 However, 
hard nucleophiles such as alkoxides and acetate also produced the target BODIPYs in moderate 
yields (Table 3.3). Other nucleophiles containing amine, ester and acetylene functionalities can be 
employed under our milder conditions, thus allowing for further functionalization or conjugation 
to the BODIPY through the boron atom.18,25,31  
Table 3.3: Yields and 11B NMR chemical shifts (128 MHz, CDCl3, all singlets) for BODIPYs 7a-
g and 8a-g. 
BODIPY R R1 Yield (%) δ (ppm) 
7a Et F 52 2.43 
7b Et OMe 63 2.18 
7c Et CN 17 -9.42 
7d Et OAc 25 -0.48 
7e Et OCH2CH2NHBoc 32 1.54 
7f Et O(CH2CH2O)3Me 21 1.63 
7g Et OCH2C≡CH 25 1.73 
8a H F 41 2.23 
8b H OMe 49 2.10 
8c H CN 18 -7.43 
8d H OAc 16 -0.34 
8e H OCH2CH2NHBoc 14 1.10 
8f H O(CH2CH2O)3Me 15 1.21 
8g H OCH2C≡CH 31 1.65 
 
The addition of a polyethylene glycol group is used for increasing solubility of BODIPY 
without changing the absorption and emission wavelengths. We also attempted to deprotect the 
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Boc group in BODIPY 7e to give BODIPY 7h, but the deprotection failed and resulted in BODIPY 
7j. We suspected that the B-O bond is reactive toward TFA conditions as previously reported.22 
 
Scheme 3.5: Attempt Boc deprotection reaction of BODIPY 7e. 
3.2.2 Structural Characterization 
All BODIPYs were characterized by 1H, 13C, and 11B NMR, HRMS (ESI-TOF), and UV-
Vis absorbance and fluorescence spectrophotometry. BODIPYs 1a, 3a-5a, 7b, 7c, and 8c were 
also characterized by X-ray crystallography (see Figure 3.1). Different substituents on the boron 
center have no substantial effect on the 3,5-dimethyl and 2,6-diethyl chemical shifts. Indeed, the 
1H NMR spectra clearly show that the 3,5-methyl groups appear as a singlet around 2.2 ppm and 
the 1,7-methyl groups at 1.3 ppm for BODIPYs 7a-g. However, the 1,3,5,7-methyl groups for 
BODIPYs 8a-g consist of 4 singlets at 2.2, 2.1, 1.4 and 1.3 ppm. Significant differences were 
observed in the 11B NMR of the BODIPYs using BF3•OEt2 as reference (δ = 0 ppm), as shown in 
Table 3.3. The 11B NMR spectra clearly shows the 4,4’-dicyano-BODIPYs 1a-5a via the singlet 
peaks attributed to B(CN)2 at ca. -16.9 ppm. Indeed, the 
11B NMR spectra showed that the chemical 
shifts are influenced by the electron density of the substituents bound to boron, which is greater 
for BODIPYs 1a-5a and less for the 4-phenyl-BODIPYs 7c and 8c, and lowest for the mono-
fluorides 7a and 8a. BODIPYs 4 and 9 bearing two fluorides, have a triplet peak at 0.7 ppm with 
ca. J(11B-19F) = 33 Hz. The 11B NMR spectra clearly shows a singlet for all BODIPYs 7a-g and 
8a-g with chemical shifts ranging from the mono-fluoride 7a (2.43 ppm) to the cyano derivative 
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7c (9.42 ppm). For the case of 7a and 8a, the lack of boron-fluorine coupling might be due to 
quadrupolar broadening, as previously observed.6,14  
Crystals suitable for X-ray analysis were grown by slow diffusion of hexane in 
dichloromethane (for BODIPYs 7c and 8c) or in ethyl acetate (for BODIPY 7b) and slow diffusion 
in dichloromethane for BODIPYs 1a-5a. Structures are shown in Figure 3.1. The C3N2B cores of 
both of the two independent molecules of 1a (only one shown in Fig. 1) are nearly planar, with 
mean deviations 0.012 and 0.017 Å.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.1: Molecular structures of BODIPYs 1a and 3a-5a from X-ray crystal analysis, with 
50% probability ellipsoids. 
 
The phenyl groups form dihedral angle of 75.8 and 78.8° with those planes. In 3a, the 
central ring is nonplanar, with the B(CN)2 substituent tilted such that the B atom is 0.157 Å out of 
1a 
3a 
4a 5a 
1a 
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the plane of the other five atoms. The phenyl group of the meso substituent is nearly orthogonal to 
the central plane, with a dihedral angle of 88.1°. The central ring of 4a has a similar conformation 
to that of 3a, but with a smaller out-of-plane deviation for the B atom, 0.057 Å and a 77.6° dihedral 
angle for the phenyl ring. In 5a, the out-of-plane deviation for the B atom is somewhat larger, 
0.205 Å. In all cases, the central BN2C3 ring is fairly planar, with mean deviation of 0.020 Å for 
both 7b and 7c and 0.056 Å for 8c (Figure 3.2). The 8-mesophenyl is oriented approximately 
perpendicular to the BODIPY core plane, to avoid steric hindrance from the 1,7-dimethyl 
substituents, the dihedral angles being 84.1° for 7b, 85.3° for 7c, and 87.6° for 8c. Likewise, the 
phenyl group on boron forms dihedral angles with the central ring of 86.1° for 7b, 85.9° for 7c, 
and 83.2° for 8c. 
 
 
Figure 3.2: Molecular structures of BODIPYs 7b-c, and 8c from X-ray crystal analysis, with 
50% probability ellipsoids. 
 
3.2.3 Spectroscopic Study 
The spectroscopic properties of BODIPYs 7a-g, 8a-g, 4 and 9 were determined in 
dichloromethane at room temperature and the results are summarized in Table 3.4. All BODIPYs 
show absorptions (511-524 nm) in the visible range that correspond to the S0-S1 (π-π*) transition. 
The symmetric BODIPYs 7a-g showed strong absorption bonds with high molar absorption 
7b 7c 8c 
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coefficients (log ε = 4.6-4.9) in the range of 521-524 nm and emission bands between 533-537 nm. 
The asymmetric BODIPYs 8a-g also showed strong absorption bonds with high molar absorption 
coefficients (log ε = 4.7-5.0) and blue-shifted absorption bands (511-513 nm) and emission bands 
(521-523 nm). All BODIPYs showed Stokes shift ranging from 9 to 15 nm. 
Table 3.4: Absorption and emission spectroscopic properties of BODIPYs 7a-g, 8a-g, 4, and 9 in 
CH2Cl2 at room temperature. 
BODIPYs 
Absorption 
λmax (nm) 
Emission 
λmax (nm) 
log ε (M-1 cm-1) Φf 
Stokes’ shift  
(nm) 
7a 524 535 4.86 0.53 11 
7b 522 537 4.77 0.42 15 
7c 521 533 4.63 0.65 12 
7d 522 533 4.63 0.64 11 
7e 523 533 4.73 0.60 11 
7f 523 534 4.82 0.48 11 
7g 523 534 4.61 0.51 11 
8a 513 523 4.85 0.61 10 
8b 512 523 4.92 0.50 11 
8c 511 521 4.97 0.78 10 
8d 512 522 4.81 0.68 10 
8e 513 523 4.76 0.60 10 
8f 512 521 4.72 0.51 9 
8g 513 523 4.78 0.64 10 
4 526 536 4.68 0.74 10 
9 514 524 4.49 0.82 10 
ε = extinction coefficient;  Φf  = fluorescence quantum yield 
BODIPYs bearing flexible groups show decreased fluorescence quantum yields due to 
increased energy lost to non-radiative decay to the ground state, which is in agreement with 
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previous observations.25,32 BODIPYs bearing cyano substituents showed the largest fluorescence 
quantum yields, 0.65 for 7c and 0.78 for 8c when compared to other 4-phenyl-BODIPYs. 
3.3 Conclusions 
A series of new 4,4’-dicyano-BODIPYs 1a-5a were investigated and synthesized 
following a previous procedure. Lewis acid tin tetrachloride provided a convenient and robust 
methodology for functionalization at the boron center with cyano nucleophile. In addition, a novel 
route for the preparation of 4,4’-difunctionalized BODIPYs 7a-g and 8a-g bearing two different 
substituents at the boron center was developed. A three step one-pot reaction between dipyrrins 
with phenylboron dichloride, followed by addition with a nucleophile produced the target 
BODIPYs in moderate yields ranging from 14% to 63%. BODIPYs 7b and 8b containing a 
methoxide substituent were obtained in the highest yields while lower yields were achieved for 
milder nucleophiles (alcohols, TMSCN, acetate ion) due to the competing formation of the 
corresponding 4-hydroxyl-BODIPY derivatives. BODIPYs 7c and 8c containing cyano groups on 
boron exhibit the highest quantum yields compared to other substituents.  
3.4 Experimental 
3.4.1 General Information 
 All commercially available reagents were purchased from Sigma-Aldrich and were used 
without further purification. All anhydrous reactions were carried out with oven-dried glassware 
under a dry argon atmosphere. All the reactions were monitored by using Sorbent Technologies 
pre-coated polyester backed TLC (200 µm silica gel with indicator UV-254 nm). Flash column 
chromatography was performed using Sorbent Technologies 60 Å silica gel (230-400 mesh). Prep-
TLC 60 Å silica gel 20 x 20 cm (210-270 µm) was used. All 1H-, 13C-, and 11B-NMR spectral were 
collected using a Bruker AV-400 spectrometer in deuterated dichloromethane or chloroform as 
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solvents. The CDCl3 chemical shifts (δ) are reported in ppm with 7.27 for proton and 77.16 for 
carbon NMR as reference. The CD2Cl2 chemical shifts (δ) are reported in ppm with 5.23 for proton 
and 54.00 for carbon NMR as reference. The BF3•OEt2 was used as an external reference (δ 0.00) 
for boron NMR. Coupling constants are reported in hertz (Hz). All the mass spectra were collected 
using an Agilent 6210 ESI-TOF mass spectrometer. All melting points were recorded using a 
MEL-TEMP electrothermal instrument. 
3.4.2 Syntheses  
General procedure for synthesis of 4,4-dicyano-BODIPYs 1a-5a.18 BODIPYs 1-5 were 
dissolved in anhydrous dichloromethane (3 mL). Tin tetrachloride (1 M in dichloromethane, 0.5 
equiv) solution was added dropwise, followed by trimethylsilyl cyanide (7.0 equiv). After 10 min, 
the reaction was quenched with water and extracted with dichloromethane (2 x 5 mL). The organic 
layers were washed with sat. NaHCO3 (2 x 5 mL). The combined organic layers were washed with 
water (2 x 5 mL), dried over Na2SO4, and concentrated under reduced pressure. 
 
4,4-Dicyano-8-phenyl-1,3,5,7-tetramethyl-BODIPY (1a). The crude product was purified 
via TLC (eluent 80/20 hexane/ethyl acetate) to give a bright orange solid BODIPY 1a (16.5 mg, 
79%) that was recrystallized from 100% dichloromethane: 1H NMR (CDCl3, 400 MHz) δ 7.49-
7.40 (m, 3H), 7.25-7.17 (m, 3H), 6.09 (s, 2H), 2.66 (s, 6H), 1.34 (s, 6H); 13C NMR (CDCl3, 100 
MHz) δ 155.91, 144.47, 142.66, 133.97, 129.73, 129.49, 129.45, 127.67, 126.07, 125.33, 122.61, 
122.58, 15.43, 14.59; 11B NMR (CDCl3, 128 MHz) δ -16.92 (s); HRMS (ESI-TOF) m/z 360.1631 
[M + Na]+ calculated for C21H19BN4: 360.1645. 
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4,4-Dicyano-8-(3,4-dimethoxyphenyl)-1,3,5,7-tetramethyl-BODIPY (2a). The crude 
product was purified via TLC (eluent 50/50 hexane/ethyl acetate) to give a bright orange solid 
BODIPY 2a (10.8 mg, 37%) that was recrystallized from 100% acetone: 1H NMR (CDCl3, 400 
MHz) δ 7.02 (d, J = 8.2 Hz, 1H), 6.84 (dd, J = 8.2, 2.0 Hz, 1H), 6.79 (d, J = 2.0 Hz, 1H), 6.17 (s, 
2H), 3.97 (s, 3H), 3.89 (s, 3H), 2.73 (s, 6H), 1.53 (s, 6H); 13C NMR (CDCl3, 100 MHz) δ 155.83, 
150.08, 149.90, 144.46, 142.56, 130.07, 126.05, 122.50, 120.20, 111.71, 110.72, 56.21, 55.97, 
15.44, 14.71; 11B NMR (CDCl3, 128 MHz) δ -16.93 (s); HRMS (ESI-TOF) m/z 420.1843 [M + 
Na]+ calculated for C23H23BN4O2: 420.1828. 
 
4,4-Dicyano-8-(4-methoxycarbonylphenyl)-1,3,5,7-tetramethyl-BODIPY (3a). The crude 
product was purified via TLC (eluent 30/70 hexane/dichloromethane) to give a bright orange solid 
BODIPY 3a (18.0 mg, 65%) that was recrystallized from 100% acetone: 1H NMR (CDCl3, 400 
MHz) δ 8.23 (d, J = 7.9 Hz, 2H), 7.42 (d, J = 7.9 Hz, 2H), 6.18 (s, 2H), 3.99 (s, 3H), 2.74 (s, 6H), 
1.41 (s, 6H); 13C NMR (CDCl3, 100 MHz) δ 166.22, 156.51, 144.21, 138.65, 131.35, 130.64, 
128.13, 122.89, 52.49, 15.48, 14.76; 11B NMR (CDCl3, 128 MHz) δ -16.94 (s); HRMS (ESI-TOF) 
m/z 396.1867 [M + H]+ calculated for C23H21BN4O2: 396.1869. 
 
4,4-Dicyano-8-phenyl-2,6-diethyl-1,3,5,7-tetramethyl-BODIPY (4a). The crude product 
was purified via TLC (eluent 80/20 hexane/ethyl acetate) to give a bright orange solid BODIPY 
4a (17.5 mg, 81%) that was recrystallized from 1:1 acetone/dichloromethane: 1H NMR (CDCl3, 
400 MHz) δ 7.45 (p, J = 3.5 Hz, 3H), 7.20 (dd, J = 6.8, 3.1 Hz, 3H), 2.62 (s, 6H), 2.28 (q, J = 7.6 
Hz, 4H), 1.24 (s, 6H), 0.93 (t, J = 7.6 Hz, 6H); 13C NMR (CDCl3, 100 MHz) δ 153.97, 141.04, 
139.85, 134.78, 134.21, 129.32, 129.27, 127.98, 17.21, 14.51, 13.39, 11.85; 11B NMR (CDCl3, 
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128 MHz) δ -16.84 (s); HRMS (ESI-TOF) m/z 416.2257 [M + Na]+ calculated for C25H27BN4: 
416.2264. 
 
4,4-Dicyano-2,6-diethyl-1,3,5,7-tetramethyl-BODIPY (5a). The crude product was 
purified via TLC (eluent 80/20 hexane/ethyl acetate) to give a bright orange solid BODIPY 5a 
(12.3 mg, 51%) that was recrystallized from 1:1 acetone/dichloromethane: 1H NMR (CDCl3, 400 
MHz) δ 7.07 (s, 1H), 2.66 (s, 6H), 2.45 (q, J = 7.5 Hz, 4H), 2.22 (s, 6H), 1.10 (t, J = 7.5 Hz, 6H); 
13C NMR (101 MHz, Chloroform-d) δ 155.15, 138.11, 133.23, 130.74, 119.34, 17.40, 14.48, 
13.28, 9.49; 11B NMR (CDCl3, 128 MHz) δ -16.93 (s); HRMS (ESI-TOF) m/z 340.1944 [M + Na]+ 
calculated for C19H23BN4: 340.1949. 
 
General procedure for synthesis of dipyrrins 7 and 8.27 2,4-dimethyl ketopyrrole (1.0 equiv) 
was dissolved in anhydrous 8:1 pentane/dichloromethane at 0 °C. 2,4-dimethyl pyrrole or 3-ethyl-
2,4-dimethyl pyrrole (1.0 equiv) was added dropwise to the stirred mixture and warmed to room 
temperature. After 24 h, Et3N (1.0 equiv) was added dropwise to the reaction mixture for an hour 
and quenched with water (10 mL) and extracted with dichloromethane (10 mL). The combined 
organic layers were dried over MgSO4 and concentrated under reduced pressure. The crude 
products were purified by column chromatography (eluent EtOAc to 5% MeOH/EtOAc to 30% 
MeOH/EtOAc) to afford the corresponding dipyrrins 7 and 8. 
 
Dipyrrin (7). 27% yield: 1H NMR (CDCl3, 400 MHz) δ 7.37 (s, 3H), 7.27-7.21 (m, 2H), 
2.28 (s, 6H), 2.24 (q, 4H, J = 7.32 Hz) 1.15 (s, 6H), 0.93 (t, 6H, J = 7.16 Hz); 13C NMR (CDCl3, 
100 MHz) δ 150.25, 138.92, 137.65, 136.08, 134.88, 131.39, 129.73, 128.53, 128.10, 17.69, 15.00, 
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14.50, 11.85; HRMS (ESI-TOF) m/z 333.2325 [M + H]+ calculated for C23H28N2: 333.2335. These 
data are in agreement with previous reported.33 
 
Dipyrrin (8). 31% yield: 1H NMR (CDCl3, 400 MHz) δ 7.61 (t, 1H, J = 7.36 Hz), 7.51 (t, 
2H, J = 7.80 Hz), 7.32 (d, 2H, J = 7.20 Hz), 6.17 (s, 1H), 2.71 (s, 3H), 2.68 (s, 3H), 2.39 (q, 2H, J 
= 7.52 Hz), 1.41 (s, 3H), 1.34 (s, 3H), 1.04 (t, 3H, J = 7.48 Hz); 13C NMR (CDCl3, 100 MHz) δ 
139.35, 137.74, 134.40, 130.65, 130.33, 129.88, 129.54, 128.86, 118.19, 50.45, 17.61, 14.67, 
14.52, 14.34, 12.29; HRMS (ESI-TOF) m/z 305.2012 [M + H]+ calculated for C21H24N2: 305.2024. 
 
General procedure for synthesis of BODIPYs 7a-g and 8a-g. Dipyrrins 7 or 8 (1.0 equiv.) 
were dissolved in anhydrous CH2Cl2 (5 mL). Et3N (5.0 equiv) was added dropwise to the solution 
at room temperature. Dichlorophenylborane (5.0 equiv) was added dropwise and the mixture was 
stirred for 1 h. Nucleophile (10.0 equiv) was added dropwise and the final mixture stirred for an 
additional 1-2 h while followed by TLC. All crude products were concentrated under reduced 
pressure and purified as described below to afford BODIPYs 7a-g and 8a-g.  
  
4-Fluoro-4-phenyl-8-phenyl-2,6-diethyl-1,3,5,7-tetramethyl-BODIPY (7a). The crude 
product was purified via TLC (eluent 50/50 hexane/dichloromethane) to give an orange solid 
BODIPY 7a (11.4 mg, 52%) that was recrystallized from 50/50 hexane/EtOAc: mp 210-215 °C; 
1H NMR (CD2Cl2, 400 MHz) δ 7.57-7.51 (m, 3H), 7.43-7.40 (m, 3H), 7.37-7.35 (m, 1H), 7.20 (t, 
2H, J = 6.9 Hz), 7.15-7.11 (m, 1H), 2.23 (q, 4H, J = 7.6 Hz), 2.17 (s, 6H), 1.32 (s, 6H), 0.91 (t, 
3H, J = 7.5 Hz); 13C NMR (CDCl3, 100 MHz) δ 153.91, 140.55, 137.07, 136.54, 132.81, 132.10, 
132.07, 130.48, 129.11, 129.05, 128.80, 128.73, 128.58, 127.00, 126.09, 17.25, 14.78, 13.20, 
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13.16, 11.89; 11B NMR (CDCl3, 128 MHz) δ 2.43 (s); HRMS (ESI-TOF) m/z 438.2752 [M + H]+ 
calculated for C29H32BFN2: 438.2740. 
 
4-Methoxy-4-phenyl-8-phenyl-2,6-diethyl-1,3,5,7-tetramethyl-BODIPY (7b). The crude 
product was purified via TLC (eluent 50/50 hexane/dichloromethane) to give an orange solid 
BODIPY 7b (29.3 mg, 63%) that was recrystallized from 50/50 hexane/EtOAc: mp 160-165 °C; 
1H NMR (CD2Cl2, 400 MHz) δ 7.56-7.50 (m, 3H), 7.43-7.36 (m, 4H), 7.15 (t, 2H, J = 7.4 Hz), 
7.10-7.05 (m, 1H), 3.09 (s, 3H), 2.23 (q, 4H, J = 7.6 Hz), 2.16 (s, 6H), 1.32 (s, 6H), 0.90 (t, 3H, J 
= 7.6 Hz); 13C NMR (CDCl3, 100 MHz) δ 153.66, 140.51, 136.91, 136.00, 132.51, 132.36, 131.32, 
129.08, 128.89, 128.83, 128.82, 128.58, 126.79, 125.59, 49.20, 17.31, 14.85, 12.86, 11.93; 11B 
NMR (CDCl3, 128 MHz) δ 2.18 (s); HRMS (ESI-TOF) m/z 472.2771 [M + Na]+ calculated for 
C30H35BN2O: 472.2775. 
 
4-Cyano-4-phenyl-8-phenyl-2,6-diethyl-1,3,5,7-tetramethyl-BODIPY (7c). The crude 
product was purified via TLC (eluent 80/20 hexane/EtOAc) to give an orange solid BODIPY 7c 
(8.6 mg, 17%) that was recrystallized from 50/50 hexane/dichloromethane: mp 110-115 °C; 1H 
NMR (CD2Cl2, 400 MHz) δ 7.56-7.54 (m, 3H), 7.49 (d, 2H, J = 6.6 Hz), 7.42-7.38 (m, 1H), 7.25 
(t, 2H, J = 6.9 Hz), 7.21-7.17 (m, 1H), 2.25 (q, 4H, J = 7.6 Hz), 2.15 (s, 6H), 1.34 (s, 6H), 0.91 (t, 
3H, J = 7.6 Hz); 13C NMR (CDCl3, 100 MHz) δ 154.0, 140.43, 136.89, 136.18, 132.76, 132.29, 
130.57, 129.11, 128.99, 128.78, 128.73, 128.64, 126.90, 125.70, 17.30, 14.83, 13.55, 11.89; 11B 
NMR (CDCl3, 128 MHz) δ -9.42 (s); HRMS (ESI-TOF) m/z 467.2618 [M + Na]+ calculated for 
C30H32BN3: 467.2613. 
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4-Acetoxy-4-phenyl-8-phenyl-2,6-diethyl-1,3,5,7-tetramethyl-BODIPY (7d). The crude 
product was purified via TLC (eluent 80/20 hexane/EtOAc) to give an orange solid BODIPY 7d 
(9.5 mg, 25%) that was recrystallized from 50/50 hexane/EtOAc: mp 150-155 °C; 1H NMR 
(CD2Cl2, 400 MHz) δ 7.56-7.48 (m, 3H), 7.44-7.41 (m, 2H), 7.39-7.36 (m, 1H), 7.21 (t, 2H, J = 
6.8 Hz), 7.17-7.12 (m, 1H), 2.22 (q, 4H, J = 7.6 Hz), 2.07 (s, 3H), 2.04 (s, 6H), 1.33 (s, 6H), 0.89 
(t, 6H, J = 7.6 Hz); 13C NMR (CDCl3, 100 MHz) δ 172.40, 152.41, 140.88, 136.76, 136.71, 132.47, 
131.25, 129.10, 129.06, 128.89, 128.60, 126.94, 126.06, 23.19, 17.38, 14.75, 13.12, 12.09; 11B 
NMR (CDCl3, 128 MHz) δ -0.48 (s); HRMS (ESI-TOF) m/z 500.2720 [M + Na]+ calculated for 
C31H35BN2O2: 500.2737. 
 
4-(N-Boc-ethanolyl)-4-phenyl-8-phenyl-2,6-diethyl-1,3,5,7-tetramethyl-BODIPY (7e). 
The crude product was purified via TLC (eluent 80/20 Hexane/EtOAc) to give an orange solid 
BODIPY 7e (15.5 mg, 32%) that was recrystallized from 50/50 hexane/EtOAc: mp 55-60 °C; 1H 
NMR (CD2Cl2, 400 MHz) δ 7.56-7.51 (m, 3H), 7.45-7.36 (m, 3H), 7.37-7.35 (m, 1H), 7.15 (t, 2H, 
J = 7.4 Hz), 7.10-7.05 (m, 1H), 3.24-3.18 (m, 2H), 3.16-3.15 (m, 2H), 2.21 (q, 4H, J = 7.6 Hz), 
2.12 (s, 6H), 1.42 (s, 9H), 1.31 (s, 6H), 0.89 (t, 6H, J = 7.6 Hz); 13C NMR (CDCl3, 100 MHz) δ 
156.34, 153.54, 140.56, 136.81, 136.14, 132.57, 131.21, 129.07, 128.99, 128.83, 128.76, 128.63, 
126.71, 125.64, 28.65, 17.30, 14.80, 13.06, 11.93; 11B NMR (CDCl3, 128 MHz) δ 1.54 (s); HRMS 
(ESI-TOF) m/z 601.3561 [M + Na]+ calculated for C36H46BN3O3: 601.3573. 
 
4-(Triethyleneglycol monomethyl ether)-4-phenyl-8-phenyl-2,6-diethyl-1,3,5,7-
tetramethyl-BODIPY (7f). The crude product was purified via TLC (eluent 80/20 hexane/EtOAc) 
to give an orange/red oil BODIPY 7f (11.4 mg, 21%) that was recrystallized from 50/50 
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hexane/EtOAc. 1H NMR (CD2Cl2, 400 MHz) δ 7.56-7.50 (m, 3H), 7.44-7.40 (m, 3H), 7.38-7.36 
(m, 1H), 7.15 (t, 2H, J = 8 Hz), 7.10-7.06 (m, 1H), 3.64-3.62 (m, 2H), 3.60-3.57 (m, 6H), 3.51-
3.48 (m, 2H), 3.33 (s, 3H), 3.30 (t, 2H, J = 5.6 Hz), 2.22 (q, 4H, J = 7.6 Hz), 2.15 (s, 6H), 1.31 (s, 
6H), 0.89 (t, 6H, J = 7.5 Hz); 13C NMR (CD2Cl2, 100 MHz) δ 137.26, 136.64, 133.02, 132.64, 
131.67, 129.53, 129.41, 129.32, 129.23, 129.00, 127.09, 126.02, 73.21, 72.51, 71.23, 71.14, 70.99, 
61.49, 59.18, 17.62, 15.06, 13.21, 12.12; 11B NMR (CDCl3, 128 MHz) δ 1.63 (s); HRMS (ESI-
TOF) m/z 604.3557 [M + Na]+ calculated for C36H47BN2O4: 604.3565. 
 
4-(Pro-2-yn-1-yloxy)-4-phenyl-8-phenyl-2,6-diethyl-1,3,5,7-tetramethyl-BODIPY (7g). 
The crude product was purified via TLC (eluent 50/50 hexane/dichloromethane) to give an orange 
solid BODIPY 7g (13.9 mg, 25%) that was recrystallized from 50/50 hexane/ethyl acetate: mp 
130-135 °C; 1H NMR (CDCl3, 400 MHz) δ 7.56-7.50 (m, 3H), 7.42 (d, 3H, J = 6.6 Hz), 7.38-7.34 
(m, 1H), 7.17 (t, 2H, J = 8.1 Hz), 7.10 (t, 1H, J = 7.2 Hz), 3.92 (d, 1H, J = 2.4 Hz), 2.22 (q, 4H, J 
= 6.6 Hz), 2.21 (s, 3H), 2.17 (s, 3H), 1.32 (s, 3H), 1.31 (s, 3H), 0.90 (t, 6H, J = 7.5 Hz); 13C NMR 
(CDCl3, 100 MHz) δ 154.19, 140.33, 136.79, 136.34, 132.73, 132.55, 131.20, 129.10, 128.96, 
128.81, 128.79, 128.64, 126.73, 125.69, 70.92, 50.09, 17.28, 14.80, 13.22, 11.93; 11B NMR 
(CDCl3, 128 MHz) δ 1.73 (s); HRMS (ESI-TOF) m/z 496.2771 [M + Na]+ calculated for 
C32H35BN2O: 496.2754. 
 
4-Fluoro-4-phenyl-8-phenyl-6-ethyl-1,3,5,7-tetramethyl-BODIPY (8a). The crude product 
was purified via TLC (eluent 50/50 hexane/dichloromethane) to give an orange solid BODIPY 8a 
(11.4 mg, 41%) that was recrystallized from 50/50 hexane/EtOAc: mp 120-125 °C; 1H NMR 
(CD2Cl2, 400 MHz) δ 7.57-7.51 (m, 3H), 7.43-7.40 (m, 3H), 7.37-7.35 (m, 1H), 7.20 (t, 2H, J = 
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6.8 Hz), 7.16-7.12 (m, 1H), 5.88 (s, 1H), 2.24 (q, 2H, J = 7.6 Hz), 2.19 (s, 3H), 2.15 (s, 3H), 1.39 
(s, 3H), 1.35 (s, 3H), 0.91 (t, 3H, J = 7.6 Hz); 13C NMR (CDCl3, 100 MHz) δ 141.27, 140.64, 
136.12, 133.58, 132.06, 132.02, 129.17, 129.11, 128.84, 128.62, 128.43, 127.05, 126.19, 120.85, 
17.25, 15.35, 14.68, 14.56, 13.32, 11.94; 11B NMR (CDCl3, 128 MHz) δ 2.23 (s); HRMS (ESI-
TOF) m/z 410.2439 [M + H]+ calculated for C27H28BFN2: 410.2398. 
 
4-Methoxy-4-phenyl-8-phenyl-6-ethyl-1,3,5,7-tetramethyl-BODIPY (8b). The crude 
product was purified via TLC (eluent dichloromethane) to give an orange solid BODIPY 8b (34.4 
mg, 49%) that was recrystallized from 50/50 hexane/EtOAc: mp 120-125 °C; 1H NMR (CD2Cl2, 
400 MHz) δ 7.57-7.51 (m, 3H), 7.43-7.36 (m, 4H), 7.15 (t, 2H, J = 7.3 Hz), 7.10-7.06 (m, 1H), 
5.86 (s, 1H), 3.10 (s, 3H), 2.24 (q, 2H, J = 7.5 Hz), 2.19 (s, 3H), 2.13 (s, 3H), 1.38 (s, 3H), 1.34 
(s, 3H), 0.91 (t, 3H, J = 7.6 Hz); 13C NMR (CDCl3, 100 MHz) δ 155.61, 153.68, 141.30, 139.67, 
137.10, 136.54, 133.41, 132.38, 131.94, 131.56, 129.21, 129.03, 128.77, 128.73, 126.91, 125.77, 
120.71, 60.59, 49.27, 21.24, 17.37, 15.24, 14.82, 14.71, 14.40, 13.04, 12.06; 11B NMR (CDCl3, 
128 MHz) δ 2.10 (s); HRMS (ESI-TOF) m/z 444.2458 [M + Na]+ calculated for C28H31BN2O: 
444.2468. 
 
4-Cyano-4-phenyl-8-phenyl-6-ethyl-1,3,5,7-tetramethyl-BODIPY (8c). The crude product 
was purified via TLC (eluent 80/20 hexane/EtOAc) to give an orange solid BODIPY 8c (5.1 mg, 
18%) that was recrystallized from 50/50 hexane/dichloromethane: mp 90-95 °C; 1H NMR 
(CD2Cl2, 400 MHz) δ 7.57-7.53 (m, 3H), 7.50-7.48 (m, 2H), 7.42-7.38 (m, 2H), 7.25 (t, 2H, J = 
6.8 Hz), 7.22-7.18 (m, 1H), 5.96 (s, 1H), 2.26 (q, 2H, J = 9.3 Hz), 2.17 (s, 3H), 2.13 (s, 3H), 1.40 
(s, 3H), 1.37 (s, 3H), 0.92 (t, 3H, J = 7.5 Hz); 13C NMR (CD2Cl2, 100 MHz) δ 141.53, 133.25, 
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129.78, 129.71, 129.49, 128.94, 128.80, 128.01, 127.39, 121.82, 112.37, 17.66, 16.00, 14.84, 
14.06, 12.28; 11B NMR (CDCl3, 128 MHz) δ -7.43 (s); HRMS (ESI-TOF) m/z 439.2305 [M + Na]+ 
calculated for C28H28BN3: 439.2297. 
 
4-Acetoxy-4-phenyl-8-phenyl-6-ethyl-1,3,5,7-tetramethyl-BODIPY (8d). The crude 
product was purified via TLC (eluent 80/20 hexane/EtOAc) to give an orange solid BODIPY 8d 
(3.2 mg, 16%) that was recrystallized from 50/50 hexane/EtOAc: mp 100-105 °C; 1H NMR 
(CDCl3, 400 MHz) δ 7.55-7.49 (m, 5H), 7.45-7.43 (m, 2H), 7.22 (t, 2H, J = 7.1 Hz), 7.19-7.16 (m, 
1H), 5.82 (s, 1H), 2.24 (q, 2H, J = 7.5 Hz), 2.11 (s, 3H), 2.05 (s, 3H), 2.02 (s, 3H), 1.38 (s, 3H), 
1.33 (s, 3H), 0.88 (t, 3H, J = 7.3 Hz); 13C NMR (CDCl3, 100 MHz) δ 172.45, 154.27, 152.31, 
146.25, 141.63, 140.05, 137.76, 136.32, 133.25, 132.42, 132.21, 131.78, 129.15, 128.95, 128.90, 
128.70, 128.43, 127.01, 126.19, 120.86, 29.85, 23.15, 17.35, 15.75, 15.35, 14.69, 14.65, 14.34, 
13.66, 13.24, 12.06; 11B NMR (CDCl3, 128 MHz) δ -0.34 (s); HRMS (ESI-TOF) m/z 472.2407 [M 
+ Na]+ calculated for C29H31BN2O2: 472.2397. 
 
4-(N-Boc-ethanolyl)-4-phenyl-8-phenyl-6-ethyl-1,3,5,7-tetramethyl-BODIPY (8e). The 
crude product was purified via TLC (eluent 80/20 hexane/EtOAc) to give an orange solid BODIPY 
8e (5.0 mg, 14%) that was recrystallized from 50/50 hexane/EtOAc: mp 60-65 °C; 1H NMR 
(CDCl3, 400 MHz) δ 7.56-7.51 (m, 3H), 7.45-7.41 (m, 3H), 7.37-7.36 (m, 1H), 7.17 (t, 2H, J = 6.8 
Hz), 7.10 (t, 1H, J = 7.0 Hz), 5.85 (s, 1H), 3.24 (t, 2H, J = 5.0 Hz), 3.18 (t, 2H, J = 4.6 Hz),  2.22 
(q, 2H, J = 7.9 Hz), 2.15 (s, 3H), 2.09 (s, 3H), 1.43 (s, 9H), 1.37 (s, 3H), 1.33 (s, 3H), 0.90 (t, 3H, 
J = 7.5 Hz); 13C NMR (CD2Cl2, 100 MHz) δ 132.78, 129.60, 129.50, 129.15, 129.03, 127.15, 
126.21, 120.97, 61.04, 28.74, 28.64, 17.61, 15.46, 14.92, 14.78, 13.38, 12.18; 11B NMR (CDCl3, 
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128 MHz) δ 1.10 (s); HRMS (ESI-TOF) m/z 601.3561 [M + Na]+ calculated for C36H46BN3O3: 
601.3573. 
 
4-(Tri(ethyleneglycol monomethyl ether)-4-phenyl-8-phenyl-6-ethyl-1,3,5,7-tetramethyl-
BODIPY (8f). The crude product was purified via TLC (eluent 80/20 hexane/EtOAc) to give an 
orange/red oil BODIPY 8f (6.1 mg, 15%) that was recrystallized from 50/50 hexane/EtOAc. 1H 
NMR (CD2Cl2, 400 MHz) δ 7.56-7.51 (m, 3H), 7.42 (t, 3H, J = 6.3 Hz), 7.38-7.34 (m, 1H), 7.16 
(t, 2H, J = 6.8 Hz), 7.12-7.07 (m, 1H), 5.85 (s, 1H), 3.64-3.61 (m, 2H), 3.60-3.56 (m, 6H), 3.51-
3.48 (m, 2H), 3.33 (s, 3H), 3.33-3.28 (m, 2H), 2.23 (q, 2H, J = 7.8 Hz), 2.17 (s, 3H), 2.12 (s, 3H), 
1.38 (s, 3H), 1.33 (s, 3H), 0.90 (t, 3H, J = 7.6 Hz); 13C NMR (CD2Cl2, 100 MHz) δ 156.02, 154.00, 
141.85, 140.19, 137.69, 136.84, 133.86, 132.81, 132.49, 132.24, 129.58, 129.46, 129.15, 129.10, 
127.30, 127.12, 126.21, 126.12, 120.90, 73.22, 73.01, 72.52, 71.23, 71.16, 70.99, 61.54, 59.18, 
17.63, 15.43, 14.96, 14.78, 13.34, 12.18; 11B NMR (CDCl3, 128 MHz) δ 1.21 (s); HRMS (ESI-
TOF) m/z 576.3244 [M + Na]+ calculated for C34H43BN2O4: 576.3240. 
 
4-(Pro-2-yn-1-yloxy)-4-phenyl-8-phenyl-6-ethyl-1,3,5,7-tetramethyl-BODIPY (8g). The 
crude product was purified via TLC (eluent 50/50 hexane/dichloromethane) to give an orange solid 
BODIPY 8g (7.0 mg, 31%) that was recrystallized from 50/50 hexane/EtOAc: mp 120-125 °C; 1H 
NMR (CD2Cl2, 400 MHz) δ 7.57-7.51 (m, 3H), 7.43-7.41 (m, 3H), 7.38-7.36 (m, 1H), 7.17 (t, 2H, 
J = 6.9 Hz), 7.13-7.09 (m, 1H), 5.87 (s, 1H), 3.94 (q, 2H, J = 1.7 Hz), 2.27 (t, ), 2.19 (s, 3H), 2.14 
(s, 3H), 1.38 (s, 3H), 1.34 (s, 3H), 0.90 (t, 3H, J = 7.5 Hz); 13C NMR (CD2Cl2, 100 MHz) δ 156.38, 
154.17, 141.85, 140.58, 138.17, 136.66, 134.12, 132.70, 132.25, 129.63, 129.51, 129.18, 129.06, 
129.02, 127.23, 126.30, 121.09, 84.51, 71.40, 50.35, 17.60, 15.56, 14.90, 14.78, 13.55, 12.20;  11B 
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NMR (CDCl3, 128 MHz) δ 1.65 (s); HRMS (ESI-TOF) m/z 468.2458 [M + Na]+ calculated for 
C30H31BN2O: 468.2449. 
 
General procedure for synthesis of BODIPYs 4 and 9. Dipyrrins 7 or 8 (1.0 equiv.) were 
dissolved in anhydrous CH2Cl2 (5 mL). Et3N (7.5 equiv) was added dropwise followed by 
BF3·OEt2 (10.0 equiv). The final mixture was stirred for an additional 1 h. The crude products 
were concentrated under reduced pressure and purified via TLC (eluent 50/50 
hexane/dichloromethane) to afford BODIPYs 4 and 9. 
 
4,4-Difluoro-8-phenyl-2,6-diethyl-1,3,5,7-tetramethyl-BODIPY (4). This BODIPY was 
isolated as an orange solid (41.2 mg, 68%) that was recrystallized from 50/50 hexane/EtOAc: mp 
175-180 °C; 1H NMR (CDCl3, 400 MHz) δ 7.49-7.47 (m, 3H), 7.30-7.28 (m, 2H), 2.55 (s, 6H), 
2.31 (q, 4H, J = 7.6 Hz), 1.29 (s, 6H), 0.99 (t, 3H, J = 7.6 Hz); 13C NMR (CDCl3, 100 MHz) δ 
153.80, 140.33, 138.54, 135.94, 132.87, 130.91, 129.14, 128.85, 128.40, 17.20, 14.74, 12.62, 
11.74; 11B NMR (CDCl3, 128 MHz) δ 0.69 (t, J = 33.5 Hz); HRMS (ESI-TOF) m/z 402.2164 [M 
+ Na]+ calculated for C23H27BF2N2: 402.2143. These data are in agreement with those previously 
reported.8 
 
4,4-Difluoro-8-phenyl-6-ethyl-1,3,5,7-tetramethyl-BODIPY (9). This BODIPY was 
isolated an orange solid (27.2 mg, 41%) that was recrystallized from 50/50 hexane/EtOAc: mp 
195-200 °C; 1H NMR (CDCl3, 400 MHz) δ 7.49-7.48 (m, 3H), 7.30-7.27 (m, 2H), 5.95 (s, 1H), 
2.56 (s, 6H), 2.32 (q, 2H, J = 7.6 Hz), 1.36 (s, 3H), 1.31 (s, 3H), 0.99 (t, 3H, J = 7.6 Hz); 13C NMR 
(CDCl3, 100 MHz) δ 155.56, 153.98, 142.07, 141.03, 139.49, 135.55, 133.63, 131.42, 129.20, 
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128.96, 128.26, 120.70, 29.84, 17.21, 14.67, 14.61, 14.40, 12.77, 11.82; 11B NMR (CDCl3, 128 
MHz) δ 0.67 (t, J = 33.3 Hz); HRMS (ESI-TOF) m/z 352.2031 [M + H]+ calculated for 
C21H23BF2N2: 352.2034. 
  
3.4.3 X-ray Determined Molecular structures  
 Crystal structures were determined using low-temperature data from a Bruker Kappa 
APEX-II DUO diffractometer with either Mo K or Cu K radiation. For all structures, H atoms 
were located from difference maps but constrained in calculated positions during refinement.  
 
Crystal data 1a: C21H19BN4, M = 338.21, monoclinic, a = 23.449(6), b = 7.1532(18), c = 
21.231(5) Å, U = 3561.2(15) Å3, T = 100 K, space group Pca21, Z = 8, Dc = 1.262 g cm
-3,  (Cu 
K) = 0.08 mm-1, 9965 reflections measured, max = 26.8˚, 3858 unique (Rint = 0.043). The final 
R = 0.037 (3858 I>2σ(I) data), wR(F2) = 0.088 (all data), CCDC 1457137. 
  
Crystal data 3a: C23H21BN4O2, M = 396.25, monoclinic, a = 9.6379(6), b = 29.7309(19), c 
= 7.1824(5) Å, U = 2009.5(2) Å3, T = 100 K, space group P21/c, Z = 4, Dc = 1.310 g cm
-3,  (Cu 
K) = 0.09 mm-1, 1798 reflections measured, max = 26.4˚, 4065 unique (Rint = 0.044). The final 
R = 0.046 (2670 I>2σ(I) data), wR(F2) = 0.110 (all data), CCDC 1457138. 
  
Crystal data 4a: C25H27BN4, M = 394.32, monoclinic, a = 20.4760(3), b = 11.3191(2), c = 
11.2060(2) Å, U = 2231.02(6) Å3, T = 100 K, space group Cc, Z = 4, Dc = 1.174 g cm-3,  (Cu 
K) = 0.07 mm-1, 9990 reflections measured, max = 29.2˚, 3028 unique (Rint = 0.034). The final 
R = 0.034 (2878 I>2σ(I) data), wR(F2) = 0.089 (all data), CCDC 1457139. 
 95 
 
Crystal data 5a: C19H23BN4, M = 318.22, monoclinic, a = 13.8407(4), b = 8.5881(2), c = 
16.2914(4) Å, U = 1778.09(8) Å3, T = 100 K, space group P21/c, Z = 4, Dc = 1.189 g cm
-3,  (Cu 
K) = 0.07 mm-1, 9892 reflections measured, max = 30.1˚, 5209 unique (Rint = 0.043). The final 
R = 0.045 (3990 I>2σ(I) data), wR(F2) = 0.120 (all data), CCDC 1457139. 
 
Crystal data 7b: C30H35BN2O, M = 450.41, monoclinic, a = 11.7029(5), b = 13.0834(6), c 
= 17.1865(7) Å, U = 2502.11(19) Å3, T = 90 K, space group P21/n, Z = 4, Dc = 1.196 g cm
-3,  
(Cu K) = 0.55 mm-1, 11723 reflections measured, max = 63.7˚, 4074 unique (Rint = 0.046). The 
final R = 0.041 (3284 I>2σ(I) data), wR(F2) = 0.115 (all data), CCDC 1415153. 
 
Crystal data 7c: C30H32BN3, M = 445.40, triclinic, a = 8.0820(5), b = 10.8718(6), c = 
15.3444(9) Å, β = 91.560(4)ᵒ, U = 1247.30(13) Å3, T = 100 K, space group PI, Z = 2, Dc = 1.186 
g cm-3, (CuK) = 0.53 mm-1, 11402 reflections measured, max = 67.7˚, 4208 unique (Rint = 
0.032). The final R = 0.045 (3469 I>2σ(I) data), wR(F2) = 0.113 (all data), CCDC 1415154. 
  
Crystal data 8c: C28H28BN3, M = 417.34, orthorhombic, a = 7.4105(5), b = 14.0956(10), c 
= 22.5059(17) Å, U = 2350.9(3) Å3, T = 90 K, space group P212121, Z = 4, Dc = 1.179 g cm
-3, 
(CuK) = 0.53 mm-1, 10612 reflections measured, max = 68.3˚, 4063 unique (Rint = 0.051). The 
final R = 0.045 (3417 I>2σ(I) data), wR(F2) = 0.109 (all data), CCDC 1415155. 
3.4.4 Steady-state Absorption and Fluorescence Spectroscopy  
 The photophysical properties of these compounds 7a-g, 8a-g, 4 and 9 in dichloromethane 
at room temperature were measured by preparing a stock solution with a concentration of 5 × 10-5 
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M and diluting it to appropriate concentrations for absorbance and emission spectra measurements. 
All the absorption spectra were obtained using a Perkin Elmer Lambda 35 UV/VIS Spectrometer. 
The optical density, ε, were taken by preparing solution concentrations between 7.5 × 10-6 and 2.5 
× 10-5 M in order to get λmax between 0.5 and 1.0. Emission spectra were measured on a Perkin 
Elmer LS 55 Luminescence spectrometer with the slit width set at 3 nm. All absorbance and 
emission spectra were acquired within 3 h of fresh solution preparation, at room temperature. A 
spectrophotometric cell with a path length of 10 nm was used. 
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CHAPTER 4: SYNTHESIS AND CHARACTERIZATION OF BODIPY-
CARBOHYDRATE CONJUGATES AND CHIRAL BODIPYS FOR BIOIMAGING  
 
4.1 Introduction 
 In the last 10 years, the growth of in vivo molecular imaging has progressed rapidly for 
evaluation of cancer for collaborations among physicians, imaging specialists, chemists, and 
physicists.1 There are three types of molecular imaging: metabolic, targeted, and physiologic. One 
category of molecular imaging is targeted imaging which consists of fluorophore labeling with a 
specific ligand that bonds to a receptor. On the other hand, metabolic imaging involves the 
visualization of metabolic processes of glucose uptake by cells. 
The three most common modes of in vivo oncologic imaging are nuclear medicine imaging, 
optical imaging, and magnetic resonance imaging (MRI). Nuclear medicine imaging is a 
noninvasive treatment that uses a small amount of radioactive tracer with temporal/spatial 
detection to diagnose a variety of diseases. Positron emission tomography (PET) and single photon 
emission computed tomographic (SPECT) are the two methods used for in vivo nuclear imaging. 
The advantage of PET and SPECT is their ability to detect the radiotracer amount in a matter of 
minutes. PET and SPECT are used as imaging techniques that barely disturb the biological system. 
PET produces higher image resolution than SPECT by using coincident rays to determine 
radionucleotide location. SPECT is a more cost efficient option that produces a broader image 
range, compared to PET, by using a collimator to select for certain angles of incidence of 
radionucleotide emissions. SPECT imaging modalities, when using advanced equipment, in small 
animal systems can produce an image resolution better than PET. Although PET and SPECT are 
advantageous, they do have certain limitations. SPECT has a limit on isotope combinations; so 
multiple isotopes have to be targeted many times to produce a single image. Both PET and SPECT 
are more expensive than other imaging methods and they potentially expose patients to more 
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radioactivity due the ionizing radiation so it is recommended that these tests are performed at a 
minimum for the safety of the patient. 
In metabolic imaging, one particular glucose analog, fluoro-2-deoxy-D-glucose (FDG), has 
been used extensively for chemotherapeutic uses in order to study the glucose uptake in the body. 
However, when FDG was injected at therapeutic drug dose, it was found to cause toxicity to the 
nervous central system and thus was discarded.2 The alternative analog, 18F-2-deoxy-D-glucose 
(18F-FDG), which is sensitive in PET and can be used to approximate the amount of glucose uptake 
during glycolysis. It enters the cell through glucose transporters (GLUTs) and is then 
phosphorylated. Dephosphorylation by glucose-6-phosphotase allows for a flow of 18F-FDG in a 
cell, however the process is extremely slow due to naturally low levels of glucose-6-phosphotase 
present. It was suggested that 18F-FDG is much more successful in healthy cells undergoing 
aerobic respiration than in malignant cells that utilize anaerobic respiration. During aerobic 
respiration in cells, glycolysis begins to slow down in the presence of oxygen as predicted by the 
Pasteur effect. The Warburg effect demonstrates that malignant cells use a glycolytic anaerobic 
respiration pathway even in the presence of oxygen. Although it is less efficient than aerobic 
respiration; this is a possible adaptation to long-term hypoxia experienced in tumors.3-4 The half-
life of radioactive 18F is 110 min, which is long enough to carry out the synthesis and transport it 
to an imaging laboratory. 
4.1.1 Click Chemistry 
Nobel Laureate Professor Barry Sharpless first introduced click chemistry in 2001. Since 
then, it has become a popular method used in many diverse fields. The characteristics of click 
chemistry are fast reactions and high reaction yields, easy to purify, versatile, and regiospecific.5 
One of the most widely used class of click reaction is copper-catalyzed Huisgen 1,3-dipolar 
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cycloaddition (HDC) reaction. This reaction does not require high temperature conditions and 
results in regiospecific 1,4-substituted products. Although “click reactions” was developed in 
2001, the utility of click chemistry in BODIPY’s core or 8-phenyl were not reported until the last 
few years. Approaches to conjugate biomolecules via the meso-phenyl with folate,6 polyethylene 
glycol and carbohydrate,7 and zinc-TPP8-9 have been reported. The triazole group can directly 
insert into the dipyrromethene core at either the 2,6-positions10 or 3,5-positions.10-11 On the other 
hand, the triazole has also provided a linker between fluorophores for intramolecular resonance 
energy transfer (RET).12-14 However, having triazole moieties on the boron center for post 
functionalization of F-BODIPY has not been reported until recently.15  
Figure 4.1: Selected examples of (1,2,3-triazole)-BODIPYs. 
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4.1.2 Chiral fluorophore 
 Chiral recognition has been growing in the last few decades for determination of 
enantiomeric purity in many chiral functional groups using organic fluorophores.16 The study of 
chiral properties of organic molecules is very important in drug discovery and pharmaceutical 
chemistry. Fluorophores that are capable of distinguishing one enantiomer from another have an 
advantage in rapid chiral assays. Some examples of BODIPYs containing a chiral functionality 
have been reported.17-20 Ziessel and coworkers reported the synthesis of 4-mono-aryl BODIPY 
which has hydrogen bonding between the fluoride atom and 3-aldehyde hydrogen. On the other 
hand, Sanchez-Carnerero et al. demonstrated that a chiral O-BODIPY can be applied in circularly 
polarized luminescence (CPL) spectroscopy with a 1,1’-binaphthyl moiety on the boron center. 
 
Figure 4.2: Selected examples of chiral BODIPYs. 
 In order to extend the scope of (1,2,3-triazole)-BODIPYs synthesis, we decided to design 
and synthesize new fluorophores containing mono-, di-, and tri-(1,2,3-triazole)-BODIPYs bearing 
a carbohydrate framework in order to study and compare their biological properties. In addition, 
the synthesis of chiral BODIPY is investigated for chiral recognition applications or 
stereoselective aldol reactions. 
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4.2 Results and Discussion 
4.2.1 Syntheses of (1,2,3-triazole)-BODIPYs 
                                            
Figure 4.3: Our designed synthetic platform. 
The goal for this project was to synthesize a series of fluorescent bioconjugates comprising 
of a BODIPY fluorophore bearing a triazole group connected to carbohydrate moiety for target-
specific cell accumulation. This has been previously investigated for synthesis of porphyrins and 
related macrocycles with conjugates for use as photosensitizers for PDT.21-23 In addition, mono 
radioactive 18F can be installed on the boron center as a dual-modality fluorescent probe.24  
 
Scheme 4.1: Synthesis of BODIPY 1 from 3-ethyl-,2,4-dimethyl pyrrole. 
The starting BODIPY 1 was synthesized, as previously reported,7,25 by condensation 
between the commercially available 3-ethyl-2,4-dimethylpyrrole and p-propargyloxy-
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benzaldehyde using a 3-step-1-pot reaction in high yield, as shown in Scheme 4.1. The progaryloxy 
benzaldehyde was synthesized as a crude product via Williamson reaction between propargyl 
bromide and p-hydroxyl benzaldehyde, according to the literature procedure.25 
 
Scheme 4.2: Synthesis of 4,4-dipropargyl-BODIPY 2. 
The propargyloxy groups were introduced at the boron center via activation of BODIPY 1 
with aluminum chloride15,26 followed by excess propargyl alcohol to afford tri-alkyne BODIPY 2 
in 69% yield (Scheme 4.2). The goal was to provide three terminal alkyne groups for further 
functionalization using click chemistry. 
 
Scheme 4.3: Synthesis of BODIPYs 3a and 3b. 
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BODIPY 2 was subjected to either commercially available benzyl azide or 1-azido-1-
deoxy-β-D-glucopyranoside tetraacetate, using solution-phase “click” conditions, which consists 
of copper(II) sulfate, copper(0) and sodium ascorbate in THF/water (3:1), to give tri-(1,2,3-
triazoles)-BODIPYs 3a and 3b. Under an inert gas atmosphere, the mixture were refluxed at 70 
°C for 6 h for compounds 3a and 3b. Upon reaction completion, the mixture was cooled to room 
temperature and partitioned between ethyl acetate and water to remove the generated copper salt 
by-product. The combined organic layers were dried over Na2SO4 and concentrated under reduced 
pressure. The crude products were purified using preparative-TLC (thin layer chromatography) to 
give tri-(1,2,3-triazoles)-BODIPYs 3a and 3b in 76% and 64% yields, respectively. Indeed, the 
click reaction has provided a high yield to conjugate glucose derivate or benzyl to BODIPYs core. 
 
Scheme 4.4: Fail attempted hydrolysis of BODIPY 3b. 
We then attempted to hydrolyze compound 3b under basic condition (NaOMe in MeOH) 
at 0 °C to give 3c, but the reaction failed. We also attempted various hydrolysis conditions such as 
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BBr3 or NaOH. The BBr3 conditions gave the corresponding dipyrromethene while the NaOH 
conditions replaced the BF2 with B(OH)2. 
 
Scheme 4.5: Synthesis of BODIPYs 4a and 4b. 
 
Having the optimized conditions for the tri-(1,2,3-triazole)-BODIPYs, we turned our 
attention to the synthesis of mono- and di-(1,2,3-triazole)-BODIPYs. For the mono-azido 
synthesis, BODIPY 1 was exposed to Cu(I)-catalyzed azide-alkyne cycloaddition with 
commercially available benzyl azide or 1-azido-1-deoxy-β-D-glucopyranoside tetraacetate to 
afford BODIPY 4a (93%) and the mono-triazole-tetraacetate-sugar BODIPY 4b (82%) as shown 
in Scheme 4.5. The mono-triazole-sugar BODIPY 4b was hydrolyzed under basic conditions to 
give the desired glucose triazole 4c in 93% yield. Surprisingly, the B-(OR)2 was still intact under 
strong nucleophilic reaction conditions such as NaOMe as confirmed by 1H-, 13C- and 11B-NMR 
spectroscopy and also HRMS. Note, when hydrolysis was attempted at room temperature, the B-
(OR)2 moiety was removed to give dipyrromethene. 
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Scheme 4.6: Hydrolysis of BODIPY 4b. 
In order to synthesize the di-triazole-sugar BODIPY, compound 4a was exposed to 
aluminum chloride (AlCl3), followed by excess propargyl alcohol to give meso-triazolephenyl 
BODIPY 5a in 73% yield (Scheme 4.7). The meso-triazolephenyl BODIPY 5a was subjected to 
Cu(I)-catalyzed azide-alkyne cycloaddition with commercially available 1-azido-1-deoxy-β-D-
glucopyranoside tetraacetate to afford compound 6a in 72% yield. BODIPY 6a was purified by 
silica gel column chromatography but the compound was immobile. Then we decided to use 
neutral alumina column chromatography and were able to isolate the targeted product in good 
yield. We also attempted to subject BODIPY 6a to hydrolysis conditions (NaOMe in MeOH at 0 
°C) but obtained the 4,4-dihydroxy product. In addition, if we treated BODIPY 5a with the 
commercially available unprotected glucose azide under the same click reaction conditions, we 
recovered the starting material and dipyrromethene as a by-product. 
4.2.2 Synthesis of chiral BODIPY 
We now turned to the synthesis of BODIPY with a boron atom bearing a chiral motif. We 
began our investigation by introducing a carboxylate group to the boron center through two 
different methods. Method B consists of treating BODIPY 7 with AlCl3 and excess addition of 
108 
 
acetic acid to give BODIPY 8b in moderate yield (42%). The conditions were milder and required 
a shorter time than those previously reported.27-28 However, when BODIPY 7 was exposed using 
method C, a mixture of 4-mono- and 4,4-disubstituted BODIPYs 8a and 8b were obtained with 
8% and 14% yields, respectively. Even though method B gave a high yield of the di-substituted 
product, this method typically required an excess amount of the nucleophile (278 equiv.). For that 
reason, we decided to use method C for our next investigation.  
 
 
 
Scheme 4.7: Synthesis of 4,4-tri(1,2,3-triazole)-BODIPY. 
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Scheme 4.10: Synthesis of 4-acetyl- and 4,4-diacetyl-BODIPYs. 
 To further explore the extent of this reaction, we used 4-bromobenzoic acid as the 
nucleophile using method C and were able to obtain the targeted BODIPY 9 in 5% yield (Scheme 
4.11). BODIPY 9 was characterized by 1H- and 11B-NMR spectroscopy and X-ray crystallography.  
 
Scheme 4.11: Synthesis of carboxylate BODIPY 9. 
 Next, we investigated an amino acid containing carboxylic acid. When we tried tryptophan 
with Boc-protected amine using method C, we were hoping to isolate the mono- or di-substituted 
products. Interestingly, the product obtained was the cyclic BODIPY product 10 (Scheme 4.12). 
To the best of our knowledge, this is the first report of a chiral group and nitrogen atom on the 
boron center. This compound has a potential for fluorescent chiral recognition. In addition, 
BODIPY 10 was characterized by 1H- and 11B-NMR spectroscopy and X-ray crystallography. 
110 
 
 
Scheme 4.12: Synthesis of chiral BODIPY 10. 
These results prompted us to further investigate unprotected amino acids. When amino 
acids without Boc or Fmoc groups were used, the resulting products were dipyrromethenes. It is 
possible that electron withdrawing Boc protecting group makes the nitrogen atom less basic. We 
decided to use ethanolamine as the nucleophile with methods B and C. Similar to acetate, the di-
substituted product 11b was obtained in 70% yield with method B while a mixture of mono- and 
di-products was obtained with method C in 14% and 10% yields, respectively. This indicates that 
the indole of the tryptophan plays a steric factor and facilitates the cyclization.   
 
Scheme 4.13: Synthesis of 4-mono- and 4,4-disubstituted BODIPYs. 
 Finally, we used ethylene glycol as the nucleophile using methods B and C (Scheme 4.14). 
We were able to obtain the targeted BODIPY 12 in 21% and 37% yields, respectively. 
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Scheme 4.14: Synthesis of cyclic 4,4-dialkoxy BODIPY 12. 
4.2.3 Structural Characterization 
 All BODIPYs were characterized by 1H-, 13C-, and 11B-NMR, and HRMS. BODIPYs 4a-
b, 9, 10, 11a and 12 were characterized by X-ray crystallography (see Figures 4.4 and 4.5). The 
disappearance of the triplet for the BF2 (at ca. 0.6 ppm) and the appearance of the singlet attributed 
to B(OR)2 (at ca. 2 ppm) in the 
11B-NMR spectra clearly showed the formation of the targeted 4,4-
dialkoxy-BODIPY. The 1H-NMR spectrum clearly indicated the formation of the 1,2,3-triazoles 
of BODIPY 3a-b, 4a-c, and 6a with singlets ranging from 7.50-8.12 ppm. 
 
 
 
 
 
 
 
 
 
 
Figure 4.4: Molecular structures of BODIPYs 4a-b from X-ray crystal analysis, with 50% 
probability ellipsoids. 
4b 4a 
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Figure 4.5: Molecular structures of BODIPYs 9, 10, 11a and 12 from X-ray crystal analysis, with 
50% probability ellipsoids. 
 
Full structural confirmation of all compounds was obtained from the X-ray crystal 
structures. Crystals suitable for X-ray analysis were grown by slow evaporation of 
dichloromethane diffused in acetone (for 4a-b), hexane in dichloromethane (for 9, 11a, and 12), 
10 9 
12 11a 
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and EtOAc in MeOH (for 10). The alkoxy groups on the boron center adopt a nearly tetrahedral 
geometry. 
4.3 Conclusions 
 A series of six 1,2,3-triazole-BODIPYs were synthesized in high yields under the Cu(I)-
catalyzed Huisgen cycloaddition reaction conditions. A BODIPY bearing one triazole group was 
shown to undergo hydrolysis while two or three triazole resulted in the 4,4-hydroxyl product. 
Acetyl and 1,2-Boc-aminoalcohol groups were introduced to the boron center through two 
different methods. Method B was the most effective way to give the di-substituted BODIPYs 8b 
and 11b in 42% and 70% yields, respectively. Method C gave a mixture of 4-mono-acetyl-
BODIPYs 8a (8%) and 4,4-di-acetyl-BODIPY 8b (14%) and 4-mono-alkoxy 11a (14%) and 4,4-
dialkoxy 11b (10%). A novel BODIPY bearing a chiral moiety was synthesized using method C 
and X-ray crystallography confirmed its identity. 
4.4 Experimental 
 
4.4.1 General Considerations  
All commercially available reagents were purchased from Sigma-Aldrich and were used 
without further purification. All anhydrous reactions were carried out with oven-dried glassware 
under a dry argon atmosphere. All the reactions were monitored by using Sorbent Technologies 
pre-coated polyester backed TLC (200 µm silica gel with indicator UV-254 nm). Flash column 
chromatography was performed using Sorbent Technologies 60 Å alumina neutral (230-400 
mesh). All preparative-TLC were used with Silica Gel 60 Å silica gel 20 x 20 cm (210-270 µm). 
All 1H-, 13C-, 11B-NMR spectral were collected using AV-400 spectrometer (operating at 400 MHz 
for 1H NMR and 100 MHz for 13C NMR) and deuterated acetone or chloroform as solvents. The 
CDCl3 chemical shifts (δ) are reported ppm with 7.27 for proton and 77.16 for carbon NMR as 
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reference. The (CD3)2CO chemical shift (δ) are reported ppm with 2.05 for proton and 29.84 and 
206.26 for carbon NMR as reference. The BF3•OEt2 chemical shift (δ) is reported with 0.00 for 
boron NMR as reference. Coupling constants are reported in Hertz (Hz). All the mass spectra were 
collected using an Agilent 6210 ESI-TOF mass spectrometer.  
4.4.2 Syntheses 
BODIPY (1). The BODIPY 1 was synthesized according to the literature.7,25 1H NMR 
(CDCl3, 400 MHz) δ 7.20 (d, J = 8.0 Hz, 2H), 7.09 (d, J = 8.0 Hz, 2H), 4.77 (s, 2H), 2.57 (s, 1H), 
2.54 (s, 6H), 2.31 (q, J = 7.3 Hz, 4H), 1.33 (s, 6H), 0.99 (t, J = 7.4 Hz, 6H); 13C NMR (CDCl3, 100 
MHz) δ 158.06, 153.70, 140.04, 138.51, 132.81, 129.60, 128.94, 115.64, 75.97, 56.14, 17.18, 
14.75, 12.60, 11.94;  11B NMR (CDCl3, 128 MHz) δ 0.68 (t, J = 33.3 Hz). 
 
BODIPY (2). In an oven-dried flask, meso-alkynylphenyl-BODIPY 1 (100 mg, 0.230 
mmol, 1.0 equiv.) and AlCl3 (61 mg, 0.460 mmol, 2.0 equiv.) were dissolved in anhydrous CH2Cl2 
(20 mL). The mixture was refluxed for 30 min and propargyl alcohol (3.7 mL, 64.007 mmol, 278.0 
equiv.) was added for an additional 30 min. After the mixture was cooled to room temperature and 
stirred for 2 h, the crude product was concentrated under reduced pressure. The crude product was 
purified via TLC (eluent 80:20 hexane/EtOAc) to afford BODIPY 2 (80.6 mg, 69% yield) as an 
orange solid, that was recrystallized from 1:1 hexane/dichloromethane. 1H NMR (CDCl3, 400 
MHz) δ 7.21 (d, J = 8 Hz, 2H), 7.09 (d, J = 8 Hz, 2H), 4.78 (s, 2H), 3.81 (s, 4H), 2.57 (s, 6H), 2.31 
(q, J = 7.3 Hz, 4H), 2.04 (s, 2H), 1.33 (s, 6H), 0.98 (t, J = 7.2 Hz, 6H); 13C NMR (CDCl3, 100 
MHz) δ 157.86, 154.72, 139.39, 137.15, 132.71, 132.30, 129.69, 129.38, 115.44, 83.27, 78.15, 
75.80, 70.44, 56.06, 49.80, 17.11, 14.71, 12.75, 11.89; 11B NMR (CDCl3, 128 MHz) δ 1.76 (s); 
HRMS (ESI-TOF) m/z 528.2669 [M + Na]+ calculated for C32H35BN2O3: 528.2681.  
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BODIPY (3a). BODIPY 2 (17.5 mg, 0.035 mmol, 1.0 equiv.) and Cu(0) (2.2 mg, 0.035 
mmol, 1.0 equiv.) were dissolved in a mixture of THF/water (8 mL, 3:1) under inert gas 
atmosphere. Benzyl azide (0.043 mL, 0.346 mmol, 10.0 equiv.) was added dropwise to the reaction 
mixture. A solution of CuSO4·5H2O (1.7 mg, 0.007 mmol, 0.2 equiv.) and sodium-ascorbate (3.4 
mg, 0.017 mmol, 0.5 equiv.) in THF/water (8 mL, 3:1) was added (after sonication for 30 min) 
and the reaction mixture was heated for 22 h at 70 °C. Once TLC indicated complete consumption 
of starting material, the mixture was cooled to room temperature and partitioned between ethyl 
acetate (30 mL) and water (30 mL). The combined organic layers were dried over Na2SO4 and 
then concentrated under reduced pressure. The crude product was purified via TLC (eluted 20:80 
hexane/EtOAc) to afford triazoles BODIPY 3a (23.8 mg, 76% yield) and was recrystallized from 
1:3 acetone/hexanes. 1H NMR (CDCl3, 400 MHz) δ 7.59 (s, 1H), 7.38-7.23 (m, 15H), 7.17 (d, J = 
8.0 Hz, 2H), 7.07 (d, J = 8 Hz, 2H), 5.57 (s, 2H), 5.42 (s, 4H), 5.25 (s, 2H), 4.22 (s, 4H), 2.39 (s, 
6H), 2.22 (q, J = 7.12 Hz, 4H), 1.28 (s, 6H), 0.93 (t, J = 6.8 Hz, 6H); 13C NMR (CDCl3, 100 MHz) 
δ 158.67, 153.79, 149.71, 144.31, 140.18, 137.32, 134.93, 134.51, 132.72, 132.53, 129.85, 129.31, 
129.24, 129.11, 129.00, 128.90, 128.69, 128.27, 128.24, 122.78, 121.65, 115.35, 62.21, 56.84, 
54.43, 54.10, 21.15, 17.20, 14.81, 14.30, 12.62, 11.99; 11B NMR (CDCl3, 128 MHz) δ 2.10 (s); 
HRMS (ESI-TOF) m/z 927.4589 [M + Na]+ calculated for C53H56BN11O3: 927.4593.  
 
BODIPY (3b). Tri-alkynyl-BODIPY 2 (27.2 mg, 0.054 mmol, 1.0 equiv.), Cu(0) (13.7 mg, 
0.215 mmol, 4.0 equiv.), and 1-azido-1-deoxy-β-D-glucopyranoside tetraacetate (301 mg, 0.806 
mmol, 15.0 equiv.) were dissolved in a mixture of THF/water (8 mL, 3:1) under an inert gas 
atmosphere. A solution of CuSO4·5H2O (10.1 mg, 0.040 mmol, 0.75 equiv.) and sodium-ascorbate 
(21.3 mg, 0.107 mmol, 2.0 equiv.) in THF/water (8 mL, 3:1) was added (after sonication for 30 
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min) and the reaction mixture was heated for 14 h at 70 °C. Once TLC indicated complete 
consumption of starting material, the mixture was cooled to room temperature and partitioned 
between ethyl acetate (30 mL) and water (30 mL). The combined organic layers were dried over 
Na2SO4 and then concentrated under reduced pressure. The crude product was purified via alumina 
neutral flash chromatography (eluent 100% EtOAc to 95:5 EtOAc/MeOH) to give BODIPY 3b 
(56.3 mg, 64% yield) and was recrystallized from EtOAc. 1H NMR ((CD3)2CO, 400 MHz) δ 8.43 
(s, 1H), 8.12 (s, 1H), 7.98 (d, J = 8.0 Hz, 2H), 7.37 (d, J = 8.0 Hz, 2H), 7.27 (d, J = 8.0 Hz, 2H), 
6.30 (d, J = 8.0 Hz, 1H), 6.22 (d, J = 8.1 Hz, 1H), 6.17 (d, J = 8.1 Hz, 1H), 5.64 (d, J = 8.0 Hz, 
2H), 5.62 (s, 6H), 5.54 (d, 2H), 5.29 (d, 2H), 4.36-4.32 (m, 4H), 4.26-4.23 (m, 4H), 4.22-4.19 (m, 
4H), 2.54 (s, 6H), 2.35 (q, J = 7.52 Hz, 4H), 2.04 (s, 9H), 2.01 (s, 9H), 1.97 (s, 9H), 1.79 (s, 9H), 
1.41 (s, 6H), 0.98 (t, J = 7.44 Hz, 6H); 13C NMR (CDCl3, 100 MHz) δ 170.79, 170.34, 170.14, 
169.30, 154.93, 141.63, 137.82, 133.43, 130.86, 123.73, 121.79, 121.42, 116.44, 86.06, 85.88, 
75.42, 75.32, 73.65, 71.53, 71.46, 68.93, 68.86, 62.91, 62.8, 57.10, 55.03, 20.71, 20.68, 20.59, 
20.28, 20.23, 17.73, 15.14, 12.98, 12.33; 11B NMR (CDCl3, 128 MHz) δ 2.05 (s); HRMS (ESI-
TOF) m/z 1647.6033 [M + Na]+ calculated for C74H92BN11O30: 1647.6019.  
 
BODIPY (4a). BODIPY 1 (30 mg, 0.069 mmol, 1.0 equiv.) and Cu(0) (4.4 mg, 0.069 
mmol, 1.0 equiv.) were dissolved in a mixture of THF/water (8 mL, 3:1) under an inert gas 
atmosphere. Benzyl azide (0.022 mL, 0.180 mmol, 2.6 equiv.) was added dropwise to the reaction 
mixture. A solution of CuSO4·5H2O (3.4 mg, 0.014 mmol, 0.2 equiv.) and sodium-ascorbate (6.8 
mg, 0.035 mmol, 0.5 equiv.) in THF/water (8 mL, 3:1) was added (after sonication for 30 min) 
and the reaction mixture was heated for 6 h at 70 °C. Once TLC indicated complete consumption 
of starting material, the mixture was cooled to room temperature and partitioned between ethyl 
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acetate (30 mL) and water (30 mL). The combined organic layers were dried over Na2SO4 and 
then concentrated under reduced pressure. The crude product was purified via TLC (eluent 50:50 
hexane/EtOAc) to afford BODIPY 4a (36.4 mg, 93% yield) and was recrystallized from 1:3 
dichloromethane/hexane. 1H NMR (CDCl3, 400 MHz) δ 7.60 (s, 1H), 7.39-7.28 (m, 5H), 7.18 (d, 
J = 8.0 Hz, 2H), 7.09 (d, J = 8.0 Hz, 2H), 5.58 (s, 2H), 5.25 (s, 2H), 2.54 (s, 6H), 2.30 (q, J = 7.4 
Hz, 4H), 1.31 (s, 6H), 1.00 (t, J = 7.16 Hz, 6H); 13C NMR (CDCl3, 100 MHz) δ 158.75, 153.69, 
144.24, 140.11, 138.49, 134.52, 132.81, 131.23, 129.66, 129.30, 129.00, 128.63, 128.26, 122.83, 
115.41, 62.18, 54.42, 17.18, 14.74, 12.59, 11.91; 11B NMR (CDCl3, 128 MHz) δ 0.68 (t, J = 33.7 
Hz); HRMS (ESI-TOF) m/z 589.2910 [M + Na]+ calculated for C33H36BF2N5O: 589.2895.  
 
BODIPY (4b). BODIPY 1 (50 mg, 0.115 mmol, 1.0 equiv.), Cu(0) (14.6 mg, 0.230 mmol, 
2.0 equiv.), and 1-azido-1-deoxy-β-D-glucopyranoside tetraacetate (214.9 mg, 0.576 mmol, 5 
equiv.) were dissolved in a mixture of THF/water (8 mL, 3:1) under an inert gas atmosphere. A 
solution of CuSO4·5H2O (11.5 mg, 0.046 mmol, 0.4 equiv.) and sodium-ascorbate (22.8 mg, 0.115 
mmol, 1.0 equiv.) in THF/water (8 mL, 3:1) was added (after sonication for 30 min) and the 
reaction mixture was heated for 21 h at 70 °C. Once TLC indicated complete consumption of 
starting material, the mixture was cooled to room temperature and partitioned between ethyl 
acetate (30 mL) and water (30 mL). The combined organic layers were dried over Na2SO4 and 
then concentrated under reduced pressure. The crude product was purified via TLC (eluent 50:50 
hexane/EtOAc) to afford BODIPY 4b (76.5 mg, 82% yield) and was recrystallized from 1:3 
dichloromethane/hexane. 1H NMR ((CD3)2CO, 400 MHz) δ 8.43 (s, 1H), 7.30-7.25 (m, 4H), 6.30 
(d, J = 8.1 Hz, 1H), 5.67 (t, J = 9.4 Hz, 1H), 5.57 (t, J = 9.4 Hz, 1H), 5.31 (s, 2H), 4.40-4.36 (m, 
1H), 4.30-4.25 (m, 1H), 4.21-4.18 (m, 1H), 2.49 (s, 6H), 2.35 (q, J = 7.5 Hz, 4H), 2.00 (s, 3H), 
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1.98 (s, 3H), 1.96 (s, 3H), 1.83 (s, 3H), 1.39 (s, 6H), 0.99 (t, J = 7.5 Hz, 6H); 13C NMR ((CD3)2CO, 
100 MHz) δ 170.76, 170.35, 170.17, 169.40, 160.18, 154.24, 144.92, 141.80, 139.29, 133.58, 
131.97, 130.56, 129.01, 123.76, 116.55, 86.07, 75.43, 73.52, 71.53, 68.84, 62.78, 62.63, 20.67, 
20.58, 20.27, 17.56, 15.04, 12.66, 12.19; 11B NMR (CDCl3, 128 MHz) δ 0.67 (t, J = 33.9 Hz); 
HRMS (ESI-TOF) m/z 829.3391 [M + Na]+ calculated for C40H48BF2N5O10: 829.3384.  
 
BODIPY (4c). BODIPY 4b (22.5 mg, 0.028 mmol, 1.0 equiv.) and NaOMe (6.3 mg, 0.117 
mmol, 4.2 equiv.) were dissolved in MeOH (5 mL) at 0 °C. The mixture was stirred for 30 min 
and then warmed to room temperature. Once TLC indicated complete consumption of starting 
material, Dowex 50WX8 H+ resin was added and stirred until the solution is neutral. The resin was 
filtered off and crude product was concentrated by reduced pressure. The crude product was 
purified using alumina column chromatography (eluent 50:50 dichloromethane/acetone) to afford 
BODIPY 4c (16.5 mg, 93% yield) and was recrystallized from 1:6 water/dichloromethane. 1H 
NMR ((CD3)2CO, 400 MHz) δ 8.31 (s, 1H), 7.29 (s, 4H), 5.70 (d, 1H), 5.30 (s, 2H), 4.71 (d, J = 
4.0 Hz, 2H), 4.64 (d, J = 4.0 Hz, 2H), 4.46 (d, J = 4.0 Hz, 2H), 4.04-3.98 (m, 1H), 3.89-3.82 (m, 
2H), 3.74-3.63 (m, 3H), 3.60-3.54 (m, 1H), 2.49 (s, 6H), 2.35 (q, J = 7.56 Hz, 4H), 1.39 (s, 6H), 
0.99 (t, J = 7.5 Hz, 6H); 13C NMR ((CD3)2CO, 100 MHz) δ 160.63, 154.58, 139.65, 133.91, 132.32, 
130.92, 129.27, 124.43, 116.81, 89.39, 81.17, 78.92, 74.19, 71.41, 62.98, 62.90, 17.91, 15.39, 
13.02, 12.55; 11B NMR (CDCl3, 128 MHz) δ 0.60 (t, J = 34.3 Hz); HRMS (ESI-TOF) m/z 639.3149 
[M + H]+ calculated for C32H40BF2N5O6: 639.3109.  
 
BODIPY (5a). In an oven-dried flask, BODIPY 4a (45.2 mg, 0.080 mmol, 1.0 equiv.) with 
AlCl3 (21 mg, 0.159 mmol, 2.0 equiv.) were dissolved in anhydrous CH2Cl2 (10 mL). The mixture 
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was refluxed for 30 min and propargyl alcohol (1.278 mL, 22.143 mmol, 278.0 equiv.) was added 
for an additional 30 min. After the reaction cooled to room temperature and stirred for 1 h, the 
crude product was concentrated under reduced pressure. The crude product was purified via TLC 
(eluent 50:50 hexane/EtOAc) to afford BODIPY 5a (37.3 mg, 73% yield) and was recrystallized 
from 1:1 hexane/EtOAc. 1H NMR (CDCl3, 400 MHz) δ 7.59 (s, 1H), 7.39-7.32 (m, 5H), 7.19 (d, 
J = 8.0 Hz, 2H), 7.08 (d, J = 8.0 Hz, 2H), 5.58 (s, 2H), 5.25 (s, 2H), 3.80 (s, 4H), 2.57 (s, 6H), 2.30 
(q, J = 7.3 Hz, 4H), 2.04 (s, 2H), 1.30 (s, 6H), 0.98 (t, J = 6.8 Hz, 6H); 13C NMR (CDCl3, 100 
MHz) δ 158.64, 154.75, 144.26, 139.56, 137.21, 134.52, 132.77, 132.40, 129.82, 129.28, 129.11, 
128.97, 128.25, 122.80, 115.28, 83.35, 70.55, 62.18, 54.41, 49.88, 17.20, 14.81, 12.83, 11.96; 11B 
NMR (CDCl3, 128 MHz) δ 1.77 (s); HRMS (ESI-TOF) m/z 661.3309 [M + Na]+ calculated for 
C39H42BN5O3: 661.3318. 
 
BODIPY (6a). BODIPY 5a (7.8 mg, 0.012 mmol, 1.0 equiv.), Cu(0) (3.1 mg, 0.049 mmol, 
4.0 equiv.), and 1-azido-1-deoxy-β-D-glucopyranoside tetraacetate (68.3 mg, 0.183 mmol, 15 
equiv.) were dissolved in a mixture of THF/water (4 mL, 3:1) under an inert gas atmosphere. A 
solution of CuSO4·5H2O (2.3 mg, 0.009 mmol, 0.75 equiv.) and sodium-ascorbate (4.8 mg, 0.024 
mmol, 2.0 equiv.) in THF/water (4 mL, 3:1) was added (after sonication for 30 min) and the 
reaction mixture was heated for 21 h at 70 °C. Once TLC indicated complete consumption of 
starting material, the mixture was cooled to room temperature and partitioned between ethyl 
acetate (30 mL) and water (30 mL). The combined organic layers were dried over Na2SO4 and 
then concentrated under reduced pressure. The crude product was purified via alumina column 
chromatography (eluent 100% EtOAc to 1:1 EtOAc/acetone) to afford BODIPY 6a (12.1 mg, 72% 
yield) and was recrystallized from acetone. 1H NMR ((CD3)2CO, 400 MHz) δ 8.12 (s, 2H), 7.97 
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(s, 2H), 7.39-7.36 (m, 5H), 7.35 (d, J = 8.1 Hz, 2H), 7.24 (d, J = 8.2 Hz, 2H), 6.17 (d, J = 8.0 Hz, 
2H), 5.68 (s, 2H), 5.64 (t, J = 9.48 Hz, 2H), 5.53 (t, J = 9.48 Hz, 2H), 5.29 (s, 2H), 4.16 (s, 4H), 
2.54 (s, 6H), 2.34 (q, J = 7.32 Hz, 4H), 2.04 (s, 6H), 2.01 (s, 6H), 1.97 (s, 6H), 1.79 (s, 6H), 1.41 
(s, 6H), 0.98 (t, J = 7.48 Hz, 6H); 13C NMR ((CD3)2CO, 100 MHz) δ 200.13, 199.00, 197.50, 
196.91, 189.04, 181.45, 170.60, 169.75, 167.30, 159.01, 155.38, 142.14, 133.87, 130.27, 129.70, 
129.47, 121.88, 116.89, 86.36, 75.80, 74.12, 71.94, 69.41, 57.60, 54.81, 50.28, 21.20, 21.07, 20.76, 
15.63, 13.45, 12.77; 11B NMR ((CD3)2CO, 128 MHz) δ 2.16 (s); HRMS (ESI-TOF) m/z 1407.5552 
[M + Na]+ calculated for C67H80BN11O21: 1407.5546.  
 
BODIPY (7). Benzaldehyde (1.0 mL, 9.81 mmol) was suspended in anhydrous CH2Cl2 
(300 mL). 2,4-Dimethylpyrrole (2.12 mL, 20.6 mmol) was added, followed by 6 drops of BF3•OEt2 
to the reaction mixture. After stirring for 48 h, TLC indicated no more aryl aldehyde in the reaction 
mixture, and DDQ (1.113 g, 4.91 mmol) in CH2Cl2 was then added. After 1.5 h stirring at room 
temperature, NEt3 (10.3 mL, 73.58 mmol) was added and after another 1 h BF3•OEt2 (12.1 mL, 
98.1 mmol) was added. The final mixture was stirred at room temperature for 6 h and then poured 
into water (50 mL). The organic layer was washed with water (2 x 50 mL). The combined organic 
layers were dried over anhydrous Na2SO4 and concentrated under reduced pressure. The product 
was purified by silica gel flash column chromatography using mixtures of petroleum ether and 
dichloromethane to afford BODIPY 7 as a green/orange solid (20% yield, 650 mg). 1H NMR 
(CDCl3, 400 MHz) δ 7.47-7.26 (m, 5H), 5.98 (s, 2H), 2.56 (s, 6H), 1.38 (s, 6H); 13C NMR (CDCl3, 
100 MHz) δ 155.57, 143.29, 141.87, 135.14, 131.57, 129.26, 129.26, 128.08, 121.34, 14.71, 14.46; 
11B NMR (CDCl3, 128 MHz) δ 0.65 (t, J = 33.4 Hz); HRMS (ESI-TOF) m/z 324.1718 [M + H]+ 
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calculated for C19H20BF2N2: 324.1728. These data are in agreement with those previously 
reported.29-30 
 
Synthesis of BODIPY 8b using method B. In an oven-dried flask, BODIPY 7 (20.0 mg, 
0.062 mmol, 1.0 equiv.) with AlCl3 (16.5 mg, 0.123 mmol, 2.0 equiv.) were dissolved in anhydrous 
CH2Cl2 (5 mL). The mixture was refluxed for 30 min and acetic acid (0.987 mL, 17.236 mmol, 
278.0 equiv.) was added for an addition 30 min. After the reaction cooled to room temperature and 
stirred for 2 h, the crude product was concentrated under reduced pressure. The crude product was 
purified via TLC (eluent 50:50 hexane/EtOAc) to afford BODIPY 8b (10.4 mg, 42% yield) as an 
orange solid, that was recrystallized from 1:1 hexane/dichloromethane. 1H NMR (CDCl3, 400 
MHz) δ 7.47 (d, J = 5.6 Hz, 3H), 7.39 (d, J = 5.7 Hz, 2H), 5.94 (s, 2H), 2.45 (s, 6H), 2.05 (s, 6H), 
1.39 (s, 6H); 13C NMR (CDCl3, 100 MHz) δ 171.61, 152.98, 142.99, 135.36, 133.12, 129.09, 
128.86, 128.27, 121.44, 23.09, 14.73; 11B NMR (CDCl3, 128 MHz) δ -0.40 (s); HRMS (ESI-TOF) 
m/z 426.1836 [M + Na]+ calculated for C23H25BN2O4: 426.1851.   
 
Synthesis of BODIPYs 8a and 8b using method C. In an oven-dried flask, BODIPY 7 (20 
mg, 0.062 mmol, 1.0 equiv.) and TMSOTf (28.0 µL, 0.154 mmol, 2.5 equiv.) were dissolved in 
anhydrous toluene (5 mL) and the mixture was refluxed for 30 min. The solution was allowed to 
cool down to room temperature and acetic acid (18 µL, 0.308 mmol, 5.0 equiv.) was added, 
followed by DIPEA (27.0 µL, 0.154 mmol, 2.5 equiv.). After 1 h stirring at room temperature, the 
crude product was concentrated under reduced pressure and was purified via TLC (eluent 50:50 
hexane/EtOAc) to afford BODIPYs 8a (1.7 mg, 8% yield) and 8b (3.4 mg, 14% yield). 
 
122 
 
BODIPY (8a). Recrystallized from 1:1 hexane/dichloromethane. 1H NMR (CDCl3, 400 
MHz) δ 7.56-7.36 (m, 3H), 7.31-7.29 (m, 2H), 5.96 (s, 2H), 2.50 (s, 6H), 2.01 (s, 3H), 1.57 (s, 
6H); 11B NMR (CDCl3, 128 MHz) δ 0.33 (d, J = 26.88 Hz); HRMS (ESI-TOF) m/z 386.1687 [M 
+ Na]+ calculated for C21H22BFN2O2: 386.1697.   
 
BODIPY (8b). Recrystallized from 1:1 hexane/dichloromethane. 1H NMR (CDCl3, 400 
MHz) δ 7.47 (d, J = 5.6 Hz, 3H), 7.39 (d, J = 5.7 Hz, 2H), 5.94 (s, 2H), 2.45 (s, 6H), 2.05 (s, 6H), 
1.39 (s, 6H); 13C NMR (CDCl3, 100 MHz) δ 171.61, 152.98, 142.99, 135.36, 133.12, 129.09, 
128.86, 128.27, 121.44, 23.09, 14.73; 11B NMR (CDCl3, 128 MHz) δ -0.40 (s); HRMS (ESI-TOF) 
m/z 426.1836 [M + Na]+ calculated for C23H25BN2O4: 426.1851.   
 
BODIPY (9). In an oven-dried flask, BODIPY 7 (20 mg, 0.062 mmol, 1.0 equiv.) and 
TMSOTf (28.0 µL, 0.154 mmol, 2.5 equiv.) were dissolved in anhydrous toluene (5 mL) and the 
mixture was refluxed for 30 min. The solution was allowed to cool down to room temperature and 
4-bromobenzoic acid (61.9 mg, 0.308 mmol, 5.0 equiv) was added, followed by DIPEA (27.0 µL, 
0.154 mmol, 2.5 equiv.). After 1 h stirring at room temperature, the crude product was concentrated 
under reduced pressure and was purified via TLC (eluent 50:50 hexane/EtOAc) to afford BODIPY 
9 (2.1 mg, 5% yield) and was recrystallized from 1:1 hexane/dichloromethane. 1H NMR (CDCl3, 
400 MHz) δ 8.05 (d, J = 8.1 Hz, 4H), 7.59 (d, J = 8.1 Hz, 4H), 7.26 (s, 5H), 5.92 (s, 2H), 2.36 (s, 
6H); 11B NMR (CDCl3, 128 MHz) δ 0.48 (s). 
 
BODIPY (10). In an oven-dried flask, BODIPY 7 (20 mg, 0.062 mmol, 1.0 equiv.) and 
TMSOTf (28.0 µL, 0.154 mmol, 2.5 equiv.) were dissolved in anhydrous toluene (5 mL) and the 
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mixture was refluxed for 30 min. The solution was allowed to cool down to room temperature and 
Boc-Trp-OH (94.0 mg, 0.308 mmol, 5.0 equiv) was added, followed by DIPEA (54.0 µL, 0.154 
mmol, 5.0 equiv.). After 1 h stirring at room temperature, the crude product was concentrated 
under reduced pressure and was purified via TLC (eluent 50:50 hexane/EtOAc) to afford BODIPY 
10 (4.9 mg, 13% yield) and was recrystallized from 1:1 MeOH/EtOAc. 1H NMR (CDCl3, 400 
MHz) δ 8.13 (s, 1H), 8.07 (s, 1H), 7.53-7.45 (m, 4H), 7.41-7.32 (m, 3H), 7.26 (s, 4H), 7.17 (dd, J 
= 6.6, 3.3 Hz, 3H), 6.03 (s, 1H), 5.95 (s, 1H), 4.53 (d, J = 9.0 Hz, 1H), 3.72 (d, J = 13.8 Hz, 1H), 
3.37 (dd, J = 13.6, 9.0 Hz, 2H), 2.52 (s, 3H), 2.17 (s, 3H), 1.38 (d, J = 6.6 Hz, 6H), 1.25 (s, 9H). 
11B NMR (CDCl3, 128 MHz) δ 1.66 (s); HRMS (ESI-TOF) m/z 589.2986 [M + H]+ calculated for 
C35H38BN4O4: 589.3004.  
 
Synthesis of BODIPY 11b using method B. In an oven-dried flask, BODIPY 7 (20.0 mg, 
0.062 mmol, 1.0 equiv.) with AlCl3 (16.5 mg, 0.123 mmol, 2.0 equiv.) were dissolved in anhydrous 
CH2Cl2 (5 mL). The reaction was refluxed for 30 min and N-Boc-ethanolamine (0.143 mL, 0.925 
mmol, 15.0 equiv.) was added for an additional 30 min. After the reaction cooled to room 
temperature and stirred for 2 h, the crude product was concentrated under reduced pressure. The 
crude product was purified via TLC (eluent 50:50 hexane/EtOAc) to afford BODIPY 8b (26.2 mg, 
70% yield) as an orange solid, that was recrystallized from 1:1 hexane/dichloromethane. 1H NMR 
(CDCl3, 400 MHz) δ 7.54-7.46 (m, 3H), 7.32-7.28 (m, 2H), 5.96 (s, 2H), 3.22-3.12 (m, 4H), 3.12-
3.00 (m, 4H), 2.56 (s, 6H), 1.42 (s, 18H), 1.37 (s, 6H); 13C NMR (CDCl3, 100 MHz) δ 156.95, 
156.24, 155.20, 142.12, 135.34, 132.73, 129.18, 128.95, 128.20, 121.44, 79.73, 62.69, 60.99, 
43.28, 42.42, 28.55, 28.49, 14.83, 14.56; 11B NMR (CDCl3, 128 MHz) δ 2.05 (s); HRMS (ESI-
TOF) m/z 628.3517 [M + Na]+ calculated for C33H47BN4O6: 628.3507. 
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Synthesis of BODIPYs 11a and 11b using method C. In an oven-dried flask, BODIPY 7 
(20 mg, 0.062 mmol, 1.0 equiv.) and TMSOTf (28.0 µL, 0.154 mmol, 2.5 equiv.) were dissolved 
in anhydrous toluene (5 mL) and the mixture was refluxed for 30 min. The solution was allowed 
to cool down to room temperature and N-Boc-ethanolamine (48 µL, 0.308 mmol, 5.0 equiv) was 
added, followed by DIPEA (27.0 µL, 0.154 mmol, 2.5 equiv.). After 1 h stirring at room 
temperature, the crude product was concentrated under reduced pressure and was purified via TLC 
(eluent 50:50 hexane/EtOAc) to afford BODIPYs 11a (3.9 mg, 14% yield) and 11b (3.8 mg, 10% 
yield). 
 
BODIPY (11a). Recrystallized from 1:1 hexane/dichloromethane. 1H NMR (CDCl3, 400 
MHz) δ 7.53-7.45 (m, 3H), 7.36-7.24 (m, 2H), 5.97 (s, 2H), 3.17 (t, J = 5.3 Hz, 2H), 3.09 (t, J = 
5.0 Hz, 2H), 2.56 (s, 6H), 1.42 (s, 9H), 1.38 (s, 6H); 13C NMR (CDCl3, 100 MHz) δ 142.68, 135.26, 
132.15, 129.22, 129.02, 128.17, 128.14, 121.42, 28.57, 28.51, 14.84, 14.54; 11B NMR (CDCl3, 
128 MHz) δ 1.47 (d, J = 23.04 Hz); HRMS (ESI-TOF) m/z 487.2540 [M + H]+ calculated for 
C31H30BN3O2: 487.2535.  
 
BODIPY (11b). Recrystallized from 1:1 hexane/dichloromethane. 1H NMR (CDCl3, 400 
MHz) δ 7.54-7.46 (m, 3H), 7.32-7.28 (m, 2H), 5.96 (s, 2H), 3.22-3.12 (m, 4H), 3.12-3.00 (m, 4H), 
2.56 (s, 6H), 1.42 (s, 18H), 1.37 (s, 6H); 13C NMR (CDCl3, 100 MHz) δ 156.95, 156.24, 155.20, 
142.12, 135.34, 132.73, 129.18, 128.95, 128.20, 121.44, 79.73, 62.69, 60.99, 43.28, 42.42, 28.55, 
28.49, 14.83, 14.56; 11B NMR (CDCl3, 128 MHz) δ 2.05 (s); HRMS (ESI-TOF) m/z 628.3517 [M 
+ Na]+ calculated for C33H47BN4O6: 628.3507.  
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BODIPY (12). In an oven-dried flask, BODIPY 7 (20 mg, 0.062 mmol, 1.0 equiv.) and 
TMSOTf (28.0 µL, 0.154 mmol, 2.5 equiv.) were dissolved in anhydrous toluene (5 mL) and the 
mixture was refluxed for 30 min. The solution was allowed to cool down to room temperature and 
ethylene glycol (17.0 µL, 0.308 mmol, 5.0 equiv) was added, followed by DIPEA (27.0 µL, 0.154 
mmol, 2.5 equiv.). After 1 h stirring at room temperature, the crude product was concentrated 
under reduced pressure and was purified via TLC (eluent 50:50 hexane/EtOAc) to afford BODIPY 
12 (8.0 mg, 37% yield), that was recrystallized from 1:1 hexane/dichloromethane. 1H NMR 
(CDCl3, 400 MHz) δ 7.50 (d, J = 5.7 Hz, 3H), 7.31 (d, J = 4.2 Hz, 3H), 5.97 (s, 2H), 4.30 (s, 4H), 
2.57 (s, 6H), 1.38 (s, 6H); 13C NMR (CDCl3, 100 MHz) δ 133.32, 129.82, 129.09, 128.75, 128.55, 
128.28, 65.89, 29.84, 15.26, 14.66; 11B NMR (CDCl3, 128 MHz) δ 5.90 (s); HRMS (ESI-TOF) 
m/z 346.1962 [M + H]+ calculated for C21H23BN2O2: 346.1959. 
   
4.4.3 X-ray Determined Molecular structures  
 Crystal structures were determined using low-temperature data from a Bruker Kappa 
APEX-II DUO diffractometer with either Mo K or Cu K radiation. For all structures, H atoms 
were located from difference maps but constrained in calculated positions during refinement.  
 
Crystal data 4a: C33H36BF2N5O, M = 567.48, triclinic, a = 11.1039(3), b = 11.3734(3), c = 
12.9720(4) Å, U = 1445.82(7) Å3, T = 90 K, space group P1, Z = 2, Dc = 1.304 g cm-3,  (Cu K) 
= 0.09 mm-1, 5542 reflections measured, max = 30.5˚, 8843 unique (Rint = 0.040). The final R = 
0.053 (8843 I>2σ(I) data), wR(F2) = 0.129 (all data).  
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Crystal data 4b: C40H48BF2N5O10, M = 807.64, monoclinic, a = 13.3965(15), b = 
9.2534(10), c = 17.1816(19) Å, U = 2059.0(4) Å3, T = 90 K, space group P21, Z = 2, Dc = 1.303 g 
cm-3,  (Cu K) = 0.83 mm-1, 1814 reflections measured, max = 59.0˚, 4680 unique (Rint = 0.060). 
The final R = 0.062 (4680 I>2σ(I) data), wR(F2) = 0.131 (all data).  
 
Crystal data 9: C33H27BBr3N2O4, M = 686.20, Orthorhombic, a = 8.537(1), b = 10.710(2), 
c = 32.867(5) Å, U = 3005.1(8) Å3, T = 100 K, space group P212121, Z = 4, Dc = 1.517 g cm
-3,  
(Cu K) = 2.74 mm-1, 3292 reflections measured, max = 25.7˚, 5682 unique (Rint = 0.146). The 
final R = 0.068 (5682 I>2σ(I) data), wR(F2) = 0.104 (all data). 
 
Crystal data 10: C35H37BN4O4, M = 588.50, monoclinic, a = 11.4670(8), b = 8.8110(6), c 
= 15.9543(11) Å, U = 1581.82(19) Å3, T = 90 K, space group P21, Z = 2, Dc = 1.236 g cm
-3,  (Cu 
K) = 0.65 mm-1, 4547 reflections measured, max = 60.1˚, 4657 unique (Rint = 0.040). The final 
R = 0.028 (4657 I>2σ(I) data), wR(F2) = 0.071 (all data). 
 
Crystal data 11a: C26H33BFN3O3, M = 465.36, monoclinic, a = 5.9290(2), b = 25.0122(14), 
c = 16.4436(8) Å, U = 2429.9(2) Å3, T = 90 K, space group P21/c, Z = 4, Dc = 1.272 g cm
-3,  (Cu 
K) = 0.09 mm-1, 7361 reflections measured, max = 33.2˚, 9239 unique (Rint = 0.030). The final 
R = 0.049 (9239 I>2σ(I) data), wR(F2) = 0.128 (all data). 
 
Crystal data 12: C21H23BN2O2, M = 346.22, monoclinic, a = 11.306(2), b = 8.9098(10), c 
= 17.990(3) Å, U = 1812.0(5) Å3, T = 100 K, space group P21/n, Z = 4, Dc = 1.269 g cm
-3,  (Cu 
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K) = 0.08 mm-1, 4878 reflections measured, max = 34.8˚, 7459 unique (Rint = 0.051). The final 
R = 0.057 (7459 I>2σ(I) data), wR(F2) = 0.153 (all data). 
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CHAPTER 5: CHLORINATION OF ALCOHOLS AND ASYMMETRIC SN1 
REACTION[a] 
 
5.1 Introduction 
 
5.1.1 Chlorination 
 
Alkyl chlorides are useful building blocks in organic chemistry. Transformation of 
unreactive alcohols into reactive alkyl halides has proven to produce important intermediates in 
many organic syntheses.1-3 Chlorination reactions have become widespread in organic chemistry 
and useful in organic synthesis. The chlorination reaction mechanism typically requires the 
activation of an unreactive alcohol to give a better leaving group. Then in the presence of an excess 
of chloride anions, SN2 attack at the adjacent, electropositive carbon atom to give the 
corresponding alkyl chloride product.  
 
 
Figure 5.1: Structures of chlorosulfolipid natural products: danicalipin A,4-6 malhamensilipin 
A,4,7-9 hexachlorosulfolipid,10 undecachlorosulfolipid A and B.11 
 
More than 2000 known natural products containing the alkyl chloride motif have displayed 
enormous antibiotic and cytotoxic activities.12 The chlorosulfolipids are one class of 
polychlorinated natural product and some examples include danicalipin A,4-6 malhamensilipin 
A,4,7-9 hexachlorosulfolipid,10 and undecachlorosulfolipid11 (Figure 5.1). Malhamensilipin A, a 
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protein tyrosine kinase inhibitor, has antimicrobial activity which can be extracted from 
Poterioochromonas malhamensis.  
Classic chlorination methods using chlorinating agents such as thionyl chloride (SOCl2),
13 
phosphorus chloride (PCl5),
14-17 Lucas’ reagent,18-19 and Appel20 reagents have been reported to 
convert alcohols to the corresponding alkyl chlorides (Scheme 5.1). The use of toxic halogenating 
agents is unappealing to organic chemists because these chlorinating agents resulted in inseparable 
or gaseous byproducts. Chlorination using Appel’s reagent typically results in inversion of 
stereochemistry.  
 
Scheme 5.1: Classical chlorination methods. 
Recently, several new methods have been developed for chlorination reactions (Scheme 
5.2). Vilsmeier and Haack’s salt was reported as a reagent to chlorinate primary alcohols.21 
However, the disadvantage of this method is due to long reaction time, selectivity for only primary 
alcohols, and low yields (47%-70%). In 2004, Baba and coworkers22 reported a direct chlorination 
reaction of alcohols under neutral conditions with HSiMe2Cl and benzil as an additive. The 
transformation produces moderate yields of alkyl chlorides at high temperature. However, 
transformation of a primary alcohol such as 2-phenylethanol did not give the chlorinated product. 
They also reported highly regioselective chlorination for tertiary alcohols over primary alcohols 
using the HSiMe2Cl/benzil/cat. InCl2 conditions. Recently in 2010, Denton et al.
23 demonstrated 
rapid chlorination of primary and secondary alcohols under phosphine oxide-catalyzed conditions. 
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Using (COCl)2 and Ph3PO conditions have been shown to result in high yield but removal of the 
phosphine oxides by-products during purification remains a challenge. Jeong and coworkers24 
have shown an alternative method towards chlorination by using strong organic base DBU and 
sulfonylating agents to afford the alkyl chloride product in moderate yields.  
 
Scheme 5.2: Recent chlorination methods. 
5.1.2 A Chiral auxiliary for an Asymmetric SN1 reaction 
 
Substitution reactions are ubiquitous in many organic chemistry transformations. In 
organic chemistry, there are many substitution reactions such as nucleophilic, electrophilic, 
radical, and organometallic reactions. There are two types of nucleophilic substitution reaction: 
SN2, and SN1. The SN2 reaction gives inversion of stereochemistry while the SN1 reaction results 
in a racemic mixture. In order to control enantioselectivity in a SN1 reaction, the nucleophilic attack 
must be induced via chirality substrate control such as a chiral auxiliary. Chiral auxiliaries have 
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become an essential tool for organic chemists to synthesize stereospecific natural products and 
pharmaceutical drugs. In 1975, Nobel laureate E. J. Corey developed the use of chiral auxiliaries 
in order to control the stereochemical outcome of a given compound in an organic 
transformation.25 There are three steps to induce stereoselective transformation with auxiliary 
incorporation: i) the chiral auxiliary is coupled to the target substrate; ii) the compound undergoes 
diastereoselective conversions; and iii) cleavage of the chiral auxiliary to result in an 
enantioselective product. Evans and coworkers26-27 introduced the concept of oxazolidinone 
auxiliaries and it has been widely used in complex natural synthesis. For example, many 
stereoselective reactions such as aldol reactions,27 alkylation reactions,28 and Diels-Alder 
reactions29-30 have utilized this methodology. Numerous groups have subsequently extended and 
improved this chiral auxiliary asymmetric induction.31-33 For example, Olivo and coworkers34 
particularly focused on indene-based thiazolidinethione as the chiral auxiliary replacement. There 
are many ways for removal of the oxazolidinone auxiliary and transforming it to other functional 
groups. 
5.2 Results and Discussion 
 
5.2.1 Chlorination Syntheses 
 
To explore mild reaction conditions for chemoselective chlorination of primary alcohols in 
presence of tertiary alcohols, 3-phenylbutane-1,3-diol (CAS#7133-68-8) was used as a model 
substrate. There are currently two different pathways to synthesize the 1,3-diol. The first pathway 
requires acetophenone 1, which is commerically available, to react with allylmagnesium bromide 
in a Grignard reaction, which resulted in the desired homoallyl alcohol 2 in 93% yield (Scheme 
5.3). The alkene  product 2 was subjected to reductive ozonolysis gas (O3) to give the intermediate 
134 
 
molozonide, which was then reduced by NaBH4 to achieve the 1,3-diol 4 in 77% yield. Although 
path 1 gave the target compound in good yield, we also investigated an alternative way. 
                  
Scheme 5.3: Path 1 towards synthesis of 3-phenylbutane-1,3-diol 4. 
Path 2, the less efficient pathway, began by reacting ethyl acetate and acetophenone 
through an aldol reaction (Scheme 5.4). Strong base, such as LDA, deprotonates the α proton of 
ethyl acetate to form the enolate. The anion in the α position of the enolate then attacks the carbonyl 
of acetophenone 1 to produce ester 3. The crude materials were taken on to the next step without 
purification. The ester product 3 was reduced by LiAlH4 in THF to give 1,3-diol 4 in 69% over 
two steps.  
The diol was treated with various chlorinating reagents for preliminary studies, as depicted 
in Table 5.1. Classical chlorinating agents such as SOCl2 and PCl5 have resulted in crude complex 
mixtures. 
Scheme 5.4: Path 2 towards synthesis of 3-phenylbutane-1,3-diol 4.  
Next, CCl4-PPh3 and triphosgene-PPh3 were investigated (entries 1 and 2) and produced 
the chlorinated product 4a in 30% and 78%, respectively. The triphenylphosphine by-products 
were responsible for these modest yields. In the presence of triphosgene and triethylamine, the 
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chloro-alcohol product was obtained rapidly in a yield of 98%. Indeed, when phosgene was used 
in place of triphosgene, the desired product 4a was still obtained but in a lower yield of 89%. On 
the other hand, other bases such as pyridine and Hünig’s base (DIPEA) were also investigated and 
these reactions resulted in cyclic carbonate 8.  
Table 5.1: Preliminary studies on chlorination of 1,3-diol 4 with various chlorinate reagents. 
 
Entry Chlorinate reagents 4a, yield (%) 8, yield (%) 
1 CCl4, PPh3 30 --- 
2 Triphosgene, PPh3 78 --- 
3 Triphosgene, TEA 98 --- 
4 Phosgene, TEA 89 --- 
5 Triphosgene, Pyridine --- 86 
6 Triphosgene, DIPEA --- 45 
TEA: triethylamine, CCl4: carbon tetrachloride, PPh3: triphenylphosphine 
Our typical chlorination protocol includes 0.5 equiv. of triphosgene and 2.5 equiv of 
triethylamine under anhydrous conditions in dichloromethane. The reaction started at 0 °C and 
then was warmed to room temperature. Based on TLC, it was shown that the starting material was 
fully consumed within 5 minutes. However, the reaction was stirred for an additional 3 hours for 
general purpose for all the diols. The 1,3-diols 4-7 containing primary and tertiary alcohols were 
converted into their corresponding chloroalcohol products 4a-7a in excellent yield ranging from 
85-98%. It was initally suspected that chlorination could possibly occur at the primary and tertiary 
hydroxyl positions.  
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Table 5.2: Chemoselective chlorination of aliphatic primary alcohol vs. tertiary alcohol 
 
 
  
entry starting material product yield 
 
 
1 
 
 
 
 
 
 
98% 
 
 
 
2 
 
 
 
 
 
 
 
85% 
 
 
 
3 
 
 
 
 
 
 
 
97% 
 
 
4 
 
 
 
 
 
 
96% 
 
However, the chlorination reactions were chemoselective only for primary alcohols in the 
presence of tertiary alcohols. In addition, non-anhydrous conditions were also performed and 
effectively resulted in an excellent yield of 98%. 
To further our investigation, various groups binding to the tertiary carbon were synthesized 
and studied. As shown in Table 5.1, highly ionizable tertiary alcohols were unaffected by the 
activation reagents due to sterically demanding substituents such as phenyl and methyl. In addition, 
whenever the phenyl and methyl were substituted with larger substituents, primary alcohols were 
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still converted to its corresponding primary chloride products. My role in the published 
chlorination paper was to investigate aliphatic alcohols and substitute other bases while other co-
authors (Ayala and Villalpando) were to investigate different functional group compatibility, 
secondary alcohols and α–branched alcohols.  
5.2.2 Asymmetric SN1 Reaction 
 
Scheme 5.5: Retrosynthetic analysis of oxazolidinone 17. 
As shown in retrosynthetic Scheme 5.5, the target compound 17 can be derived from 
acylation between chloroformate 16 and oxazolidone 13. This fragment 16 comes from 1,3-diol 4 
through a series steps of protection and deprotection. The diol will be synthesized through two 
pathways. The first pathway consists of treating acetophenone with Grignard reagent and 
ozonolysis. Fragment 13 can be made through cyclization of aminoalcohol 12. The amino alcohol 
12 can be synthesized from the commercially available indene 9, which was previously reported.35  
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 Our first approach was to treat commercially available indene 9 with osmium tetroxide, N-
methylmorpholine-N-oxide (NMO), and water in an Upjohn dihydroxylation reaction to produce 
racemic diol 10 in 89% yield, as shown in Scheme 5.6. The next step was to treat the diol with 
acetonitrile and sulfuric acid to form a cyclic imine as an intermediate. By introducing a 
nucleophile such as water, the heterocycle opened up to give ammonium-alcohol enantiomers 11a 
and 11b. 
 
Scheme 5.6: Synthesis of oxazolidone 13 from commerically available indene 9. 
The next approach was to perform kinetic resolution on the two enantiomers with L-tartaric 
acid. In order to distinguish between the two amino alcohol enantiomers, methods such as 
recrystallization and filtration were applied. The targeted amino alcohol 12 was separated as a 
recrystallized solid. Unfortunately, when comparing the optical rotation for the amino alcohol to 
the authentic commercially available amino alcohol from Aldrich, the values were significantly 
different. The optical rotation for our synthesized amino alcohol was +26.13° and for the authentic 
amino alcohol was -96.6°. Therefore, the authentic commercial amino alcohol was used for the 
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next step. The amino alcohol 12 was treated with phosgene and triethylamine and afforded 
oxazolidinone 13 in 96% yield (Scheme 5.6). 
 
Scheme 5.7: Protection and selective deprotection of 1,3-diol 4. 
With fragment 13 in hand, we next turned our attention to fragment 16. The hydroxyl 
groups of 1,3-diol 4 were subjected to mixture of tert-butyldimethylsilyl triflate (TBSOTf) and 
2,6-lutidine to give 1,3-di-O-TBS compound 14 in an excellent yield of 93% (Scheme 5.7). Then 
compound 14 was exposed to selective deprotection of the primary TBS ether with p-
toluenesulfonic acid (p-TsOH) in methanol to produce alcohol 15 in 73% yield. The alcohol was 
then reacted with phosgene to form chloroformate 16 in 75% yield as a crude product (Scheme 
5.8). No purification was performed on the chloroformate since it is very unstable on silica gel and 
to moisture. The chloroformate was carried into the next step of the synthesis. 
 
Scheme 5.8: Synthesis of chloroformate 16. 
As shown in Table 5.3, we explored acylation coupling conditions between chloroformate 
16 and oxazolidone 13 in order to synthesize the target oxazolidinone 17. Screening of various 
bases in THF at different temperature afforded the desired compound 17 with a wide range of 
yields ranging from no product to 59% yield. When triethylamine was used as the base, the target 
compound 17 was obtained in 52% yield, while no product was produced when 1,8-
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diazabicyclo[5.4.0]undec-7-ene (DBU), pyridine and diisopropylethylamine (DIPEA) were used. 
When a mixture of TEA and DMAP was used, the yield increased to 59%. Surprisingly, stronger 
bases such as n-BuLi resulted in a yield of 49% while sec-BuLi only gave trace amount of the 
desired product. The reaction with n-BuLi proceeded in the fastest time when compared to other 
bases.  
Table 5.3: Optimized acylation reaction conditions for synthesis of oxazolidinone 17. 
 
Entry Base Temp  17, Yield (%) 
1 Triethylamine 0 °C 52  
2 DBU 0 °C 0 
3 Triethylamine + DMAP 0 °C 59  
4 DIPEA 0 °C 0 
5 NaH 0 °C 23 
6 n-BuLi -78 °C 49 
7 sec-BuLi -78 °C trace 
8 LDA -78 °C 22 
9 Pyridine 0 °C 0 
 
 Next, we explored using n-BuLi at various temperatures and reaction times (Table 5.4). At 
higher temperature, the yields of compound 17 decreased possibly due to the degradation of THF. 
The degradation transforms n-butylithium into butane and inhibits the reaction. With longer times 
(6-8 h), the yields are relatively unchanged and ranged from 37-43%.  
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Table 5.4: Optimization of coupling conditions between chloroformate 16 and oxazolidone 13. 
 
Entry Time Temp  17, Yield (%) 
1 3 h -78 °C 49 
2 3 h -40 °C 31 
3 3 h 0 °C 9 
4 6 h -78 °C 37 
5 8 h -78 °C 43 
 
 With compound 17 in hand, we now turned our attention to perform the asymmetric SN1 
reaction. Oxazolidinone 17 undergoes ionization with BF3OEt2 to form a tertiary carbocation and 
furan undergoes nucleophilic attack to give oxazolidinone 18 in 96% yield (Scheme 5.9). The 
optical rotation is [α] = +146.2 for compound 18. Finally, hydrolytic cleavage of the chiral 
auxiliary is performed with potassium carbonate and methanol to give the alcohol 19. The optical 
rotation is [α] = +2.3, which shows that the alcohol 19 is enantiopure. 
5.3 Conclusions 
 
 In summary, a series of chloroalcohol compounds 4a-7a were synthesized in high yields 
(85-98%) via triphosgene-triethylamine activation conditions. The chlorination reaction was 
chemoselective only for primary alcohols in the presence of tertiary alcohols due to steric 
hindrance. Other bases such as pyridine and diisopropylethylamine resulted in the cyclic carbonate 
8. Fragment 13 was made through a series of steps from the commerically available indene 9 while 
fragment 16 was made from the commercially available acetophenone 1. Oxazolidinone 17 was 
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synthesized in moderate yield from acylation reaction between chloroformate 16 and oxazolidone 
13. Compound 17 was ionizated with Lewis acid (BF3OEt2) and undergoes nucleophilic attack 
with furan in an asymmetric SN1 reaction to give compound 18 in excellent yield of 96%. The 
oxazolidone was cleaved under hydrolysis conditions to produce alcohol 19 in good yield of 48%.  
 
 
Scheme 5.9: SN1 reaction and auxiliary cleavage.  
5.4 Experimental 
 
5.4.1 General Information 
 
2-Phenyl-4-penten-2-ol (2). Acetophenone (0.500 g, 4.16 mmol) was dissolved in THF (42 
mL) and cooled to -78 °C. AllyMgBr (4.57 mL, 4.51 mmol) was added dropwise to the reaction 
mixture. After 45 minutes, the reaction was quenched with half saturated NH4Cl (20 mL) and 
extracted with EtOAc (3 x 20 mL). The combined organic layers were dried over MgSO4, filtered, 
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and concentrated under reduced pressure. The crude product was purified via silica (90/10 
Hex/EtOAc) to afford alcohol 2 (93%, 0.630 g). 
 
(±)-3-Phenylbutane-1,3-diol (4). Path 1: Alcohol 2 (25.0 mg, 0.154 mmol) was dissolved 
in MeOH (5 mL) and cooled to 0 °C. O3 was bubbled into the solution until the solution turned 
blue. NaBH4 (11.7 mg, 0.308 mmol) was added as solid and warmed to room temperature. The 
crude product was purified via silica (eluent 60/40 Hex/EtOAc) to afford 1,3-diol 4 (77%, 19.8 
mg). 1H NMR (CDCl3, 250 MHz) δ 7.47-7.18 (m, 5H), 3.75 (dq, J = 9.5, 4.6 Hz, 1H), 3.62-3.45 
(m, 1H), 2.12-2.01 (m, 2H), 1.58 (s, 3H). 
 
(±)-3-Phenylbutane-1,3-diol (4). Path 2: DIPEA (3.9 mL, 27.4 mmol) was suspended in 
anhydrous THF (100 mL) and cooled to -78 °C. n-butyllithium (11.0 mL, 27.4 mmol) was added 
dropwise, followed by anhydrous EtOAc (2.5 mL, 25.7 mmol) and then acetophenone (2 mL, 17.1 
mmol). After 1.5 hours, the reaction mixture was quenched with half saturated NH4Cl (20 mL) 
and extracted with EtOAc (3 x 20 mL). The combined organic layers were dried over MgSO4, 
filtered, and concentrated under reduced pressure to afford crude ester 3. The crude ester 3 was 
taken to next step without purification. The LiAlH4 (0.715 g, 18.8 mmol) was dissolved in THF 
(250 mL) and cooled to 0 °C. The ester was added to the reaction mixture and rinsed three times 
with THF. After 15 min, the mixture was quenched with water (0.72 mL) and then washed with 
15% NaOH (0.72 mL) and then water (2.2 mL). The aqeous layers were extracted with EtOAc 
(200 mL), dried over small amount of MgSO4, filtered, and concentrated under reduced pressure. 
The crude product was purified via silica (eluent 60/40 Hex/EtOAc) to afford 1,3 diol 4 (69% over 
two steps, 1.96 g). 1H NMR (CDCl3, 250 MHz) δ 7.47-7.18 (m, 5H), 3.75 (dq, J = 9.5, 4.6 Hz, 
1H), 3.62-3.45 (m, 1H), 2.12-2.01 (m, 2H), 1.58 (s, 3H). 
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General Procedure for Chlorination. In an over-dried flask, diol (2.00 mmol) was dissolved 
in anhydrous CH2Cl2 (15 mL) and cooled to 0 °C. Triethylamine (5.00 mmol) was added dropwise 
to the reaction mixture, followed by triphosgene (1.00 mmol). The reaction was warmed up to 
room temperature and stirred for an addition 3 hours. The mixture was quenched with saturated 
NaHCO3 (30 mL). The aqueous layer was extracted with CH2Cl2 (2 x 30 mL). The combined 
organic layers were dried over MgSO4, filtered, and concentrated under reduced pressure. 
 
(±)-4-Chloro-2-phenylbutan-2-ol (4a). Diol 4 (332 mg, 2.00 mmol, CAS #7133-68-8) was 
utilized along with the requisite amounts of triethylamine and triphosgene. The crude product was 
purified via silica (eluent 90/10 hexane/EtOAc) to give a colorless oil 4a (98%, 361 mg). 1H NMR 
(CDCl3, 250 MHz) δ 7.46-7.24 (m, 5H), 3.56 (ddd, J = 10.8, 8.4, 7.8 Hz, 1H), 3.35 (ddd, J = 10.7, 
8.9, 6.4 Hz, 1H), 2.35-2.29 (m, 2H), 2.04 (s, 1H), 1.62 (s, 3H); 13C NMR (CDCl3, 62.5 MHz) δ 
146.30, 128.36, 126.94, 124.48, 74.24, 46.54, 40.42, 30.70; IR (cm-1): f = 3553, 3421, 3028, 2931, 
1375, 1099, 699; HRMS (ESI-TOF) m/z 167.0622 [M - OH]+ calculated for C10H12Cl: 167.0626. 
 
(±)-(E)-5-Chloro-3-phenylpent-1en-3-ol (5a). Diol 5 (385 mg, 2.00 mmol) was utilized 
along with the requisite amounts of triethylamine and triphosgene. The crude product was purified 
via silica (eluent 90/10 hexane/EtOAc) to give a yellow oil 5a (85%, 356 mg). 1H NMR (CDCl3, 
250 MHz) δ 7.42- 7.23 (m, 5H), 6.64 (d, J = 16.1 Hz, 1H), 6.25 (d, J = 16.1 Hz, 1H), 3.74-3.56 
(m, 2H), 2.25-2.06 (m, 2H), 1.79 (s, 1H), 1.45 (s, 3H). 13C NMR (CDCl3, 62.5 MHz,) δ 136.40, 
134.92, 128.55, 127.87, 127.61, 126.40, 72.75, 44.94, 40.33, 28.86; IR (cm-1): f = 3553, 3399, 
3026, 2928, 1272, 969, 692; HRMS (ESI-TOF) m/z 193.0779 [M - OH]+ calculated for C12H14Cl: 
193.0787. 
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2-Benzyl-4-chloro-1-phenylbutan-2-ol (6a). Diol 6 (550 mg, 2.00 mmol, CAS #497845-
92-8) was utilized along with the requisite amounts of triethylamine and triphosgene. The crude 
product was purified via silica (eluent 90/10 hexane/EtOAc) to give a colorless oil 6a (97%, 532 
mg). 1H NMR (CDCl3, 250 MHz) δ 7.40-7.22 (m, 10H), 3.72-3.66 (m, 2H), 2.83 (s, 4H), 1.99-
1.92 (m, 2H), 1.55 (s, 1H); 13C NMR (CDCl3, 62.5 MHz) δ 136.36, 130.59, 128.41, 126.80, 73.74, 
45.81, 41.39, 40.25; IR (cm-1): f = 3561, 3468, 3028, 2923, 1453, 1089, 700; HRMS (ESI-TOF) 
m/z 297.1022 [M + Na]+ calculated for C17H19ClNaO: 297.1000. 
 
1-(2-Chloroethyl)cyclopentanol (7a). Diol 7 (260 mg, 2.00 mmol, CAS #73089-93-7) was 
utilized along with the requisite amounts of triethylamine and triphosgene. The crude product was 
purified via silica (eluent 70/30 pentane/Et2O) to give a colorless oil 7a (96%, 285 mg). 
1H NMR 
(CDCl3, 250 MHz); δ 3.72-3.66 (m, 2H), 2.12-2.01 (m, 2H), 1.83-1.55 (m, 8H), 1.41 (s, 1H); 13C 
NMR (CDCl3, 62.5 MHz) δ 81.47, 44.05, 41.07, 39.70, 23.32; IR (cm-1): f = 3393, 2961, 2874, 
1452, 1211, 731; HRMS (ESI-TOF) m/z 131.0622 [M - OH]+ calculated for C7H12Cl: 131.0634. 
 
(±)-4-Methyl-4-phenyl-1,3-dioxan-2-one (8). Diol 4 (332 mg, 2.00 mmol) was utilized 
along with the requisite amounts of pyridine (0.40 mL, 5.00 mmol) and triphosgene (297 mg, 0.500 
mmol). The crude product was purified via silica (eluent 60/40 hexane/EtOAc) to give a colorless 
oil 8 (86%, 329 mg). 1H NMR (CDCl3, 250 MHz) δ 7.40-7.25 (m, 5H), 4.31 (ddd, ddd, J = 11.2, 
4.7, 4.2 Hz, 1H), 4.03 (ddd, J = 11.2, 10.0, 4.5 Hz, 1H), 2.46-2.26 (m, 2H), 1.70 (s, 3H); 13C NMR 
(CDCl3, 62.5 MHz) δ 148.62, 142.24, 128.76, 127.83, 123.80, 84.26, 64.99, 33.16, 29.99; IR (cm-
1): f = 2983, 2917, 1733, 1087, 699; HRMS (ESI-TOF) m/z 215.0684 [M + Na]+ calculated for 
C11H12NaO3: 215.0698. 
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5.4.2 Asymmetric SN1 Syntheses 
 
Compound (10). Indene 9 (2mL, 17.15 mmol) was suspended in THF (28.5 mL). After 30 
min, tert-butanol (28.5 mL) was added, followed by water (5.67 mL) and NMO (2.05 g, 18.86 
mmol). One crystal solid of OsO4 was added to the reaction mixture. The reaction was stirred 
overnight, quenched with Na2S2O3 (50 mL), and extracted with ethyl acetate (50 mL). The 
combined organic layers were dried over MgSO4, filtered, and concentrated under reduced 
pressure. The crude product was purified via silica (eluent 50/50 Hex/EtOAc) to afford diol 10 
(89% yield, 2.2838 g). 
 
Compound (12). Diol 10 (3.88 g, 25.8 mmol) was dissolved in dry acetonitrile (25 mL). 
The reaction was cooled to 0 °C and H2SO4 (2.875 mL) was added dropwise. The reaction mixture 
was warmed to room temperature. After 6 hours, the mixture was quenched with water (15 mL), 
diluted with water (15 mL), and concentrated by atmosphere pressure. The reaction residue was 
refluxed at 100 °C overnight and warmed to room temperature. Then isobutanol (15 mL) was 
added, followed by NaOH (50% solution, 15 mL) and diluted with tert-butanol (15 mL). The 
aqeuous was extracted with ethyl acetate (5 x 10 mL) and dried over MgSO4. The crude amino 
alcohols mixture (4.54 g, 30.44 mmol) were dissolved in MeOH (68 mL). L-tartaric acid (5.05 g, 
33.48 mmol) dissolved in MeOH (68 mL) were added to the reaction and refluxed for 3 hours. 
Then the mixture was cooled to room temperature and recrystallized with methanol to afford amino 
alcohol 12 (210 mg). 
 
Compound (13). Commercially available amino alcohol 12 (2.5 g, 16.75 mmol) was 
suspended in CH2Cl2 (180 mL). The reaction was cooled to 0 °C and triethylamine (5.84 mL, 41.89 
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mmol) was added dropwise. Then triphosgene (1.987 g, 6.70 mmol) dissolved in CH2Cl2 (10 mL) 
were cannula over to the reaction mixture. The reaction was quenched with half saturated NH4Cl 
(200 mL) after stirring for 2 hours. The mixture was extracted with CH2Cl2 (50 mL). The combined 
organic layers were dried over MgSO4, filtered, and concentrated under reduced pressure to afford 
a white yellow solid oxazolidone 13 (96%, 3.048 g). 
 
Compound (14). 1,3 diol 4 (0.9371 g, 5.64 mmol) was dissolved in anhydrous CH2Cl2 (33.6 
mL) and cooled to -78 °C. Then 2,6-lutidine (2.63 mL, 22.5 mmol) was added dropwise, followed 
by TBSOTf (3.107 mL, 13.53 mmol). After 1 hour, the reaction was warmed to room temperature 
and continued stirring for additional 1 hour. The mixture was quenched with half saturated 
NaHCO3 (10 mL) and extracted with CH2Cl2 (3 x 10 mL). The combined organic layers were dried 
over MgSO4, filtered, and concentrated under reduced pressure. The crude product was purified 
via silica (eluent 100% hexanes to 95/5 Hex/EtOAc) to afford ligh yellow oil TBS ether 14 (93%, 
2.0706 g). 1H NMR (CDCl3, 250 MHz) δ 7.61-7.22 (m, 6H), 3.85 (td, J = 9.5, 6.1 Hz, 1H), 3.53 
(td, J = 9.6, 6.1 Hz, 1H), 2.20 (dt, J = 16.6, 8.4 Hz, 2H), 1.78 (s, 3H), 1.13 (s, 9H), 1.00 (s, 9H), 
0.28 (s, 3H), 0.14 (s, 3H), 0.11 (d, J = 3.1 Hz, 6H).  
 
Compound (15). 1,3-TBS ether 14 (0.200 g, 0.507 mmol) was dissolved in anhydrous 
MeOH (25 mL) and cooled to 0 °C. TsOH (0.012g, 0.06 mmol) was added as solid to the reaction 
mixture. After 1 hour, the mixture was quenched with a drop of triethylamine and concentrated 
under reduced pressure. The crude product was purified via silica (eluent 90/10 Hex/EtOAc) to 
afford a colorless oil compound 15 (73%, 0.104 g). 1H NMR (CDCl3, 250 MHz) δ 7.49-7.20 (m, 
5H), 3.62 (t, J = 6.1 Hz, 2H), 2.03 (tt, J = 14.1, 7.1 Hz, 2H), 1.73 (s, 3H), 0.98 (s, 9H), 0.14 (s, 
3H), -0.04 (s, 3H). 
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Compound (16). Alcohol 15 (100 mg, 0.357 mmol) was dissolved in THF (6 mL) and 
cooled to 0 °C. Phosgene (0.256 mL, 15% in toluene, 0.392 mmol) solution was added and the 
reaction was warmed to room temperature. After 15 minutes, the reaction was quenched with cold 
saturated NaHCO3 (5 mL) and extracted with cold pentane (5 mL). The organic layer was dried 
over MgSO4, filtered, and concentrated under reduced pressure to afford the crude chloroformate 
16 (75%, 92.3 mg). 1H NMR (CDCl3, 250 MHz) δ 7.59-7.14 (m, 11H), 4.45-4.26 (m, 2H), 4.09 
(ddd, J = 10.6, 9.2, 6.2 Hz, 1H), 2.23 (ddd, J = 16.8, 12.8, 6.8 Hz, 2H), 1.68 (s, 3H), 0.98 (s, 11H), 
0.16 (s, 3H), 0.02 (s, 3H). 
 
Compound (17). Oxazolidone 13 (64.6 mg, 0.188 mmol) was dissolved in THF (1 mL) and 
cooled to -78 °C. n-BuLi (0.088 mL, 2.135 M in hexane, 0.188 mmol) was added dropwise to the 
reaction. Chloroformate 16 (30.0 mg, 0.171 mmol) dissolved in THF (1 mL) was cannula over the 
reaction mixture. After 3 hours, the reaction was quenched with half saturated NH4Cl (5 mL) and 
extracted with EtOAc (3 x 5 mL). The combined organic layers were dried over MgSO4, filtered, 
and concentrated under reduced pressure. The crude product was purified via silica (eluent 80/20 
Hex/EtOAc) to afford compound 17 (49%, 40 mg). 1H NMR (CDCl3, 250 MHz) δ 7.59-7.40 (m, 
3H), 7.40-7.14 (m, 7H), 5.49 (dd, J = 15.4, 7.0 Hz, 1H), 5.20 (dq, J = 8.3, 4.0 Hz, 1H), 4.56-4.36 
(m, 1H), 4.27-4.11 (m, 1H), 3.34 (s, 2H), 2.49-2.18 (m, 2H), 1.70 (d, J = 3.6 Hz, 3H), 1.00 (s, 9H), 
0.18 (s, 3H), 0.03 (d, J = 1.4 Hz, 3H). 
 
Compound (18). Compound 17 (78.0 mg, 0.162 mmol) was dissolved in anhydrous CH2Cl2 
(8 mL) and cooled to -78 °C. Furan (0.083 mL, 1.134 mmol) was added, followed by BF3•OEt2 
(0.080 mL, 0.648 mmol) to the reaction and warmed to room temperature. After 1 hour, the 
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reaction mixture was quenched with saturated NaHCO3 (10 mL) and extracted with CH2Cl2 (3 x 
10 mL). The combined organic layers were dried over MgSO4, filtered, and concentrated under 
reduced pressure. The crude product was purified via silica (eluent 80/20 Hex/EtOAc) to afford 
compound 18 (96%, 64.7 mg). 1H NMR (CDCl3, 250 MHz) δ 7.61 (d, J = 7.4 Hz, 1H), 7.42-7.12 
(m, 11H), 6.38-6.31 (m, 1H), 6.23 (d, J = 2.9 Hz, 1H), 5.64 (t, J = 6.5 Hz, 1H), 5.32-5.15 (m, 1H), 
4.45-4.21 (m, 2H), 3.37 (d, J = 3.3 Hz, 2H), 2.76-2.46 (m, 2H), 1.74 (s, 3H); 13C NMR (CDCl3, 
62.5 MHz) δ 159.90, 151.35, 151.02, 145.84, 141.54, 139.57, 138.40, 129.93, 128.29, 127.97, 
126.55, 126.40, 126.38, 126.12, 125.27, 109.84, 105.99, 64.78, 63.53, 42.38, 38.61, 37.83, 29.62, 
25.92. 
 
Compound (19). Compound 18 (12.3 mg, 0.029 mmol) was dissolved in MeOH (2 mL) 
and cooled to 0 °C. Potassium carbonate (8.1 mg, 0.059 mmol) was added as solid to the reaction 
and warmed to room temperature. After 1.5 hours, the reaction was quenched with half saturated 
NH4Cl (2 mL) and extracted with EtOAc (3 x 2 mL). The combined organic layers were dried over 
MgSO4, filtered, and concentrated under reduced pressure. The crude product was purified via 
silica (eluent 80/20 Hex/EtOAc) to afford alcohol 19 (48%, 3.0 mg). 1H NMR (CDCl3, 250 MHz) 
δ 7.37-7.11 (m, 7H), 6.34 (dd, J = 3.2, 1.9 Hz, 1H), 6.22-6.14 (m, 1H), 3.69-3.48 (m, 2H), 2.53-
2.23 (m, 2H), 1.67 (s, 3H). 
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APPENDIX A: NMR Characterization of Compounds Found in Chapter 2 
 
 
Figure A.1: 1H NMR of BODIPY 1 in CDCl3 (400 MHz) 
 
 
 
 
 
Figure A.2: 13C NMR of BODIPY 1 in CDCl3 (100 MHz) 
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Figure A.3: 1H NMR of BODIPY 1a in CDCl3 (400 MHz) 
 
 
 
 
 
Figure A.4: 13C NMR of BODIPY 1a in CDCl3 (100 MHz) 
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Figure A.5: 1H NMR of BODIPY 1b in CDCl3 (400 MHz) 
 
 
 
 
 
Figure A.6: 13C NMR of BODIPY 1b in CDCl3 (100 MHz) 
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Figure A.7: 1H NMR of BODIPY 1c in CDCl3 (400 MHz) 
 
 
 
 
 
Figure A.8: 13C NMR of BODIPY 1c in CDCl3 (100 MHz) 
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Figure A.9: 1H NMR of BODIPY 1d in CDCl3 (400 MHz) 
 
 
 
 
 
Figure A.10: 13C NMR of BODIPY 1d in CDCl3 (100 MHz) 
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Figure A.11: 1H NMR of BODIPY 1e in CDCl3 (400 MHz) 
 
 
 
 
 
Figure A.12: 13C NMR of BODIPY 1e in CDCl3 (100 MHz) 
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Figure A.13: 1H NMR of BODIPY 2 in CDCl3 (400 MHz) 
 
 
 
 
 
Figure A.14: 13C NMR of BODIPY 2 in CDCl3 (100 MHz) 
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Figure A.15: 1H NMR of BODIPY 2a in CDCl3 (400 MHz) 
 
 
 
 
 
Figure A.16: 13C NMR of BODIPY 2a in CDCl3 (100 MHz) 
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Figure A.17: 1H NMR of BODIPY 3 in CDCl3 (400 MHz) 
 
 
 
 
 
Figure A.18: 13C NMR of BODIPY 3 in CDCl3 (100 MHz) 
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Figure A.19: 1H NMR of BODIPY 3a in CDCl3 (400 MHz) 
 
 
 
 
 
Figure A.20: 13C NMR of BODIPY 3a in CDCl3 (100 MHz) 
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Figure A.21: 1H NMR of BODIPY 4 in CDCl3 (400 MHz) 
 
 
 
 
 
Figure A.22: 13C NMR of BODIPY 4 in CDCl3 (100 MHz) 
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Figure A.23: 11B NMR of BODIPY 1 in CDCl3 (128 MHz) 
 
 
 
 
 
Figure A.24: 11B NMR of BODIPY 1a in CDCl3 (128 MHz) 
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Figure A.25: 11B NMR of BODIPY 1b in CDCl3 (128 MHz) 
 
 
 
 
 
Figure A.26: 11B NMR of BODIPY 1c in CDCl3 (128 MHz) 
 
 
 
 166 
 
 
 
Figure A.27: 11B NMR of BODIPY 1d in CDCl3 (128 MHz) 
 
 
 
 
 
Figure A.28: 11B NMR of BODIPY 1e in CDCl3 (128 MHz) 
 
 
 
 167 
 
 
 
Figure A.29: 11B NMR of BODIPY 2 in CDCl3 (128 MHz) 
 
 
 
 
 
Figure A.30: 11B NMR of BODIPY 2a in CDCl3 (128 MHz) 
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Figure A.31: 11B NMR of BODIPY 3 in CDCl3 (128 MHz) 
 
 
 
 
 
Figure A.32: 11B NMR of BODIPY 3a in CDCl3 (128 MHz) 
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Figure A.33: 11B NMR of BODIPY 4 in CDCl3 (128 MHz) 
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APPENDIX B: NMR Characterization of Compounds Found in Chapter 3 
 
 
 
Figure B.1: 1H NMR of BODIPY 1a in CDCl3 (400 MHz) 
 
 
 
 
Figure B.2: 13C NMR of BODIPY 1a in CDCl3 (100 MHz) 
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Figure B.3: 1H NMR of BODIPY 2a in CDCl3 (400 MHz) 
 
 
 
 
 
Figure B.4: 13C NMR of BODIPY 2a in CDCl3 (100 MHz) 
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Figure B.5: 1H NMR of BODIPY 3a in CDCl3 (400 MHz) 
 
 
 
 
 
Figure B.6: 13C NMR of BODIPY 3a in CDCl3 (100 MHz) 
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Figure B.7: 1H NMR of BODIPY 4a in CDCl3 (400 MHz) 
 
 
 
 
 
Figure B.8: 13C NMR of BODIPY 4a in CDCl3 (100 MHz) 
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Figure B.9: 1H NMR of BODIPY 5a in CDCl3 (400 MHz) 
 
 
 
 
 
Figure B.10: 13C NMR of BODIPY 5a in CDCl3 (100 MHz) 
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Figure B.11: 1H NMR of Dipyrrin 7 in CDCl3 (400 MHz) 
 
 
 
 
 
Figure B.12: 13C NMR of Dipyrrin 7 in CDCl3 (100 MHz) 
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Figure B.13: 1H NMR of BODIPY 7a in CD2Cl2 (400 MHz) 
 
 
 
 
 
Figure B.14: 13C NMR of BODIPY 7a in CDCl3 (100 MHz) 
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Figure B.15: 1H NMR of BODIPY 7b in CD2Cl2 (400 MHz) 
 
 
 
 
 
Figure B.16: 13C NMR of BODIPY 7b in CDCl3 (100 MHz) 
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Figure B.17: 1H NMR of BODIPY 7c in CD2Cl2 (400 MHz) 
 
 
 
 
 
Figure B.18: 13C NMR of BODIPY 7c in CDCl3 (100 MHz) 
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Figure B.19: 1H NMR of BODIPY 7d in CD2Cl2 (400 MHz) 
 
 
 
 
 
Figure B.20: 13C NMR of BODIPY 7d in CDCl3 (100 MHz) 
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Figure B.21: 1H NMR of BODIPY 7e in CD2Cl2 (400 MHz) 
 
 
 
 
 
Figure B.22: 13C NMR of BODIPY 7e in CDCl3 (100 MHz) 
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Figure B.23: 1H NMR of BODIPY 7f in CD2Cl2 (400 MHz) 
 
 
 
 
 
Figure B.24: 13C NMR of BODIPY 7f in CD2Cl2 (100 MHz) 
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Figure B.25: 1H NMR of BODIPY 7g in CD2Cl2 (400 MHz) 
 
 
 
 
 
Figure B.26: 13C NMR of BODIPY 7g in CDCl3 (100 MHz) 
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Figure B.27: 1H NMR of Dipyrrin 8 in CDCl3 (400 MHz) 
 
 
 
 
 
Figure B.28: 13C NMR of Dipyrrin 8 in CDCl3 (100 MHz) 
 
 
 
184 
 
 
 
Figure B.29: 1H NMR of BODIPY 8a in CD2Cl2 (400 MHz) 
 
 
 
 
 
Figure B.30: 13C NMR of BODIPY 8a in CDCl3 (100 MHz) 
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Figure B.31: 1H NMR of BODIPY 8b in CD2Cl2 (400 MHz) 
 
 
 
 
 
Figure B.32: 13C NMR of BODIPY 8b in CDCl3 (100 MHz) 
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Figure B.33: 1H NMR of BODIPY 8c in CD2Cl2 (400 MHz) 
 
 
 
 
 
Figure B.34: 13C NMR of BODIPY 8c in CD2Cl2 (100 MHz) 
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Figure B.35: 1H NMR of BODIPY 8d in CDCl3 (400 MHz) 
 
 
 
 
Figure B.36: 13C NMR of BODIPY 8d in CDCl3 (100 MHz) 
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Figure B.37: 1H NMR of BODIPY 8e in CD2Cl2 (400 MHz) 
 
 
 
 
Figure B.38: 13C NMR of BODIPY 8e in CD2Cl2 (100 MHz) 
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Figure B.39: 1H NMR of BODIPY 8f in CD2Cl2 (400 MHz) 
 
 
 
 
Figure B.40: 13C NMR of BODIPY 8f in CD2Cl2 (100 MHz) 
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Figure B.41: 1H NMR of BODIPY 8g in CD2Cl2 (400 MHz) 
 
 
 
 
Figure B.42: 13C NMR of BODIPY 8g in CD2Cl2 (100 MHz) 
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Figure B.43: 1H NMR of BODIPY 4 in CDCl3 (400 MHz) 
 
 
 
 
Figure B.44: 13C NMR of BODIPY 4 in CDCl3 (100 MHz) 
 
 
 
192 
 
 
 
Figure B.45: 1H NMR of BODIPY 9 in CDCl3 (400 MHz) 
 
 
 
 
Figure B.46: 13C NMR of BODIPY 9 in CDCl3 (100 MHz) 
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Figure B.47: 11B NMR of BODIPY 1a in CDCl3 (128 MHz) 
 
 
 
 
 
Figure B.48: 11B NMR of BODIPY 2a in CDCl3 (128 MHz) 
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Figure B.49: 11B NMR of BODIPY 3a in CDCl3 (128 MHz) 
 
 
 
 
 
Figure B.50: 11B NMR of BODIPY 4a in CDCl3 (128 MHz) 
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Figure B.51: 11B NMR of BODIPY 5a in CDCl3 (128 MHz) 
 
 
 
 
 
Figure B.52: 11B NMR of BODIPY 7a in CDCl3 (128 MHz) 
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Figure B.53: 11B NMR of BODIPY 7b in CDCl3 (128 MHz) 
 
 
 
 
 
Figure B.54: 11B NMR of BODIPY 7c in CDCl3 (128 MHz) 
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Figure B.55: 11B NMR of BODIPY 7d in CDCl3 (128 MHz) 
 
 
 
 
 
Figure B.56: 11B NMR of BODIPY 7e in CDCl3 (128 MHz) 
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Figure B.57: 11B NMR of BODIPY 7f in CDCl3 (128 MHz) 
 
 
 
 
 
Figure B.58: 11B NMR of BODIPY 7g in CDCl3 (128 MHz) 
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Figure B.59: 11B NMR of BODIPY 8a in CDCl3 (128 MHz) 
 
 
 
 
 
Figure B.60: 11B NMR of BODIPY 8b in CDCl3 (128 MHz) 
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Figure B.61: 11B NMR of BODIPY 8c in CDCl3 (128 MHz) 
 
 
 
 
 
Figure B.62: 11B NMR of BODIPY 8d in CDCl3 (128 MHz) 
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Figure B.63: 11B NMR of BODIPY 8e in CDCl3 (128 MHz) 
 
 
 
 
 
Figure B.64: 11B NMR of BODIPY 8f in CDCl3 (128 MHz) 
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Figure B.65: 11B NMR of BODIPY 8g in CDCl3 (128 MHz) 
 
 
 
 
 
Figure B.66: 11B NMR of BODIPY 4 in CDCl3 (128 MHz) 
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Figure B.67: 11B NMR of BODIPY 9 in CDCl3 (128 MHz) 
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APPENDIX C: NMR Characterization of Compounds Found in Chapter 4 
 
 
Figure C.1: 1H NMR of BODIPY 1 in CDCl3 (400 MHz) 
 
 
 
 
Figure C.2: 13C NMR of BODIPY 1 in CDCl3 (100 MHz) 
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Figure C.3: 1H NMR of BODIPY 2 in CDCl3 (400 MHz) 
 
 
 
 
 
Figure C.4: 13C NMR of BODIPY 2 in CDCl3 (100 MHz) 
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Figure C.5: 1H NMR of BODIPY 3a in CDCl3 (400 MHz) 
 
 
 
 
 
Figure C.6: 13C NMR of BODIPY 3a in CDCl3 (100 MHz) 
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Figure C.7: 1H NMR of BODIPY 3b in acetone (400 MHz) 
 
 
 
 
 
Figure C.8: 13C NMR of BODIPY 3b in acetone (100 MHz) 
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Figure C.9: 1H NMR of BODIPY 4a in CDCl3 (400 MHz) 
 
 
 
 
 
Figure C.10: 13C NMR of BODIPY 4a in CDCl3 (100 MHz) 
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Figure C.11: 1H NMR of BODIPY 4b in acetone (400 MHz) 
 
 
 
 
 
Figure C.12: 13C NMR of BODIPY 4b in acetone (100 MHz) 
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Figure C.13: 1H NMR of BODIPY 4c in acetone (400 MHz) 
 
 
 
 
 
Figure C.14: 13C NMR of BODIPY 4c in CDCl3 (100 MHz) 
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Figure C.15: 1H NMR of BODIPY 5a in CDCl3 (400 MHz) 
 
 
 
 
 
Figure C.16: 13C NMR of BODIPY 5a in CDCl3 (100 MHz) 
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Figure C.17: 1H NMR of BODIPY 6a in acetone (400 MHz) 
 
 
 
 
 
Figure C.18: 13C NMR of BODIPY 6a in acetone (100 MHz) 
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Figure C.19: 1H NMR of BODIPY 7 in acetone (400 MHz) 
 
 
 
 
 
Figure C.20: 13C NMR of BODIPY 7 in CDCl3 (100 MHz) 
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Figure C.21: 1H NMR of BODIPY 8a in CDCl3 (400 MHz)  
 
 
 
 
 
Figure C.22: 1H NMR of BODIPY 8b in CDCl3 (400 MHz) 
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Figure C.23: 13C NMR of BODIPY 8b in CDCl3 (100 MHz)  
 
 
 
 
 
Figure C.24: 1H NMR of BODIPY 9 in CDCl3 (400 MHz) 
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Figure C.25: 1H NMR of BODIPY 10 in CDCl3 (400 MHz) 
 
 
 
 
 
Figure C.26: 1H NMR of BODIPY 11a in CDCl3 (400 MHz) 
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Figure C.27: 13C NMR of BODIPY 11a in CDCl3 (100 MHz) 
 
 
 
 
 
Figure C.28: 1H NMR of BODIPY 11b in CDCl3 (400 MHz) 
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Figure C.29: 13C NMR of BODIPY 11b in CDCl3 (100 MHz) 
 
 
 
 
 
Figure C.30: 1H NMR of BODIPY 12 in CDCl3 (400 MHz) 
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Figure C.31: 13C NMR of BODIPY 12 in CDCl3 (100 MHz) 
 
 
 
 
 
Figure C.32: 11B NMR of BODIPY 1 in CDCl3 (128 MHz) 
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Figure C.33: 11B NMR of BODIPY 2 in CDCl3 (128 MHz) 
 
 
 
 
 
Figure C.34: 11B NMR of BODIPY 3a in CDCl3 (128 MHz) 
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Figure C.35: 11B NMR of BODIPY 3b in CDCl3 (128 MHz) 
 
 
 
 
 
Figure C.36: 11B NMR of BODIPY 4a in CDCl3 (128 MHz) 
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Figure C.37: 11B NMR of BODIPY 4b in CDCl3 (128 MHz) 
 
 
 
 
 
Figure C.38: 11B NMR of BODIPY 4c in CDCl3 (128 MHz) 
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Figure C.39: 11B NMR of BODIPY 5a in CDCl3 (128 MHz) 
 
 
 
 
 
Figure C.40: 11B NMR of BODIPY 6a in ((CD3)2CO (128 MHz) 
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Figure C.41: 11B NMR of BODIPY 7 in CDCl3 (128 MHz) 
 
 
 
 
 
Figure C.42: 11B NMR of BODIPY 8a in CDCl3 (128 MHz) 
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Figure C.43: 11B NMR of BODIPY 8b in CDCl3 (128 MHz) 
 
 
 
 
 
Figure C.44: 11B NMR of BODIPY 9 in CDCl3 (128 MHz) 
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Figure C.45: 11B NMR of BODIPY 10 in CDCl3 (128 MHz) 
 
 
 
 
 
Figure C.46: 11B NMR of BODIPY 11a in CDCl3 (128 MHz) 
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Figure C.47: 11B NMR of BODIPY 11b in CDCl3 (128 MHz) 
 
 
 
 
 
Figure C.48: 11B NMR of BODIPY 12 in CDCl3 (128 MHz) 
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APPENDIX D: NMR Characterization of Compounds Found in Chapter 5 
 
 
Figure D.1: 1H NMR of compound 4 in CDCl3 (250 MHz) 
 
 
 
 
 
Figure D.2: 1H NMR of compound 4a in CDCl3 (250 MHz) 
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Figure D.3: 13C NMR of compound 4a in CDCl3 (62.5 MHz) 
 
 
 
 
 
Figure D.4: 1H NMR of compound 5a in CDCl3 (250 MHz) 
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Figure D.5: 13C NMR of compound 5a in CDCl3 (62.5 MHz) 
 
 
 
 
 
Figure D.6: 1H NMR of compound 6a in CDCl3 (250 MHz) 
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Figure D.7: 13C NMR of compound 6a in CDCl3 (62.5 MHz) 
 
 
 
 
 
Figure D.8: 1H NMR of compound 7a in CDCl3 (250 MHz) 
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Figure D.9: 13C NMR of compound 7a in CDCl3 (62.5 MHz) 
 
 
 
 
 
Figure D.10: 1H NMR of compound 8 in CDCl3 (250 MHz) 
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Figure D.11: 13C NMR of compound 8 in CDCl3 (62.5 MHz) 
 
 
 
 
 
Figure D.12: 1H NMR of compound 14 in CDCl3 (250 MHz) 
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Figure D.13: 1H NMR of compound 15 in CDCl3 (250 MHz) 
 
 
 
 
 
Figure D.14: 1H NMR of compound 16 in CDCl3 (250 MHz) 
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Figure D.15: 1H NMR of compound 17 in CDCl3 (250 MHz) 
 
 
 
 
 
Figure D.16: 1H NMR of compound 18 in CDCl3 (250 MHz) 
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Figure D.17: 13C NMR of compound 18 in CDCl3 (62.5 MHz) 
 
 
 
 
 
Figure D.18: 1H NMR of compound 19 in CDCl3 (250 MHz) 
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